Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3014133	s-koirhie	— (—)	3010	3090	100.00%	Distribution not available
3014133	s-koirhie	u/ml (u/ml)	2727	2896	2.45%
3014133	koira,hils	— (—)	568	599	100.00%	Distribution not available
3014133	igekoira	u/ml (—)	225	240	100.00%	Distribution not available
3014133	koirae	u/ml (—)	171	188	100.00%	Distribution not available
3014133	koira,hils	u/ml (u/ml)	163	165	0.00%
3014133	s-koiranhilse,igevasta-aineet	u/ml (—)	127	130	100.00%	Distribution not available
3014133	s-allige,koira(hilse)/hund(mjäll)osa	u/ml (—)	51	52	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

1002

2663

3.85

321.96

1.1

1.0

8.14

3.48

u/ml

6.11

580

971

Asthma and allergy

682

887

8.29

307.65

1.1

1.0

9.76

3.81

u/ml

3.94

464

312

Asthma, hospital admissions , main diagnosis only

1908

4728

3.72

307.65

1.1

1.0

7.03

3.19

u/ml

9.09

1068

1654

Asthma

1945

2286

4.70

307.65

1.1

1.0

6.81

3.15

u/ml

5.78

1059

720

Asthma, hospital admission 2, infections

1155

3149

3.70

307.65

1.1

1.0

7.64

3.31

u/ml

6.59

666

1117

Pollen allergy

1064

1759

6.64

307.65

1.1

7.46

3.34

u/ml

4.48

597

686

Allergic asthma (mode)

937

1436

6.80

307.65

1.1

1.0

8.62

3.59

u/ml

5.07

619

478

Asthma, excluding more controls

1935

2267

4.69

307.65

1.1

1.0

6.84

3.19

u/ml

5.67

1053

711

Asthma (only as main-diagnosis)

1823

2286

4.96

307.65

1.1

1.0

6.83

3.15

u/ml

5.67

1008

720

Asthma, including avohilmo

2808

4008

4.19

307.65

1.1

1.0

6.69

2.41

u/ml

14.83

1418

1343

Allergic rhinitis

1370

2489

5.86

307.65

1.1

7.43

3.37

u/ml

5.91

766

913

Asthma/COPD (KELA code 203)

1986

4210

3.40

307.65

1.1

1.0

7.30

2.63

u/ml

11.90

1056

1416

Asthma-related infections

1155

3149

3.70

307.65

1.1

1.0

7.64

3.31

u/ml

6.59

666

1117

Asthma and allergy, excluding more controls

682

900

8.17

307.65

1.1

1.0

9.76

3.83

u/ml

3.98

464

317

Asthma (diagnoses ohter than nonallergic)

1959

4615

3.73

307.65

1.1

1.0

7.08

3.07

u/ml

10.16

1106

1595

Asthma (only as main-diagnosis), excluding more controls

1821

2267

4.94

307.65

1.1

1.0

6.84

3.19

u/ml

5.52

1007

711

Vasomotor and allergic rhinitis

1452

2555

5.94

307.65

1.1

1.0

7.27

4.05

u/ml

3.91

794

922

Allergic asthma (mode), excluding more controls

937

1434

6.80

307.65

1.1

1.0

8.62

3.58

u/ml

5.09

619

479

Chronic lower respiratory diseases

2554

4252

3.32

307.65

1.1

1.0

6.72

2.68

u/ml

12.16

1327

1430

Asthma (mode)

1939

2294

4.78

307.65

1.1

1.0

6.76

3.16

u/ml

5.65

1061

722

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1209

3983

3.07

271.22

1.1

5.20

4.29

u/ml

0.77

613

1460

Allergic conjunctivitis

1248

4222

2.99

267.67

1.1

5.15

4.51

u/ml

0.48

636

1567

Asthma, unspecified (mode)

883

1884

3.79

262.73

1.1

1.0

5.02

3.38

u/ml

1.12

415

602

Asthma, unspecified (mode), excluding more controls

882

1876

3.77

259.37

1.1

1.0

5.03

3.42

u/ml

1.09

414

598

Conjunctivitis

1469

4959

2.64

243.35

1.1

5.38

4.71

u/ml

0.46

733

1903

Atopic dermatitis

1318

4168

2.77

237.79

1.1

9.07

3.29

u/ml

9.89

697

1550

Chronic sinusitis

755

2097

3.69

229.93

1.1

1.0

3.05

4.02

u/ml

0.68

336

699

Other diseases of upper respiratory tract

1659

3418

2.57

228.37

1.1

1.0

5.24

3.93

u/ml

1.31

766

1211

Disorders of conjunctiva

1495

5046

2.53

225.82

1.1

5.30

4.65

u/ml

0.45

746

1936

Desensitization to allergens

337

532

7.24

209.11

1.1

1.0

6.38

4.30

u/ml

0.89

194

218

Dermatitis and eczema

1721

4996

2.29

198.71

1.1

7.76

3.10

u/ml

9.07

843

1856

Chronic rhinitis, nasopharyngitis and pharyngitis

569

1549

3.77

179.04

1.1

1.0

4.72

4.14

u/ml

0.18

250

546

Atopic dermatitis, strict definition with reimbursement

829

2757

3.02

178.98

1.1

11.21

3.37

u/ml

10.08

495

1059

Obesity related asthma

517

1371

3.87

168.90

1.1

1.0

6.76

2.27

u/ml

3.38

267

422

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

732

2420

3.01

161.34

1.1

1.0

3.15

3.95

u/ml

0.60

319

819

Suggestive for eosinophilic asthma

204

249

8.62

156.08

1.2

1.0

3.97

2.10

u/ml

0.84

137

Other pulmonary diagnosis

1158

2325

2.53

153.10

1.1

1.0

3.97

3.21

u/ml

0.58

509

739

COPD differential diagnosis

1139

2294

2.52

149.63

1.1

1.0

3.98

3.16

u/ml

0.62

503

722

ILD differential diagnosis

1139

2294

2.52

149.62

1.1

1.0

3.98

3.16

u/ml

0.62

503

722

Nasal polyp

305

597

5.26

147.09

1.2

1.0

4.02

3.34

u/ml

0.24

173

206

Excluding asthma or asthma-COPD overlap

1141

2325

2.49

146.45

1.1

1.0

3.98

3.21

u/ml

0.58

503

739

Atopic dermatitis, strict definition

792

2982

2.69

138.44

1.1

11.77

3.77

u/ml

9.67

472

1191

ILD medications: prednisolone, methylprednisolone, prednisone

1596

4551

2.00

127.61

1.1

6.34

3.86

u/ml

3.38

758

1682

Oral corticosteroids

1483

4448

2.04

126.67

1.1

1.0

6.35

3.66

u/ml

3.74

719

1618

Childhood asthma (age<16), excluding more controls

446

1008

3.66

123.95

1.1

1.0

10.52

3.91

u/ml

4.52

291

376

Childhood asthma (age<16)

446

1010

3.65

123.68

1.1

1.0

10.52

3.89

u/ml

4.56

291

378

Undetermined asthma

226

414

5.63

117.38

1.1

1.0

4.06

2.10

u/ml

0.84

110

135

Undetermined asthma, excluding more controls

226

415

5.62

117.08

1.1

1.0

4.06

2.11

u/ml

0.83

110

134

Diseases of the respiratory system

857

1701

2.55

116.13

1.1

1.0

3.79

2.33

u/ml

1.88

358

522

ILD medications

1609

4818

1.85

101.70

1.1

6.21

4.12

u/ml

2.68

774

1825

Asthma, hospital admissions 3, pneumonia

408

1305

3.17

99.24

1.1

1.0

6.96

2.87

u/ml

2.71

251

444

Asthma-related pneumonia or sepsis

408

1305

3.17

99.24

1.1

1.0

6.96

2.87

u/ml

2.71

251

444

Asthma-related pneumonia

406

1299

3.17

98.72

1.1

1.0

6.80

2.88

u/ml

2.54

250

442

FESS (DNB20)

267

653

4.25

98.47

1.2

1.0

2.04

3.69

u/ml

1.41

137

246

Cough

569

2110

2.63

96.97

1.1

4.23

4.98

u/ml

0.31

254

850

Ethmoidectomy

270

679

4.13

95.86

1.2

1.0

2.02

3.59

u/ml

1.36

139

254

Deviated nasal septum

377

1197

3.20

93.03

1.1

1.0

3.16

3.70

u/ml

0.26

162

404

Abnormalities of breathing

1350

4292

1.89

92.53

1.1

4.20

4.97

u/ml

0.63

585

1698

Inflammatory bowel disease treatment related agents

1556

4947

1.80

91.41

1.1

6.27

4.00

u/ml

2.93

736

1861

Chronic diseases of tonsils and adenoids

1047

3370

1.99

84.56

1.1

1.0

4.49

3.97

u/ml

0.34

436

1194

First line medication for Crohn's disease

1534

4772

1.77

83.88

1.1

6.14

4.02

u/ml

2.65

727

1821

Childhood allergy (age < 16)

518

1731

2.57

78.77

1.1

10.92

4.65

u/ml

5.02

325

747

Symptoms and signs involving the circulatory and respiratory systems

1504

4342

1.75

78.00

1.1

4.54

4.96

u/ml

0.28

631

1718

Acute upper respiratory infections

1271

4676

1.72

64.87

1.1

5.42

4.27

u/ml

0.95

562

1813

Biological medicines for asthma

12.59

62.81

1.2

1.0

10.13

3.41

u/ml

1.38

Dermatitis due to ingested food

174

428

4.28

61.30

1.1

11.92

3.00

u/ml

4.81

118

201

Other medical care

393

1637

2.37

54.57

1.1

6.02

3.47

u/ml

1.59

208

629

Adverse effects, not elsewhere classified

353

1454

2.49

53.77

1.1

7.65

4.66

u/ml

1.42

199

592

Bronchitis

1274

5238

1.61

51.14

1.1

5.80

4.17

u/ml

1.39

578

2020

1312

4337

1.61

50.60

1.1

5.37

3.95

u/ml

1.37

575

1632

Acute upper respiratory infections of multiple and unspecified sites

992

4423

1.70

50.25

1.1

5.66

4.40

u/ml

0.87

445

1721

Dyspnoea

928

4158

1.72

50.14

1.1

3.83

4.54

u/ml

0.58

416

1591

Diseases of the skin and subcutaneous tissue

1259

3987

1.59

46.35

1.1

1.0

6.85

3.13

u/ml

4.36

579

1454

Asthma mixed form (mode)

176

5.33

44.83

1.2

1.0

6.95

2.80

u/ml

0.93

Asthma mixed form (mode), excluding more controls

176

5.33

44.82

1.2

1.0

6.95

2.83

u/ml

0.91

Acute sinusitis

714

3794

1.77

44.03

1.1

4.34

4.36

u/ml

0.01

318

1456

Urticaria

463

2315

2.03

43.67

1.1

4.24

5.05

u/ml

0.42

229

938

D07AA Corticosteroids, weak (group I)

313

1351

2.37

43.05

1.1

14.01

4.54

u/ml

4.17

200

570

Diseases of the eye and adnexa

1237

3976

1.57

42.69

1.1

5.34

4.72

u/ml

0.32

571

1509

Any reimbursement code in KELA

1044

3262

1.62

40.78

1.1

1.0

7.19

2.77

u/ml

4.95

503

1138

Urticaria and erythema

511

2709

1.91

40.55

1.1

4.63

4.96

u/ml

0.15

251

1091

Non-allergic asthma (mode), excluding more controls

197

700

2.82

39.47

1.1

1.0

4.17

4.37

u/ml

0.04

233

Non-allergic asthma (mode)

197

702

2.82

39.27

1.1

1.0

4.17

4.35

u/ml

0.03

234

Personal history of allergy to drugs, medicaments and biological substances

9.54

37.75

1.4

1.0

1.42

3.80

u/ml

0.43

Sleep apnoea, including avohilmo

953

3895

1.60

37.65

1.1

4.47

4.08

u/ml

0.18

380

1480

Chronic laryngitis and laryngotracheitis

136

412

3.35

36.70

1.1

1.0

3.20

3.00

u/ml

0.06

134

Other and unspecified effects of external causes

419

2203

1.93

34.30

1.1

7.02

4.87

u/ml

1.07

221

911

Other acute lower respiratory infections

587

3283

1.72

33.03

1.1

7.54

4.37

u/ml

1.85

299

1368

COPD/asthma related infections

1217

4134

1.48

32.59

1.1

1.0

5.40

3.99

u/ml

1.24

523

1570

COPD/asthma/ILD related infections

1217

4134

1.48

32.59

1.1

1.0

5.40

3.99

u/ml

1.24

523

1570

Migraine, single triptan purchase ok & required. ICD-code if available is included

1045

4718

1.51

32.45

1.1

5.34

4.53

u/ml

0.33

390

1908

Triptan medication for migraine, single purchase ok

1045

4718

1.51

32.45

1.1

5.34

4.53

u/ml

0.33

390

1908

Early onset COPD, excluding more controls

133

428

3.13

32.41

1.1

1.0

6.90

2.43

u/ml

1.50

124

Voice disturbances

268

1257

2.16

30.12

1.1

1.0

5.52

3.51

u/ml

0.30

109

458

Bronchiectasis

100

5.69

30.05

1.1

1.0

4.38

3.42

u/ml

0.09

Polypectomy (DHB20)

225

3.96

29.93

1.2

1.0

1.62

2.82

u/ml

0.67

Asthma and opportunity respiratory infection

6.64

28.63

1.2

1.0

4.52

0.98

u/ml

0.51

Dermatitis

543

3266

1.67

27.98

1.1

4.65

2.96

u/ml

1.36

248

1188

Gastro-oesophageal reflux disease

631

3476

1.62

27.95

1.1

3.71

4.51

u/ml

0.25

247

1325

Recurrent or chronic depression

558

2413

1.69

27.87

1.1

5.93

4.07

u/ml

0.84

213

957

Sleep apnoea

827

3705

1.52

26.91

1.1

4.91

3.99

u/ml

0.44

328

1400

Migraine

711

3945

1.55

25.67

1.1

6.40

4.53

u/ml

0.64

271

1566

Malignant neoplasm

382

3943

0.57

25.13

1.0

1.1

3.13

4.05

u/ml

0.58

128

1520

Symptoms and signs involving speech and voice

288

1489

1.95

24.83

1.1

5.71

3.40

u/ml

0.40

120

543

Episodal and paroxysmal disorders

1326

4946

1.38

24.43

1.1

5.77

4.51

u/ml

0.69

540

2030

Acute bronchitis

391

2192

1.76

24.26

1.1

7.00

4.49

u/ml

0.87

187

886

Diabetes, insulin treatment (Kela reimbursement)

450

4530

0.60

23.82

1.1

3.64

4.28

u/ml

0.37

198

1762

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

419

4135

0.60

23.49

1.0

1.1

3.22

4.20

u/ml

0.60

140

1605

Malignant neoplasm, wide definition for exclusion

419

4135

0.60

23.49

1.0

1.1

3.22

4.20

u/ml

0.60

140

1605

Depression or dysthymia

741

2735

1.52

23.49

1.1

5.85

3.98

u/ml

0.77

301

1091

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

420

4139

0.60

23.41

1.0

1.1

3.22

4.20

u/ml

0.60

140

1608

Headache

802

4574

1.47

23.21

1.1

4.50

4.39

u/ml

0.05

318

1836

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

446

4440

0.61

22.72

1.1

3.67

4.24

u/ml

0.32

196

1724

Pain in joint

670

2922

1.53

22.16

1.1

5.52

4.09

u/ml

0.76

288

1173

Coxibs

303

847

1.92

21.93

1.1

6.06

4.61

u/ml

0.21

119

383

Allergic contact dermatitis

176

803

2.23

21.47

1.1

6.71

2.33

u/ml

1.72

268

Diabetes medication

548

5101

0.65

21.10

1.1

3.93

4.31

u/ml

0.20

236

1980

Any event in cancer register

482

4500

0.63

21.07

1.0

1.1

3.30

4.39

u/ml

0.67

160

1756

Diabetes, varying definitions

562

5107

0.65

20.88

1.1

4.31

u/ml

0.00

241

1979

Dermatographic urticaria

116

446

2.67

20.85

1.1

5.05

3.38

u/ml

0.54

161

Diabetes mellitus

570

5148

0.66

20.68

1.1

4.24

4.31

u/ml

0.03

247

1992

Other and unspecified urticaria

265

1428

1.88

20.39

1.1

3.83

4.55

u/ml

0.32

129

559

Special screening examination for infectious and parasitic diseases

435

1996

1.65

20.13

1.1

1.0

4.08

4.49

u/ml

0.18

172

752

COPD

172

649

2.19

19.90

1.1

1.0

6.79

1.49

u/ml

2.38

196

Sleep disorders (combined)

963

4548

1.39

19.90

1.1

4.55

4.46

u/ml

0.04

388

1776

Abnormal findings on diagnostic imaging of lung

249

1288

1.89

19.75

1.1

1.0

4.49

3.15

u/ml

0.69

116

483

Other chronic obstructive pulmonary disease

161

607

2.21

19.09

1.1

1.0

7.09

1.48

u/ml

2.39

185

Conjunctivitis (acute, non atopic)

317

1838

1.74

18.82

1.1

8.23

5.25

u/ml

0.66

155

749

Other and unspecified dermatitis

430

2706

1.60

18.72

1.1

4.44

2.97

u/ml

1.05

199

997

Atopic conjunctivitis

268

3.08

18.67

1.1

7.52

4.80

u/ml

0.49

106

Tonsillectomy and adenotomy

901

4542

1.39

18.53

1.1

5.02

4.69

u/ml

0.18

378

1874

Acetic acid derivatives and related substances

284

818

1.82

17.58

1.1

2.90

4.71

u/ml

1.40

110

369

Renal tubulo-interstitial diseases

377

4566

0.63

17.25

1.1

5.68

4.80

u/ml

0.35

166

1817

Irritable bowel syndrome

303

1792

1.71

17.00

1.1

4.12

4.61

u/ml

0.14

124

694

Propionic acid derivatives

342

1015

1.70

16.84

1.1

4.17

4.95

u/ml

0.36

137

481

Temporomandibular joint disorders, including avohilmo

558

3806

1.48

16.76

1.1

4.11

5.06

u/ml

0.54

247

1484

Pain (limb, back, neck, head abdominally)

852

3080

1.39

16.71

1.1

5.36

4.27

u/ml

0.68

360

1275

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

537

1784

1.52

16.55

1.1

1.0

4.11

4.25

u/ml

0.06

215

723

Triptan medication for migraine, min. 3 purchases

761

4329

1.40

16.41

1.1

5.09

4.74

u/ml

0.09

277

1677

Type 2 diabetes

494

4352

0.67

16.34

1.1

4.21

4.06

u/ml

0.06

212

1632

Eosinophilic disease (BM)

7.02

16.26

1.2

1.0

6.97

1.12

u/ml

—

Other special examinations and investigations of persons without complaint or reported diagnosis

759

2732

1.41

16.24

1.1

1.0

4.26

4.72

u/ml

0.32

332

1031

Anxiety disorders

1019

5461

1.33

15.81

1.1

4.30

4.61

u/ml

0.17

427

2163

Neurotic, stress-related and somatoform disorders

1014

5452

1.33

15.72

1.1

4.28

4.63

u/ml

0.20

423

2161

Schizophrenia

1135

0.23

15.36

1.0

1.1

5.80

3.60

u/ml

—

465

Other (not insulin) diabetes medications

443

3984

0.67

15.14

1.1

3.80

4.05

u/ml

0.10

182

1480

Abnormalities of heart beat

290

1737

1.66

14.99

1.1

3.68

4.90

u/ml

0.61

121

672

Anxiety disorders, excluding more controls

930

4633

1.34

14.95

1.1

4.53

4.26

u/ml

0.14

387

1796

Idiopathic urticaria

126

3.82

14.91

1.2

1.1

4.16

6.20

u/ml

0.26

Medical observation and evaluation for suspected diseases and conditions

740

2732

1.39

14.76

1.1

1.0

5.35

4.72

u/ml

0.22

340

1031

Schizophrenia, schizotypal and delusional disorders

116

2411

0.48

14.52

1.1

2.30

4.41

u/ml

1.82

961

Schizophrenia or delusion

116

2409

0.48

14.49

1.1

2.30

4.41

u/ml

1.82

959

Type 2 diabetes, strict (exclude DM1)

446

3922

0.68

14.29

1.1

4.13

3.92

u/ml

0.08

186

1453

Biguanides

418

3839

0.67

14.28

1.1

3.62

4.12

u/ml

0.22

171

1433

Anti-inflammatory and antirheumatic products, non-steroids

330

1016

1.64

14.26

1.1

4.40

4.94

u/ml

0.22

128

482

Disorders of lacrimal system

330

2088

1.59

14.21

1.1

5.19

4.08

u/ml

0.37

129

773

Neurological diseases

1113

4320

1.30

14.19

1.1

5.34

4.71

u/ml

0.29

479

1782

Other disorders of lacrimal gland

273

1653

1.66

14.09

1.1

4.75

3.71

u/ml

0.34

108

615

Type 2 diabetes, definitions combined

447

3913

0.68

14.03

1.1

4.11

3.90

u/ml

0.08

187

1450

Exposure to unspecified factor

989

5897

1.31

13.90

1.1

5.51

4.55

u/ml

0.70

443

2361

Simple and mucopurulent chronic bronchitis

4.52

13.79

1.1

0.47

4.00

u/ml

—

Other bacterial diseases

436

4405

0.68

13.62

1.1

7.11

4.24

u/ml

1.80

188

1770

Temporomandibular joint disorders

196

1099

1.80

13.43

1.1

1.0

2.53

4.03

u/ml

0.71

413

Type 2 diabetes, definitions combined, including avohilmo

467

3981

0.69

13.27

1.1

4.14

3.90

u/ml

0.10

195

1474

Parasetamol

995

3912

1.30

12.86

1.1

3.88

4.62

u/ml

0.37

408

1567

Schizophrenia or delusion, excluding more controls

116

2281

0.50

12.68

1.1

2.30

3.81

u/ml

1.25

899

All anxiety disorders

793

4832

1.33

12.63

1.1

3.74

4.77

u/ml

0.91

335

1919

Abdominal and pelvic pain

1082

4251

1.28

12.48

1.1

4.38

4.70

u/ml

0.20

454

1736

Pain in throat and chest

817

3779

1.33

12.42

1.1

4.42

4.79

u/ml

0.21

326

1462

Insulin medication

216

3057

0.60

12.37

1.1

3.12

4.45

u/ml

0.89

105

1251

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

1238

0.37

12.33

1.0

1.1

0.51

3.22

u/ml

8.00

483

Other headache syndromes

422

2908

1.46

12.24

1.1

4.87

4.08

u/ml

0.25

167

1101

Dental caries 2, only avohilmo

887

5404

1.30

12.15

1.1

3.89

4.91

u/ml

1.03

379

2147

Oxicams

173

529

1.87

12.13

1.1

1.00

4.20

u/ml

4.04

226

Pain and other conditions associated with female genital organs and menstrual cycle

302

1868

1.57

12.09

1.1

1.98

5.88

u/ml

6.13

109

757

Symptoms and signs involving the digestive system and abdomen

1081

4252

1.28

12.06

1.1

4.32

4.70

u/ml

0.24

445

1737

Paracetamol of NSAID medication

247

740

1.69

12.05

1.1

4.51

5.04

u/ml

0.18

368

Diseases of the musculoskeletal system and connective tissue

805

3057

1.33

11.85

1.1

5.74

4.88

u/ml

0.31

350

1277

Other dorsopathies, not elsewhere classified

1117

4667

1.27

11.72

1.1

5.05

4.49

u/ml

0.26

461

1863

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

378

2377

1.48

11.71

1.1

4.23

3.85

u/ml

0.17

167

899

Diseases of middle ear and mastoid

723

4477

1.33

11.70

1.1

3.80

5.18

u/ml

1.40

326

1861

Early onset COPD

133

690

1.94

11.66

1.1

1.0

6.90

3.37

u/ml

1.10

260

ILD, hospital admissions 1, main diag only

246

2.62

11.58

1.0

1.1

3.50

2.64

u/ml

0.21

100

Eosinophilia

4.98

11.53

1.2

1.0

6.97

2.04

u/ml

—

Haemorrhage from respiratory passages

185

987

1.75

11.49

1.1

1.0

5.84

3.65

u/ml

0.60

380

Dental caries 2

890

5447

1.29

11.46

1.1

3.86

4.99

u/ml

1.19

380

2169

Low back pain

727

4253

1.32

11.25

1.1

4.10

4.31

u/ml

0.06

285

1673

Other and unspecified nonorganic psychotic disorders

1729

0.46

11.13

1.1

2.40

4.51

u/ml

1.24

708

ILD, hospital admissions

275

2.49

11.10

1.0

1.1

3.50

2.57

u/ml

0.24

113

Other interstitial pulmonary diseases

275

2.49

11.10

1.0

1.1

3.50

2.59

u/ml

0.23

112

Kela-code for severe mental illness

156

2715

0.57

11.07

1.1

2.05

4.37

u/ml

2.93

1080

Parodontitis or/and operation codes

343

2998

0.68

11.07

1.0

1.1

4.44

3.68

u/ml

0.34

146

1174

Interstitial lung disease

276

2.48

11.02

1.0

1.1

3.50

2.57

u/ml

0.24

113

Interstitial lung disease endpoints

276

2.48

11.02

1.0

1.1

3.50

2.57

u/ml

0.24

113

Type 2 diabetes, wide definition

272

2718

0.65

10.92

1.1

3.46

3.58

u/ml

0.05

126

1000

Dental caries 2 and operation codes

872

5425

1.28

10.81

1.1

3.56

5.02

u/ml

1.94

371

2158

Other respiratory diseases principally affecting the interstitium

346

2.30

10.81

1.0

1.1

3.32

2.25

u/ml

0.37

140

Anxiety (asthma-related co-morbidities)

766

4653

1.30

10.80

1.1

3.63

4.38

u/ml

0.63

320

1828

Migraine with aura

314

2098

1.51

10.78

1.1

6.54

4.52

u/ml

0.54

132

833

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

156

1772

0.57

10.73

1.0

1.1

4.34

3.54

u/ml

0.28

612

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

156

1772

0.57

10.73

1.0

1.1

4.34

3.54

u/ml

0.28

612

Codeine

1013

4413

1.27

10.69

1.1

4.44

4.64

u/ml

0.09

420

1689

Other diseases of hard tissues of teeth

646

3628

1.33

10.60

1.1

3.24

5.10

u/ml

2.81

294

1397

Other antidepressants

1020

4226

1.26

10.51

1.1

4.28

4.43

u/ml

0.08

413

1678

Bronchitis, not specified as acute or chronic

281

2.41

10.17

1.1

1.0

6.30

1.38

u/ml

1.49

Acute bronchiolitis

140

700

1.84

10.01

1.1

11.28

5.83

u/ml

1.30

357

Codeine or tramadol medication

1108

4955

1.24

10.00

1.1

4.33

4.53

u/ml

0.09

447

1894

Dorsopathies

1152

4761

1.24

9.98

1.1

5.02

4.57

u/ml

0.21

472

1917

Fenamates

134

485

1.88

9.95

1.1

1.98

4.42

u/ml

1.57

201

Soft tissue disorders related to use, overuse and pressure

190

1154

1.66

9.86

1.1

3.21

3.37

u/ml

0.05

414

Heartburn

494

2.03

9.83

1.0

1.1

2.94

3.53

u/ml

0.13

198

Exfoliative dermatitis

7.05

9.80

1.1

1.0

22.80

1.55

u/ml

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

152

2571

0.59

9.76

1.1

4.89

4.23

u/ml

0.16

1007

Vocal cord dysfunction

147

779

1.77

9.54

1.2

1.1

3.37

4.31

u/ml

0.33

279

Neurological diseases, wide definition

530

1959

1.37

9.52

1.1

6.30

4.50

u/ml

0.50

222

866

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

249

2.26

9.48

1.0

3.32

4.30

u/ml

0.24

Opioids

1083

4605

1.24

9.46

1.1

4.24

4.62

u/ml

0.20

450

1779

Alcohol use disorder, ICD-based

140

2399

0.58

9.44

1.1

4.31

4.37

u/ml

0.01

942

Acute pharyngitis

209

1308

1.60

9.43

1.1

4.03

4.95

u/ml

0.38

575

Malignant neoplasm of breast

153

1857

0.59

9.40

1.0

1.1

4.11

3.44

u/ml

0.24

628

Insulin, combination of fast acting with intermediate-acting or long-acting

216

3071

0.65

9.27

1.1

3.12

4.43

u/ml

0.87

105

1255

Migraine with aura and triptan purchases

217

1388

1.58

9.23

1.1

7.29

4.29

u/ml

0.62

554

Parodontitis

413

4172

0.73

9.11

1.1

3.92

4.01

u/ml

0.04

175

1577

Selective serotonin reuptake inhibitors

1010

4292

1.24

9.11

1.1

4.89

4.38

u/ml

0.28

395

1724

Allergic urticaria

109

579

1.91

9.11

1.2

1.1

3.98

4.64

u/ml

0.17

226

Parodontitis or operation codes

414

4174

0.73

9.07

1.1

3.90

4.01

u/ml

0.05

176

1578

Unspecified mental disorder

206

3175

0.65

8.92

1.1

2.03

4.42

u/ml

3.94

100

1271

Cystitis

824

4002

1.26

8.81

1.1

4.60

4.80

u/ml

0.10

304

1584

Chronic periodontitis, including avohilmo

413

4163

0.73

8.79

1.1

3.92

4.00

u/ml

0.03

175

1576

Gastrointestinal diseases

846

3370

1.26

8.71

1.1

5.14

5.19

u/ml

0.01

348

1379

Mouth breathing

328

2305

1.43

8.69

1.1

3.17

4.11

u/ml

0.60

134

948

COPD (mode)

371

2.00

8.66

1.1

1.0

5.89

2.52

u/ml

0.90

113

Dental caries 2 and operation codes, only avohilmo

760

3725

1.27

8.61

1.1

3.85

4.69

u/ml

0.69

326

1525

Polyarthropathies

364

3361

0.72

8.57

1.1

4.75

4.33

u/ml

0.15

140

1280

Other joint disorders

1078

4702

1.22

8.57

1.1

4.79

4.78

u/ml

0.01

456

1893

STROKE

198

2129

0.64

8.55

1.1

2.74

3.61

u/ml

0.51

775

Substance abuse

269

3730

0.69

8.55

1.1

6.43

4.23

u/ml

0.93

135

1467

Suppurative and unspecified otitis media

515

3458

1.33

8.52

1.1

4.39

5.36

u/ml

0.62

244

1478

Alcohol dependence

1287

0.46

8.44

1.1

1.63

3.47

u/ml

2.45

501

Cerebrovascular diseases

177

2007

0.63

8.43

1.1

3.91

3.14

u/ml

0.30

766

Depression medications

567

2170

1.32

8.31

1.1

4.73

5.12

u/ml

0.14

225

887

Alcohol use disorder, Swedish definition

220

3060

0.66

8.28

1.1

5.30

4.01

u/ml

0.47

102

1201

Myalgia

226

1495

1.52

8.26

1.1

3.68

4.69

u/ml

0.33

575

Persons encountering health services for examination and investigation

697

2732

1.28

8.24

1.1

1.0

3.87

4.72

u/ml

0.61

284

1031

Soft tissue disorders

1147

4928

1.21

8.22

1.1

4.20

5.03

u/ml

0.69

472

2032

Substance abuse, excluding more controls

269

3370

0.70

7.93

1.1

6.43

3.94

u/ml

1.14

135

1308

Other chronic obstructive pulmonary disease, including avohilmo

217

1186

1.53

7.92

1.1

1.0

6.40

3.16

u/ml

1.42

111

446

Mental and behavioural disorders due to psychoactive substance use

287

3825

0.71

7.87

1.1

6.71

4.15

u/ml

1.19

139

1502

Other specific joint derangements/joint disorders

838

4544

1.24

7.86

1.1

4.87

4.69

u/ml

0.08

348

1812

Diseases of the ear and mastoid process

1243

5266

1.20

7.82

1.1

4.29

4.81

u/ml

0.41

529

2086

Disorders of synovium and tendon

474

3236

1.32

7.81

1.0

1.1

3.38

4.59

u/ml

0.74

189

1251

Dorsalgia

1031

4599

1.22

7.80

1.1

5.00

4.36

u/ml

0.28

425

1822

Dentofacial anomalies [including malocclusion]

326

2316

1.40

7.75

1.1

5.50

5.69

u/ml

0.03

149

910

Other menopausal disorders

224

848

1.53

7.73

1.0

1.1

2.09

4.45

u/ml

1.73

282

Metabolic disorders

499

4039

0.77

7.69

1.1

3.75

4.32

u/ml

0.34

216

1551

280

3536

0.71

7.60

1.1

6.05

4.10

u/ml

0.84

132

1402

Lichen simplex chronicus and prurigo

193

2.46

7.59

1.1

1.0

3.90

2.12

u/ml

0.38

Urticaria due to cold and heat

4.43

7.58

1.2

1.0

11.16

4.55

u/ml

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

211

1406

1.51

7.54

1.1

5.32

5.29

u/ml

0.01

547

256

3357

0.70

7.50

1.1

6.23

4.18

u/ml

0.81

120

1331

Insulin, intermediate and long-acting

190

2809

0.66

7.45

1.1

3.34

4.04

u/ml

0.35

1146

Malignant neoplasm of breast, HER2-negative

151

1764

0.63

7.45

1.0

1.1

4.11

3.28

u/ml

0.31

593

Autoimmune diseases excluding thyroid diseases, strict definition

751

5182

0.81

7.44

1.1

4.14

4.94

u/ml

0.57

299

2153

Organic, including symptomatic, mental disorders

753

0.44

7.43

1.0

1.1

1.14

2.76

u/ml

1.63

291

Other and unspecified tonsillitis

463

2991

1.32

7.40

1.1

5.13

4.65

u/ml

0.20

201

1237

Autoimmune diseases excluding thyroid diseases

767

5255

0.81

7.38

1.1

4.07

4.92

u/ml

0.62

306

2178

Stroke, including SAH

121

1495

0.60

7.33

1.1

3.55

3.29

u/ml

0.07

572

Other anxiety disorders

578

4035

1.28

7.21

1.1

4.19

5.02

u/ml

0.48

248

1629

Depression

966

5512

1.21

7.19

1.1

6.19

4.17

u/ml

1.00

405

2171

COPD, hospital admissions

160

851

1.60

7.17

1.1

1.0

7.16

2.91

u/ml

1.50

319

Hard cardiovascular diseases

247

2271

0.70

7.16

1.1

4.72

3.64

u/ml

0.39

854

COPD, early/later onset

161

857

1.59

7.12

1.1

1.0

7.09

2.92

u/ml

1.48

320

Renal failure

1118

0.50

7.10

1.0

1.1

5.01

3.87

u/ml

0.21

462

Acute tubulo-interstitial nephritis

274

3396

0.71

7.08

1.1

5.64

4.76

u/ml

0.27

118

1366

Mental and behavioural disorders due to alcohol

225

3151

0.69

6.95

1.1

6.31

4.18

u/ml

0.78

109

1248

Heart failure, not strict

226

2249

0.69

6.90

1.1

3.47

4.01

u/ml

0.23

101

865

Parodontitis and operation codes

398

4062

0.76

6.72

1.1

4.06

3.97

u/ml

0.04

168

1538

Unspecified chronic bronchitis

3.91

6.71

1.2

1.0

14.02

0.84

u/ml

—

Somatoform disorder

158

1015

1.57

6.71

1.1

2.72

4.54

u/ml

0.89

386

Cerebrovascular diseases (FINNGEN)

126

1452

0.62

6.64

1.1

5.53

3.58

u/ml

0.62

515

Examination and observation for other reasons

565

2707

1.27

6.62

1.1

1.0

3.98

4.69

u/ml

0.43

226

1017

Hypertrophy of breast in women and men

186

1244

1.51

6.57

1.1

6.94

3.55

u/ml

0.47

451

Disorders of eyelid, lacrimal system and orbit

641

4048

1.25

6.49

1.1

5.43

4.25

u/ml

0.62

254

1584

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

1018

0.53

6.46

1.0

4.75

3.22

u/ml

0.32

404

Cervicocranial syndrome

512

1.79

6.43

1.1

1.65

3.48

u/ml

1.18

190

Symptoms and signs involving the skin and subcutaneous tissue

564

4481

1.26

6.36

1.1

5.15

4.51

u/ml

0.29

229

1757

Mood [affective] disorders

999

5526

1.19

6.36

1.1

6.06

4.19

u/ml

0.94

417

2179

Occupational exposure to risk-factors

125

2.69

6.35

1.2

1.0

3.92

3.22

u/ml

0.08

Acute suppurative otitis media

409

2934

1.31

6.32

1.1

4.60

5.43

u/ml

0.46

195

1273

Vasomotor rhinitis (mode)

303

2.04

6.30

1.1

3.45

3.53

u/ml

0.02

115

ILD, hospital admission 2, with pulmonary infections

149

2.50

6.26

1.0

1.1

4.21

3.67

u/ml

0.07

Mood disorders

998

5527

1.19

6.19

1.1

6.06

4.19

u/ml

0.94

417

2180

Otalgia

484

1.80

6.13

1.2

1.1

5.97

5.26

u/ml

0.11

201

Disorders of lipoprotein metabolism and other lipidaemias

311

2625

0.74

6.08

1.1

4.06

3.64

u/ml

0.17

136

954

Enthesopathies of lower limb, excluding foot

181

1225

1.49

6.06

1.1

2.97

3.61

u/ml

0.30

448

Allergic colitis

303

2.04

6.05

1.1

9.34

7.14

u/ml

0.27

152

Later onset COPD, excluding more controls

2.97

6.00

1.0

8.67

0.34

u/ml

—

Other diseases of urinary system

955

4519

1.19

5.96

1.1

4.41

4.75

u/ml

0.21

378

1812

Schizoaffective disorder

544

0.33

5.84

1.0

1.1

4.84

3.74

u/ml

0.15

208

TMD related operations

168

1130

1.50

5.84

1.1

3.05

3.99

u/ml

0.31

419

Inflammatory diseases of prostate (prostatitis)

361

1.89

5.81

1.0

1.1

0.87

3.77

u/ml

2.52

154

Nummular dermatitis

238

2.12

5.80

1.1

1.0

6.96

2.10

u/ml

0.62

Coronary revascularization (ANGIO or CABG)

772

0.52

5.77

1.0

2.15

3.41

u/ml

0.46

292

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

615

5121

0.81

5.77

1.1

3.45

4.70

u/ml

1.13

247

2060

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1074

5219

1.18

5.76

1.1

5.12

4.32

u/ml

0.40

457

2088

Stroke, excluding SAH

111

1320

0.62

5.75

1.1

1.0

3.48

3.04

u/ml

0.13

506

Inflammatory diseases of female pelvic organs

630

3871

1.23

5.74

1.1

4.36

4.89

u/ml

0.26

241

1459

Infective dermatitis

435

1.81

5.72

1.1

4.88

2.01

u/ml

0.82

135

Pruritus

487

1.76

5.70

1.1

1.0

1.19

1.79

u/ml

0.50

156

Restless leg syndrome

480

1.76

5.68

1.1

2.99

3.12

u/ml

0.03

179

Acute and transient psychotic disorders

781

0.44

5.68

1.1

3.41

3.85

u/ml

0.07

303

Sub-endpoint used in defining T1D endpoints

136

2030

0.66

5.67

1.1

3.67

4.42

u/ml

0.31

871

Emergency coronary revascularization (for ACS)

818

0.53

5.67

1.0

1.89

3.34

u/ml

0.65

317

Ischaemic Stroke, excluding all haemorrhages

1204

0.61

5.62

1.1

1.0

3.09

2.98

u/ml

0.03

462

Disturbances of skin sensation

261

1914

1.37

5.62

1.1

4.41

4.40

u/ml

0.00

106

733

Dislocation, sprain and strain of joints and ligaments of knee

613

4652

1.23

5.62

1.1

4.87

4.46

u/ml

0.16

259

1788

Dermatitis due to substances taken internally

255

2.06

5.61

1.1

1.0

12.57

2.10

u/ml

1.94

Hypertrophy of breast

168

1140

1.48

5.61

1.1

7.18

3.75

u/ml

0.39

405

Peritonsillar abscess

181

1246

1.46

5.59

1.1

1.0

4.00

4.35

u/ml

0.09

456

Female infertility, cervigal, vaginal, other or unspecified origin

341

1732

1.33

5.55

1.1

7.94

5.74

u/ml

0.32

113

678

Intestinal infectious diseases

887

5834

1.19

5.54

1.1

5.38

4.65

u/ml

0.39

386

2355

Functional dyspepsia

196

1372

1.44

5.54

1.1

3.55

3.64

u/ml

0.02

507

Trochanteric bursitis

506

1.73

5.54

1.0

0.97

3.27

u/ml

2.99

169

Type 1 diabetes

136

2049

0.66

5.53

1.1

3.67

4.72

u/ml

0.47

875

Other inflammation of eyelid

591

1.67

5.47

1.1

10.45

3.35

u/ml

1.32

219

Dysphagia

130

839

1.56

5.47

1.1

1.0

5.12

3.17

u/ml

0.72

314

Exposure to other specified factors

709

5529

1.21

5.45

1.1

4.94

4.64

u/ml

0.15

329

2203

Other degenerative diseases of the nervous system

767

0.52

5.36

1.0

1.50

3.02

u/ml

1.01

280

Allergic contact dermatitis due to drugs in contact with skin

2.97

5.34

1.0

14.82

2.24

u/ml

—

Generalized anxiety disorder

206

1469

1.41

5.31

1.1

2.30

4.82

u/ml

2.90

615

Migraine without aura

264

1960

1.36

5.31

1.1

6.59

4.41

u/ml

0.30

102

796

Chronic gastritis

114

721

1.59

5.24

1.1

1.0

2.35

3.72

u/ml

0.49

257

Diseases of oesophagus, stomach and duodenum

937

4844

1.18

5.23

1.1

3.88

4.48

u/ml

0.27

383

1892

Acute appendicitis, no complications

549

4465

1.23

5.22

1.1

4.01

4.29

u/ml

0.12

213

1721

Emphysema

3.06

5.21

1.2

1.0

2.23

1.70

u/ml

—

Follow-up examination after treatment for conditions other than malignant neoplasms

415

2134

1.28

5.20

1.1

1.0

6.43

4.50

u/ml

0.78

157

765

Condition for Implicit Sepsis (Organ dysfunction codes)

437

3974

0.80

5.11

1.1

4.69

4.58

u/ml

0.04

186

1596

Non-invasive ventilation

188

1246

1.42

5.09

1.1

3.10

4.43

u/ml

0.71

119

471

Internal derangement of knee

315

2407

1.31

5.07

1.1

4.02

3.98

u/ml

0.01

128

890

Subjective visual disturbances

181

1272

1.43

5.06

1.1

3.21

3.92

u/ml

0.24

494

Chondrocostal junction syndrome [Tietze]

153

2.32

5.05

1.0

1.1

5.91

8.06

u/ml

0.21

General symptoms and signs

1140

4946

1.16

4.96

1.1

5.50

4.33

u/ml

0.65

457

1999

Migraine without aura and triptan purchases

208

1505

1.39

4.96

1.1

7.51

4.51

u/ml

0.31

603

Glucagon-like peptide-1 (GLP-1) analogues

114

1436

0.65

4.94

1.0

1.33

3.13

u/ml

2.92

545

Disorders of skin appendages

465

3752

1.24

4.90

1.1

7.05

4.44

u/ml

0.68

183

1543

Lower back pain or/and sciatica

912

5412

1.17

4.90

1.1

4.79

4.38

u/ml

0.15

353

2129

Type 1 diabetes, wide definition, subgroup 1

119

1792

0.66

4.89

1.1

3.86

4.11

u/ml

0.08

767

Other soft tissue disorders, not elsewhere classified

898

4735

1.17

4.88

1.1

4.24

5.08

u/ml

0.59

358

1940

Injuries to the wrist and hand

938

5833

1.17

4.88

1.1

5.06

4.47

u/ml

0.33

423

2307

Exclusions for E4_PCOS_CONSORTIUM

560

4264

0.82

4.88

1.0

1.1

3.73

4.97

u/ml

0.74

195

1688

COPD, hospital admission 2, with asthma infections

102

543

1.61

4.87

1.1

1.0

5.31

3.04

u/ml

0.61

214

Other diseases of oesophagus

262

1.96

4.86

1.1

1.0

4.28

2.82

u/ml

0.30

Type 1 diabetes, wide definition

125

1861

0.67

4.85

1.1

4.73

4.33

u/ml

0.12

799

Benign neoplasm: Liver/bile ducts

113

2.53

4.83

1.0

1.37

3.22

u/ml

0.92

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

445

1.72

4.80

1.1

9.86

4.39

u/ml

0.81

171

Other contact dermatitis

393

1.77

4.80

1.1

10.29

2.05

u/ml

1.27

122

Non-allergic asthma

320

1.86

4.80

1.1

1.0

1.64

2.23

u/ml

0.20

112

Hypermobility syndrome

469

1.71

4.79

1.1

1.50

4.59

u/ml

2.37

170

Persons encountering health services for specific procedures and health care

1024

5480

1.16

4.77

1.1

5.02

4.57

u/ml

0.26

487

2150

Diseases of male genital organs

407

1622

1.27

4.76

1.1

3.29

4.27

u/ml

0.57

177

757

Benign neoplasm: Liver/bile ducts

114

2.50

4.75

1.0

1.37

2.93

u/ml

0.80

Other viral diseases

342

2675

1.28

4.67

1.1

5.77

5.30

u/ml

0.15

158

1153

Transplanted organ and tissue status

498

0.38

4.64

1.0

1.1

1.27

5.26

u/ml

—

217

Pain in thoracic spine

126

841

1.51

4.63

1.1

1.0

5.94

3.51

u/ml

0.49

307

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

610

0.44

4.63

1.1

5.67

4.44

u/ml

0.20

248

Embedded and impacted teeth

409

2785

1.26

4.61

1.1

6.07

5.01

u/ml

0.22

177

1211

Other neurological diseases

251

2662

0.76

4.57

1.1

3.85

4.23

u/ml

0.14

112

1032

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

101

1261

0.65

4.53

1.0

1.1

3.14

3.42

u/ml

0.10

423

Other enthesopathies

226

1682

1.35

4.51

1.1

3.22

3.75

u/ml

0.18

598

Diseases of appendix

676

5196

1.19

4.51

1.1

4.39

4.32

u/ml

0.04

262

2006

Any gastric operation

996

4319

1.16

4.51

1.1

4.97

4.92

u/ml

0.02

405

1778

GASTRO-related operations

996

4319

1.16

4.51

1.1

4.97

4.92

u/ml

0.02

405

1778

Spinal osteochondrosis

3.50

4.50

1.1

3.61

2.01

u/ml

—

Benign neoplasm: Liver

105

2.53

4.50

1.0

1.46

3.32

u/ml

0.80

Hypertensive diseases

528

3624

0.82

4.49

1.1

4.53

4.26

u/ml

0.11

216

1354

Recurring oral aphthae, including avohilmo

112

735

1.53

4.48

1.1

3.00

4.28

u/ml

0.50

298

Female infertility

372

1816

1.27

4.47

1.1

7.83

5.71

u/ml

0.35

130

720

Pure hypercholesterolaemia

242

2150

0.75

4.47

1.1

3.81

3.41

u/ml

0.15

116

790

Cervicalgia

140

962

1.46

4.46

1.1

1.0

3.20

3.35

u/ml

0.03

348

Ocular pain

501

1.65

4.46

1.1

4.44

3.70

u/ml

0.14

184

Insulin, fast-acting

160

2240

0.71

4.44

1.1

3.29

4.36

u/ml

0.58

942

Arthropathies

1071

4746

1.15

4.39

1.1

4.63

4.78

u/ml

0.07

453

1921

Hypertension

529

3619

0.83

4.37

1.1

4.58

4.27

u/ml

0.12

217

1350

Appendicitis, broad definition

671

5189

1.18

4.36

1.1

4.41

4.31

u/ml

0.04

261

2002

Insulin, fast-acting or short human

160

2232

0.71

4.35

1.1

3.29

4.22

u/ml

0.49

936

Benign neoplasm: Liver

107

2.48

4.34

1.0

1.46

2.92

u/ml

0.64

Oesophagitis

164

2.15

4.32

1.1

1.0

1.10

2.90

u/ml

0.90

Substance use, excluding alcohol

1464

0.65

4.24

1.1

9.21

3.70

u/ml

1.23

583

Endometriosis of pelvic peritoneum

176

1258

1.39

4.22

1.1

1.64

5.05

u/ml

3.78

475

Heart failure,strict

992

0.64

4.22

1.1

1.0

3.24

3.37

u/ml

0.03

398

Peripheral artery disease

700

0.55

4.19

1.0

1.04

2.60

u/ml

1.56

269

Valvular heart disease excluding rheumatic fever

128

1351

0.69

4.16

1.1

1.91

4.57

u/ml

3.33

544

Accidents

882

3811

1.16

4.13

1.1

6.16

4.13

u/ml

1.07

388

1458

Spondylolisthesis/Spondylolysis

113

757

1.50

4.12

1.0

2.48

3.24

u/ml

0.35

277

Type 1 diabetes, strict (exclude DM2)

1143

0.61

4.10

1.1

2.81

4.96

u/ml

1.44

499

Prurigo nodularis

3.12

4.10

1.0

2.69

0.77

u/ml

—

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

141

1364

0.70

4.07

1.0

1.1

1.90

2.97

u/ml

0.66

520

Acute appendicitis

636

5095

1.18

4.00

1.1

4.27

4.19

u/ml

0.04

247

1966

Disorders of the thyroid gland

832

4704

1.16

3.94

1.1

3.11

4.91

u/ml

2.29

299

1869

Visual disturbances

338

2706

1.25

3.94

1.1

5.94

4.69

u/ml

0.24

159

1103

Preparation and fitting of bite rail to mouth

131

914

1.44

3.93

1.1

2.09

3.50

u/ml

0.67

337

Heart failure, strict

999

0.65

3.93

1.1

1.0

3.15

3.22

u/ml

0.01

401

Coronary angioplasty

624

0.55

3.90

1.0

0.64

3.84

u/ml

4.06

239

Non-rheumatic valve diseases

125

1306

0.70

3.89

1.1

1.93

4.32

u/ml

2.79

516

Cervical disc disorders

209

1577

1.33

3.86

1.1

1.0

4.39

3.31

u/ml

0.40

555

Septicaemia

112

1563

0.69

3.85

1.1

9.52

4.09

u/ml

1.25

646

Olecranon bursitis

179

2.03

3.84

1.1

7.03

3.24

u/ml

0.44

Mood disorders, excluding more controls

876

4635

1.15

3.83

1.1

6.04

4.18

u/ml

0.90

364

1793

Atypical facial pain

221

1.92

3.83

1.1

1.91

3.39

u/ml

0.65

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

3.12

3.83

1.3

1.0

2.29

2.10

u/ml

—

Struck by thrown, projected or falling objec

286

1.80

3.83

1.1

2.98

4.42

u/ml

0.36

111

L04AD Calcineurin inhibitors

659

0.51

3.83

1.0

1.1

8.92

5.06

u/ml

0.30

286

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

426

0.40

3.79

1.0

1.1

—

2.99

u/ml

—

164

Acute renal failure

482

0.43

3.78

1.0

1.1

1.83

3.14

u/ml

0.58

191

Bleeding

360

3226

0.81

3.76

1.1

5.28

4.40

u/ml

0.35

155

1288

Visual disturbances and blindness

353

2857

1.24

3.75

1.1

5.99

4.55

u/ml

0.31

168

1174

Transport accidents

452

3322

1.21

3.74

1.1

5.54

4.15

u/ml

0.49

200

1280

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

280

2210

1.27

3.73

1.1

3.97

4.43

u/ml

0.18

134

882

Lichen simplex chronicus

115

2.29

3.72

1.1

1.0

5.09

1.81

u/ml

0.36

Any dementia, excluding more controls

294

0.40

3.68

1.0

1.1

0.16

1.83

u/ml

—

112

Type 1 diabetes, definitions combined

1145

0.64

3.64

1.1

4.45

4.85

u/ml

0.09

499

Other noninfective gastroenteritis and colitis

201

1523

1.32

3.63

1.1

5.20

5.00

u/ml

0.05

648

Type 1 diabetes, strict definition, subgroup 1

985

0.61

3.63

1.1

2.98

4.80

u/ml

0.95

444

Heart failure and antihypertensive medication

659

0.61

3.62

1.1

4.39

3.00

u/ml

0.23

245

Persons encountering health services in other circumstances, wide

1138

5238

1.13

3.61

1.1

5.32

4.31

u/ml

0.58

493

2095

Adenomyosis (Endometriosis of uterus)

609

1.52

3.61

1.1

4.39

4.86

u/ml

0.07

207

Other acute skin changes due to ultraviolet radiation

104

2.33

3.60

1.1

1.0

2.54

3.71

u/ml

0.25

Hypothyroidism, other/unspecified

778

4455

1.15

3.60

1.1

3.17

4.98

u/ml

2.06

277

1761

Drug-induced adrenocortical insufficiency

2.70

3.59

1.1

1.0

2.08

2.64

u/ml

—

Seborrhoeic dermatitis

344

1.70

3.59

1.1

1.0

2.28

1.76

u/ml

0.26

116

Other otitis externa (chronic)

307

1.74

3.58

1.0

2.14

3.70

u/ml

0.68

124

Deep bite

150

953

1.39

3.58

1.1

6.61

5.44

u/ml

0.17

456

Other disorders of patella

170

1262

1.35

3.57

1.1

4.16

3.42

u/ml

0.17

455

Other noninflammatory disorders of vagina

406

1.64

3.57

1.1

1.69

5.03

u/ml

1.69

142

Implicit Sepsis

320

3080

0.81

3.56

1.1

5.65

4.46

u/ml

0.45

140

1237

Acute laryngitis and tracheitis

172

1260

1.35

3.56

1.1

6.02

5.11

u/ml

0.23

560

Keratitis

269

2125

1.27

3.56

1.1

9.22

4.15

u/ml

1.09

123

825

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

607

5083

0.85

3.56

1.1

4.29

4.46

u/ml

0.07

259

2014

Reimbursement for rheumatic diseases

286

3567

0.80

3.56

1.0

1.1

2.74

4.69

u/ml

1.81

113

1397

Disorders of gallbladder, biliary tract and pancreas

541

4113

0.85

3.54

1.1

4.00

4.03

u/ml

0.01

193

1555

Use of disulfiram, acamprosate or naltrexone

494

0.46

3.53

1.0

1.1

2.64

3.24

u/ml

0.16

190

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

534

3686

1.19

3.52

1.1

3.74

4.74

u/ml

0.58

188

1378

Other congenital malformations of skin

287

1.77

3.51

1.1

20.89

6.20

u/ml

0.71

125

Any dementia

292

0.41

3.51

1.0

0.16

2.02

u/ml

—

120

Major coronary heart disease event

168

1504

0.74

3.51

1.1

1.0

4.77

3.09

u/ml

0.52

579

Other disorders of penis

455

1.59

3.49

1.1

7.95

4.41

u/ml

0.48

232

614

1.49

3.48

1.1

1.0

2.52

2.68

u/ml

0.04

241

Finngen Rheumatological endpoints

771

5047

0.87

3.48

1.1

3.47

4.79

u/ml

1.44

310

1974

Provisional assignment of new diseases of uncertain etiology

413

3426

1.21

3.48

1.1

3.65

5.13

u/ml

1.01

189

1391

Dementia, including avohilmo

389

0.50

3.47

1.0

0.90

2.02

u/ml

0.62

161

Unspecified acute lower respiratory infection

117

820

1.43

3.47

1.1

7.44

3.44

u/ml

1.47

326

Diseases of external ear

233

1815

1.29

3.47

1.1

4.56

4.52

u/ml

0.01

106

732

Codes for special purposes

413

3428

1.21

3.46

1.1

3.65

5.12

u/ml

1.00

189

1393

Persons encountering health services in other circumstances

346

2823

1.23

3.43

1.1

6.66

4.48

u/ml

0.98

140

1170

Sulfonylureas

478

0.52

3.42

1.0

1.1

4.56

2.49

u/ml

0.29

182

Bacterial Sepsis

111

1403

0.70

3.42

1.0

1.1

8.08

3.71

u/ml

0.85

568

Other and unspecified rosacea

388

1.64

3.40

1.1

1.0

5.17

2.91

u/ml

0.40

128

Leiomyoma of uterus

315

2196

0.81

3.40

1.0

1.1

4.07

3.93

u/ml

0.04

104

769

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

507

2778

1.19

3.39

1.1

4.70

5.48

u/ml

0.31

210

1065

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

189

1.93

3.37

1.0

1.1

3.55

4.73

u/ml

0.20

Dementia

357

0.48

3.36

1.0

0.90

2.05

u/ml

0.61

145

Erysipelas

178

2138

0.76

3.36

1.1

6.90

3.20

u/ml

1.58

818

Coronary artery bypass grafting

319

0.43

3.36

1.0

4.44

3.09

u/ml

—

124

All-cause Heart Failure

965

0.68

3.35

1.1

1.0

3.15

3.25

u/ml

0.02

390

Gluteal tendinitis

141

2.08

3.33

1.0

1.1

2.35

1.46

u/ml

0.33

Type 1 diabetes, strict definition

1036

0.64

3.33

1.1

4.78

4.82

u/ml

0.01

469

Panic disorder

187

1426

1.32

3.31

1.1

4.18

4.56

u/ml

0.10

580

COPD, hospital admissions 1, only main diagnosis

100

582

1.47

3.30

1.1

4.41

2.93

u/ml

0.43

226

Dislocation, sprain and strain of joints and ligaments at neck level

166

1245

1.34

3.30

1.1

3.78

4.15

u/ml

0.13

494

Other disorders of cornea

376

1.63

3.29

1.1

15.24

2.66

u/ml

0.64

137

Suicide or other Intentional self-harm

145

1955

0.74

3.29

1.1

5.20

4.61

u/ml

0.16

777

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

496

0.59

3.28

1.0

1.1

1.05

2.77

u/ml

1.79

209

Other general symptoms and signs

396

1.62

3.28

1.1

2.46

6.52

u/ml

1.71

183

Otitis externa

176

1332

1.33

3.27

1.1

4.19

4.24

u/ml

0.01

529

Blepharochalasis

100

688

1.46

3.27

1.0

4.44

2.63

u/ml

0.29

237

Other intervertebral disc disorders

664

3511

1.16

3.26

1.1

3.87

3.77

u/ml

0.05

268

1344

Hypothyreosis and Thyroxine purchase for inclusion criteria

790

4565

1.14

3.25

1.1

3.15

4.92

u/ml

2.04

279

1796

Other external causes of accidental injury

866

3811

1.14

3.24

1.1

6.39

4.13

u/ml

1.22

389

1458

Striking against or struck by other objects

313

2546

1.23

3.23

1.1

6.87

4.97

u/ml

0.40

119

1105

Injuries to the ankle and foot

716

5692

1.15

3.23

1.1

6.90

4.50

u/ml

0.96

307

2297

Idiopathic pulmonary fibrosis

2.39

3.22

1.1

1.0

5.21

1.10

u/ml

0.53

Correction of physiology of bite - very demanding therapy visit

171

1.96

3.22

1.1

1.0

0.81

4.37

u/ml

2.40

Anomalies of dental arch relationship, including avohilmo

242

1720

1.27

3.19

1.1

5.56

4.90

u/ml

0.15

120

751

External causes of morbidity and mortality

748

3264

1.15

3.19

1.1

6.20

4.03

u/ml

0.98

328

1259

Lichen planus

396

1.60

3.15

1.1

1.25

2.92

u/ml

1.57

144

Nephropathy related operations

486

0.49

3.15

1.0

1.1

0.52

4.19

u/ml

5.13

207

Short Achilles tendon (acquired)

111

2.19

3.14

1.0

0.67

3.92

u/ml

1.43

Dialysis, with operation codes

499

0.50

3.14

1.0

1.1

0.99

4.26

u/ml

3.20

215

Diarrhoea and gastroenteritis of presumed infectious origin

648

5114

1.15

3.14

1.1

4.02

4.75

u/ml

0.58

291

2081

Diseases of arteries, arterioles and capillaries

178

1733

0.76

3.12

1.0

1.1

3.91

3.30

u/ml

0.17

667

Hypothyroidism, strict autoimmune

674

3877

1.15

3.12

1.1

3.44

4.98

u/ml

1.34

245

1535

Other disorders of eyelid

165

1203

1.33

3.11

1.1

1.0

4.21

2.80

u/ml

0.45

445

Other extrapyramidal and movement disorders in other diseases

118

846

1.40

3.11

1.1

4.80

3.43

u/ml

0.27

321

Nonsuppurative otitis media

314

2217

1.23

3.10

1.1

4.03

5.98

u/ml

1.37

149

985

Disorders of sclera, cornea, iris and ciliary body

412

3462

1.19

3.07

1.1

6.86

4.05

u/ml

0.84

187

1358

Atrial fibrillation and flutter

136

1200

0.74

3.05

1.0

4.41

3.40

u/ml

0.31

428

Ovarian cyst

389

1871

1.21

3.03

1.1

2.94

5.58

u/ml

2.53

156

743

malignant neoplasm of male genital organs

504

0.60

3.03

1.0

1.1

0.71

2.82

u/ml

2.80

206

Other and unspecified drugs and medicaments

385

1.60

3.03

1.1

1.0

9.81

4.17

u/ml

0.67

141

General examination and investigation of persons without complaint and reported diagnosis

596

2732

1.16

3.02

1.1

1.0

4.68

4.72

u/ml

0.01

249

1031

Other and unspecified vaccines and biological substances

3.11

3.02

1.3

1.1

11.23

5.62

u/ml

—

Injury of muscle and tendon at shoulder and upper arm level

164

1245

1.32

3.01

1.1

1.0

2.29

3.46

u/ml

0.57

456

Fibromyalgia

555

1.49

2.98

1.1

1.0

1.43

3.67

u/ml

2.24

196

Pleural plaque

2.55

2.95

1.1

5.00

0.49

u/ml

—

Excessive attrition of teeth

409

1858

1.20

2.95

1.1

3.46

4.92

u/ml

1.26

191

715

Other disorders of eye and adnexa

119

864

1.38

2.95

1.1

5.86

4.01

u/ml

0.35

337

Mental and behavioural disorders due to cannabinoids

293

0.37

2.95

1.1

10.79

5.05

u/ml

—

125

Dislocation, sprain and strain of joint and ligaments of hip

2.29

2.94

1.2

1.0

8.35

2.28

u/ml

—

Rosacea

581

1.47

2.94

1.1

6.49

2.99

u/ml

0.84

207

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

105

1458

0.72

2.94

1.1

5.64

4.82

u/ml

0.17

588

Other obstetric conditions, not elsewhere classified

507

2819

1.17

2.93

1.1

4.75

5.46

u/ml

0.27

208

1071

Other septicaemia

1352

0.71

2.92

1.1

9.57

3.95

u/ml

1.18

570

Tinnitus

137

1018

1.35

2.92

1.1

1.90

3.75

u/ml

1.36

386

Mental retardation, wide definition

403

0.46

2.92

1.2

1.1

4.46

6.21

u/ml

—

206

Other disorders of bone

172

1322

1.31

2.91

1.1

3.60

4.22

u/ml

0.21

512

Bruxism

115

2.13

2.91

1.1

1.07

2.51

u/ml

—

Other and unspecified disorders of vitreous body

154

1158

1.33

2.91

1.0

2.06

3.16

u/ml

0.45

400

Presence of cardiac and vascular implants and grafts

822

0.67

2.91

1.0

4.08

3.34

u/ml

0.13

331

Ganglion

182

1410

1.30

2.90

1.0

1.1

4.49

4.70

u/ml

0.04

524

Any operation in hilmo

229

1.57

2.89

1.1

1.0

4.15

3.57

u/ml

0.09

COPD related to multimorbidity

100

592

1.42

2.89

1.1

1.0

9.34

2.82

u/ml

1.49

226

Other diseases of the respiratory system

485

1.51

2.88

1.1

4.91

4.12

u/ml

0.13

205

Other respiratory disorders and diseases

485

1.51

2.88

1.1

4.91

4.12

u/ml

0.13

205

Seropositive rheumatoid arthritis, strict definition

624

0.57

2.86

1.1

0.72

3.22

u/ml

3.31

219

Other abnormal products of conception

430

2425

1.19

2.85

1.1

5.94

5.01

u/ml

0.31

158

881

Benign neoplasm: Colon, unspecified

535

1.48

2.85

1.1

1.0

2.18

2.72

u/ml

0.14

203

Impacted teeth

293

2238

1.23

2.85

1.1

4.92

5.62

u/ml

0.24

124

986

Other disorders of adrenal gland

245

1.73

2.84

1.1

2.12

5.53

u/ml

1.82

101

Appendectomy

601

5044

1.15

2.84

1.1

4.61

4.39

u/ml

0.09

233

1952

COPD-related respiratory insufficiency

164

1.90

2.84

1.1

1.0

3.97

2.02

u/ml

0.42

Combinations of oral blood glucose lowering drugs

859

0.64

2.84

1.0

5.51

3.06

u/ml

0.24

315

Diaphragmatic hernia

157

1197

1.31

2.82

1.1

2.20

3.28

u/ml

0.58

446

Hyperkinetic disorders, excluding more controls

170

1278

1.30

2.81

1.1

7.89

5.01

u/ml

0.47

585

Injury, poisoning and certain other consequences of external causes

626

2729

1.15

2.78

1.1

6.28

3.75

u/ml

1.09

272

1051

Faecal incontinence

224

1.75

2.77

1.1

1.0

0.46

2.98

u/ml

2.53

Intermittent heterotropia

578

0.56

2.77

1.1

17.86

6.55

u/ml

0.38

275

Retinal breaks without detachment

491

1.49

2.75

1.1

1.48

2.65

u/ml

1.10

181

Excessive, frequent and irregular menstruation

440

2079

1.18

2.73

1.1

3.82

5.84

u/ml

1.31

166

850

Separation of retinal layers (serosa)

153

1.91

2.71

1.1

1.22

2.74

u/ml

1.04

Other diseases of stomach and duodenum

160

1.89

2.71

1.1

1.0

4.59

2.44

u/ml

0.44

Chondropathies

134

1007

1.34

2.70

1.0

1.1

3.39

3.55

u/ml

0.04

397

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

296

0.40

2.70

1.2

1.1

1.40

3.84

u/ml

—

124

Chronic kidney disease

710

0.62

2.69

1.0

1.1

6.52

3.31

u/ml

0.51

299

Other disorders of urethra and urinary system

548

3563

1.15

2.69

1.1

4.55

4.38

u/ml

0.07

221

1370

Factors influencing health status and contact with health services

294

1206

1.23

2.69

1.1

1.0

3.92

4.43

u/ml

0.19

125

428

Deforming dorsopathies

207

1648

1.26

2.68

1.0

1.1

4.45

4.37

u/ml

0.02

652

Subacute thyroiditis

161

1.88

2.68

1.0

0.65

3.22

u/ml

—

Mental retardation

389

0.48

2.67

1.2

1.1

4.46

6.35

u/ml

—

200

Other viral hepatitis

482

0.53

2.66

1.2

1.1

4.10

3.78

u/ml

0.04

187

Noninflammatory disorders of female genital tract

511

2213

1.16

2.65

1.1

5.04

5.74

u/ml

0.15

186

919

Mental and behavioural disorders due to opioids

320

0.43

2.64

1.0

1.1

2.14

4.25

u/ml

—

132

Genitourinary diseases

678

2986

1.14

2.64

1.1

3.75

5.03

u/ml

1.19

278

1341

Flat foot [pes planus] (acquired)

415

1.53

2.64

1.1

1.0

1.87

3.82

u/ml

1.01

136

Coronary atherosclerosis

180

1478

0.78

2.63

1.0

4.72

3.08

u/ml

0.54

567

Acute lymphadenitis

448

1.51

2.63

1.1

2.71

4.55

u/ml

0.84

175

Dental operations

484

2131

1.17

2.61

1.0

1.1

3.36

5.09

u/ml

1.36

183

817

Kidney transplant status

277

0.39

2.61

1.0

1.1

2.11

5.67

u/ml

—

122

Statin medication

524

3387

0.87

2.61

1.1

3.08

3.97

u/ml

0.70

189

1301

Iron deficiency

185

1.82

2.60

1.1

0.48

7.66

u/ml

2.95

ILD, hospital admissions 3, with pneumonia sepsis

120

2.01

2.60

1.0

0.75

2.84

u/ml

1.10

Peroneal tendinitis

2.34

2.60

1.0

0.54

3.07

u/ml

—

Continuous positive airway pressure

129

834

1.34

2.60

1.1

3.78

4.88

u/ml

0.37

348

Explicit Sepsis

152

1880

0.77

2.58

1.1

7.44

4.71

u/ml

0.68

781

Redundant prepuce, phimosis and paraphimosis

153

1174

1.30

2.58

1.0

1.1

5.49

4.40

u/ml

0.26

543

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

276

1.65

2.56

1.0

1.1

4.23

4.17

u/ml

0.01

103

Polyarteritis nodosa and related conditions

2.77

2.56

1.1

1.0

1.05

1.07

u/ml

—

Lichen planus, including avohilmo

624

1.42

2.54

1.1

1.11

2.72

u/ml

2.25

220

Other benign neoplasms of uterus

2.23

2.54

1.1

1.0

0.77

1.78

u/ml

—

Dental operations, only avohilmo

509

2252

1.16

2.53

1.0

1.1

3.23

4.80

u/ml

1.32

198

862

Irregular menses

531

3753

1.15

2.53

1.1

3.29

5.16

u/ml

1.55

193

1417

Insulin, fast-acting (human)

1130

0.70

2.53

1.1

3.60

4.15

u/ml

0.15

466

Ischemic heart diseases

279

2112

0.83

2.52

1.1

3.39

3.66

u/ml

0.10

111

777

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

870

0.67

2.51

1.0

5.55

2.66

u/ml

0.58

306

Atherosclerosis, excluding cerebral and coronary sclerosis

542

0.62

2.51

1.0

0.64

2.59

u/ml

2.85

217

Disorders of breast

405

3210

1.17

2.51

1.1

4.89

4.73

u/ml

0.03

139

1183

Leiomyoma of uterus

365

2451

0.85

2.51

1.0

1.1

4.29

3.91

u/ml

0.12

123

849

Herpesviral [herpes simplex] infections

643

1.41

2.51

1.1

13.23

2.91

u/ml

2.73

243

Fracture of femur

515

0.58

2.51

1.0

1.1

5.73

3.40

u/ml

—

212

Abnormal findings in secretions and smears from cervix uteri vagina vulva

505

3447

1.15

2.50

1.1

3.77

4.96

u/ml

0.69

180

1274

Diseases of salivary glands

134

1020

1.32

2.49

1.1

2.37

5.26

u/ml

1.33

353

Other demyelinating diseases of the central nervous system

284

0.42

2.48

1.1

1.0

3.61

2.69

u/ml

—

101

Lichen ruber planus, wide definition including periferal and oral lichen planus

104

763

1.37

2.47

1.1

1.00

3.47

u/ml

3.62

272

Adrenocortical insufficiency

166

1.83

2.46

1.1

1.78

2.78

u/ml

0.50

Haemorrhage in early pregnancy

288

2342

1.20

2.45

1.1

1.0

4.99

4.95

u/ml

0.01

872

Unspecific neurodegenerative disorder

254

0.49

2.44

1.1

1.0

1.49

2.04

u/ml

—

106

Other enthesopathy of foot (+metatarsalgia)

513

1.45

2.44

1.1

2.02

4.00

u/ml

1.13

182

Disorders of choroid and retina

318

2752

0.84

2.44

1.1

2.54

3.72

u/ml

1.10

139

1052

Certain infectious and parasitic diseases

1026

4648

1.11

2.44

1.1

4.81

4.38

u/ml

0.28

416

1876

Pre-eclampsia or poor fetal growth

244

2951

0.82

2.42

1.0

1.1

3.75

4.83

u/ml

0.51

1093

738

4118

1.12

2.42

1.1

1.0

5.35

3.92

u/ml

0.86

351

1562

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

738

4118

1.12

2.42

1.1

1.0

5.35

3.92

u/ml

0.86

351

1562

Oxycodone

1061

0.71

2.40

1.1

1.0

1.46

3.32

u/ml

2.36

407

Other disorders of white blood cells

197

1.74

2.39

1.2

1.0

14.42

3.32

u/ml

0.65

Hypoplasia of dental enamel, prenatal

0.00

2.39

0.0

1.2

—

10.93

—

Viral hepatitis

516

0.58

2.39

1.1

4.10

3.80

u/ml

0.04

197

Hypertensive diseases (excluding secondary)

449

3017

0.86

2.39

1.1

4.47

4.54

u/ml

0.02

186

1147

Demyelinating diseases of the central nervous system

640

0.62

2.38

1.1

1.83

3.30

u/ml

0.76

244

Other spirochaetal diseases

148

1150

1.29

2.38

1.1

3.68

4.04

u/ml

0.08

438

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

168

1.79

2.36

1.0

13.98

3.27

u/ml

—

Gonarthrosis [arthrosis of knee](FG)

362

2502

0.85

2.36

1.1

3.25

3.53

u/ml

0.13

150

863

Glaucoma suspect

136

1046

1.30

2.36

1.1

2.97

3.06

u/ml

0.02

387

Ischaemic heart disease, wide definition

267

2012

0.83

2.35

1.0

1.1

3.59

3.40

u/ml

0.06

104

746

Malaise and fatigue

315

2211

1.19

2.34

1.1

2.98

4.31

u/ml

1.20

138

909

Benign neoplasm: Colon, unspecified

556

1.42

2.34

1.1

2.18

2.81

u/ml

0.17

207

Poisoning by medicine

144

1841

0.78

2.33

1.1

4.98

4.66

u/ml

0.09

744

Postpartum care and examination

164

1321

0.79

2.33

1.1

5.38

6.16

u/ml

0.17

506

Chronic viral hepatitis

422

0.54

2.32

1.1

4.17

3.54

u/ml

0.08

167

Metatarsalgia

469

1.46

2.32

1.1

1.92

3.91

u/ml

1.07

163

Poisoning by drugs, medicaments and biological substances

161

2029

0.79

2.32

1.1

4.86

4.64

u/ml

0.06

811

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

177

1.77

2.32

1.1

10.37

4.68

u/ml

0.38

Second line medication for Crohn's disease

335

3932

0.85

2.31

1.1

5.37

4.69

u/ml

0.20

130

1595

Other symptoms and signs involving the nervous and musculoskeletal systems

311

2627

1.19

2.29

1.1

4.11

4.78

u/ml

0.28

130

1051

TMD related pain

231

1.66

2.28

1.1

1.0

1.88

5.59

u/ml

1.52

Patellar tendinitis

113

1.98

2.27

1.1

3.43

3.12

u/ml

0.05

Other/unspecified synovitis and tenosynovitis

571

1.41

2.27

1.0

1.1

2.33

3.54

u/ml

0.62

217

Hallux rigidus

389

1.50

2.27

1.0

7.59

2.53

u/ml

0.75

125

Major coronary heart disease event excluding revascularizations

147

1294

0.78

2.25

1.1

1.0

5.34

2.97

u/ml

0.70

478

Lateral epicondylitis

717

1.36

2.24

1.1

3.53

3.45

u/ml

0.01

254

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

443

0.56

2.23

1.1

0.39

3.38

u/ml

—

171

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

396

0.64

2.22

1.0

1.1

0.84

3.09

u/ml

2.06

161

Fall on same level

960

5898

0.91

2.21

1.1

6.35

4.40

u/ml

1.14

424

2370

Bacterial infection, other or unspecified

175

1962

0.80

2.21

1.1

7.91

3.76

u/ml

1.01

795

Hypothyroidism, strict autoimmune, 3 medication purchases required

702

4281

1.12

2.21

1.1

3.34

4.89

u/ml

1.45

254

1677

Umbilical hernia

163

1296

1.26

2.20

1.0

1.1

5.08

3.44

u/ml

0.43

490

Candidiasis

702

1.36

2.20

1.2

1.1

4.90

3.40

u/ml

0.26

275

Monoplegia

2.53

2.20

1.0

1.39

2.66

u/ml

—

Benign neoplasm of other and ill-defined parts of digestive system

558

1.40

2.19

1.1

4.05

2.75

u/ml

0.34

203

Implicit bacterial Sepsis

1063

0.73

2.19

1.0

1.1

6.41

3.54

u/ml

0.49

409

MS-disease / Multiple Sclerosis

552

0.61

2.19

1.0

1.1

2.17

3.34

u/ml

0.46

219

Endometriosis

339

1715

1.18

2.18

1.1

2.72

5.10

u/ml

1.95

133

670

Unspecified threat to breathing

2.35

2.17

1.1

2.73

5.51

u/ml

—

Inflammatory disease of uterus

146

1149

1.28

2.17

1.1

3.39

5.19

u/ml

0.56

434

Endometriosis ASRM stages 1,2

178

1434

1.25

2.17

1.1

1.62

4.67

u/ml

2.92

536

Persons encountering health services in circumstances related to reproduction

618

3724

1.13

2.16

1.1

5.36

4.96

u/ml

0.19

257

1553

Single spontaneous delivery

275

1744

0.84

2.15

1.1

4.66

5.07

u/ml

0.13

121

693

Postviral fatigue syndrome

2.27

2.15

1.3

1.0

0.26

3.18

u/ml

—

All influenza

174

1399

1.25

2.14

1.1

3.54

4.46

u/ml

0.43

587

Noninfective enteritis and colitis

379

3270

1.16

2.14

1.1

4.58

4.94

u/ml

0.14

156

1374

Asymmetry of jaw

123

1.91

2.14

1.1

9.88

4.86

u/ml

0.32

Transient ischemic attack

110

1194

0.76

2.13

1.1

1.0

1.46

3.00

u/ml

1.28

449

Menorrhagia

309

1444

1.19

2.13

1.1

3.77

4.90

u/ml

0.48

113

548

Lumbar disc prolapse

460

3197

1.15

2.13

1.1

4.65

3.46

u/ml

0.65

200

1214

All influenza (not pneumonia)

121

933

1.30

2.11

1.1

3.33

4.47

u/ml

0.50

390

Foreign body in alimentary tract

244

1.61

2.10

1.1

1.0

4.77

5.19

u/ml

0.05

109

Pedestrian injured in collision with pedal cycle

138

1.83

2.10

1.0

1.1

5.06

2.87

u/ml

0.19

Symptoms and signs involving the nervous and musculoskeletal systems

398

3457

1.15

2.08

1.1

4.62

4.66

u/ml

0.01

165

1411

Mental retardation, excluding more controls

348

0.53

2.06

1.2

1.1

4.46

7.16

u/ml

—

182

Diseases of oral cavity, salivary glands and jaws

799

3699

1.11

2.06

1.1

2.99

5.08

u/ml

3.75

354

1433

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

116

1031

0.77

2.06

1.1

1.0

2.05

2.90

u/ml

0.41

398

Endometriosis of rectovaginal septum and vagina

399

1.46

2.05

1.1

1.13

3.91

u/ml

1.94

140

Mental and behavioural disorders due to sedatives or hypnotics

430

0.58

2.04

1.1

8.54

3.15

u/ml

0.61

163

Other disorders starting during childhood or adolecense, excluding more controls

663

1.35

2.04

1.1

3.63

6.70

u/ml

1.33

336

Lyme disease

142

1124

1.27

2.02

1.1

3.12

3.96

u/ml

0.21

426

Rheumatoid arthritis

122

1418

0.78

2.01

1.1

3.32

3.48

u/ml

0.03

493

Keratoconus

133

1.83

2.01

1.0

1.1

31.44

2.26

u/ml

0.60

L04AX Other immunosuppressants

323

3749

0.86

1.99

1.0

1.1

5.45

4.70

u/ml

0.23

128

1518

Postmenopausal atrophic vaginitis

121

561

1.30

1.99

1.1

1.65

4.51

u/ml

1.53

186

Malignant neoplasm of breast, HER-positive

100

1290

0.76

1.98

1.0

1.1

3.14

3.24

u/ml

0.03

432

Oedema, not elsewhere classified

166

1334

1.24

1.98

1.1

2.31

3.73

u/ml

0.97

529

Cholelithiasis, broad definition with cholecystitis

462

3594

0.88

1.98

1.1

4.08

3.93

u/ml

0.05

165

1331

Other/unspecified dorsalgia

258

2167

1.19

1.97

1.1

4.13

4.26

u/ml

0.04

119

830

Benign neoplasm: Skin of eyelid, including canthus

477

1.41

1.97

1.1

5.11

3.33

u/ml

0.30

174

Other systemic involvement of connective tissue (FG)

153

1218

1.25

1.97

1.1

2.71

3.80

u/ml

0.36

447

Other and unspecified polyneuropathies, also in other diseases

477

1.41

1.97

1.1

5.10

2.29

u/ml

0.47

181

Atrial fibrillation and flutter with reimbursement

666

0.73

1.97

1.0

3.97

2.96

u/ml

0.26

248

Rheumatoid arthritis, including avohilmo

135

1699

0.79

1.97

1.1

3.13

3.15

u/ml

0.01

631

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

369

0.59

1.96

1.1

7.07

3.28

u/ml

—

150

Other immunodeficiencies

2.23

1.96

1.1

1.05

3.21

u/ml

—

Inflammation of lacrimal passages (acute and unspecified)

2.38

1.96

1.3

1.0

2.07

3.30

u/ml

—

Thyroiditis, ILD-related definition

100

761

1.32

1.95

1.1

1.0

3.40

3.54

u/ml

0.03

283

Maternal care for other known or suspected fetal problems

271

2047

0.85

1.95

1.1

5.15

5.83

u/ml

0.17

768

Hypertension, essential

521

3349

0.89

1.94

1.1

4.50

3.60

u/ml

0.48

212

1211

Deep bite that required surgery

2.15

1.94

1.0

1.1

11.89

3.19

u/ml

—

Delivery

285

1772

0.85

1.94

1.1

4.82

5.05

u/ml

0.07

125

709

Malignant neoplasm of prostate

417

0.67

1.93

1.0

1.1

0.68

3.04

u/ml

2.66

170

Correction of physiology of bite - demanding therapy visit

480

1.41

1.93

1.1

3.95

4.14

u/ml

0.03

178

Major anomalies of jaw size

165

1.72

1.92

1.2

1.0

4.31

4.40

u/ml

0.01

Viral pneumonia

633

1.35

1.92

1.1

6.26

3.98

u/ml

0.54

263

Sequelae of injuries of upper limb

506

1.39

1.91

1.1

4.04

2.58

u/ml

0.41

191

Other deformities of toe(s)

1.93

1.90

1.1

1.0

1.12

4.05

u/ml

—

Other benign neoplasms of uterus

1.97

1.90

1.1

1.0

0.77

1.61

u/ml

—

Extrapyramidal and movement disorders

159

1286

1.24

1.90

1.1

1.0

4.33

3.68

u/ml

0.14

488

Presence of other devices

591

1.36

1.89

1.1

1.0

2.02

3.66

u/ml

0.49

219

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

121

1.83

1.89

1.1

1.0

0.49

2.73

u/ml

—

Measles

2.12

1.88

1.1

1.0

12.10

3.68

u/ml

—

L02BX Other hormone antagonists and related agents

0.00

1.88

0.0

1.1

—

0.57

—

Rotator cuff syndrome

352

2267

1.15

1.87

1.1

2.42

3.68

u/ml

0.99

146

810

Carpal tunnel syndrome

387

3057

1.14

1.85

1.1

2.63

3.99

u/ml

1.16

141

1107

Erosion of teeth, including avohilmo

195

1561

1.21

1.85

1.1

4.76

4.99

u/ml

0.06

584

Cholelithiasis

444

3523

0.88

1.84

1.1

3.92

3.85

u/ml

0.02

159

1306

Injuries to the neck

202

1682

1.20

1.84

1.1

3.76

4.81

u/ml

0.48

680

Other hammer toe(s) (acquired)

359

1.44

1.83

1.1

1.0

2.13

2.71

u/ml

0.19

118

Otitis media, unspecified

155

1157

1.24

1.83

1.2

1.1

5.82

6.00

u/ml

0.04

534

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

275

0.54

1.83

1.1

12.57

2.66

u/ml

—

116

Benign neoplasm: Transverse colon

198

1.62

1.83

1.1

0.46

2.31

u/ml

—

Gout, idiopatic and unspecified

466

0.62

1.82

1.0

4.34

2.74

u/ml

0.19

184

Oter anti-inflammatory and antirheumatic agents, non-steroids

359

1.35

1.82

1.0

1.1

1.70

3.33

u/ml

1.14

148

Complications predominantly related to the puerperium

260

2217

1.18

1.81

1.1

4.15

4.71

u/ml

0.17

828

Nonalcoholic fatty liver disease

452

1.40

1.81

1.0

1.1

0.94

2.93

u/ml

2.05

168

Other retinal disorders

207

1987

0.84

1.81

1.1

2.51

3.85

u/ml

1.02

793

Gingivitis and periodontal diseases

772

3620

1.10

1.81

1.1

2.87

4.91

u/ml

3.41

345

1374

Special screening examination for neoplasms

101

1.89

1.81

1.0

0.63

1.80

u/ml

—

Inflammatory disorders of breast

478

1.39

1.80

1.1

3.70

4.12

u/ml

0.06

174

Atrial septal defect

336

0.56

1.80

1.1

1.94

8.12

u/ml

—

178

Certain disorders involving the immune mechanism

125

991

1.27

1.80

1.1

5.57

3.96

u/ml

0.32

387

Other systemic involvement of connective tissue

153

1241

1.24

1.80

1.1

2.71

3.82

u/ml

0.37

468

Malignant neoplasm of digestive organs

785

0.71

1.79

1.0

5.21

2.89

u/ml

0.43

304

Sequelae of cerebrovascular disease

670

0.71

1.79

1.0

1.1

4.88

2.89

u/ml

0.34

262

Fissure and fistula of anal and rectal regions

155

1260

1.23

1.79

1.1

5.21

3.85

u/ml

0.32

495

L02BG Aromatase inhibitors

981

0.74

1.79

1.0

2.87

3.56

u/ml

0.26

338

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

1015

0.75

1.78

1.1

2.63

3.43

u/ml

0.16

368

Open wound of hip and thigh

200

1.62

1.78

1.1

3.95

4.73

u/ml

0.09

Stenosis and insufficiency of lacrimal passages

337

1.46

1.77

1.1

10.68

2.93

u/ml

0.77

129

Pre-eclampsia

133

1651

0.80

1.77

1.1

3.02

4.72

u/ml

0.70

613

Type1 diabetes, definitions combined, early onset

881

0.73

1.76

1.1

3.91

5.41

u/ml

0.39

402

Chronic conjunctivitis

139

1.74

1.76

1.0

1.1

8.78

4.40

u/ml

0.43

Other/unspecified soft tissue disorders related to use, overuse and pressure

139

1.74

1.76

1.1

1.0

4.24

3.54

u/ml

—

Other and unspecified corneal deformities and disorders

139

1.74

1.76

1.0

1.1

4.47

2.34

u/ml

0.38

Pre-eclampsia or eclampsia

140

1728

0.81

1.76

1.1

2.89

4.79

u/ml

0.87

639

Dysplasia of cervi uteri

251

1651

1.18

1.76

1.1

3.03

5.27

u/ml

1.01

638

Benign neoplasm of middle ear and respiratory system

232

1.56

1.76

1.1

4.25

4.26

u/ml

0.00

Perforation of tympanic membrane

523

1.36

1.75

1.0

1.1

3.53

4.58

u/ml

0.26

197

Rheumatism, unspecified

592

1.34

1.74

1.1

1.0

2.75

2.99

u/ml

0.05

202

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

107

942

0.78

1.74

1.1

1.0

0.85

2.91

u/ml

3.85

361

Fitting and adjustment of other devices

113

826

1.27

1.74

1.1

1.91

2.73

u/ml

0.35

302

Vulvovaginal ulceration/inflammation in other diseases

499

1.37

1.73

1.2

1.0

3.10

3.96

u/ml

0.29

182

Hypothyroidism, levothyroxine purchases

389

1963

1.14

1.73

1.1

3.64

5.43

u/ml

1.17

149

805

Hypothyroidism and >3 levothyroxin purchases

389

1963

1.14

1.73

1.1

3.64

5.43

u/ml

1.17

149

805

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

230

0.48

1.72

1.1

1.0

0.49

2.94

u/ml

—

Oral lichen ruber planus

2.15

1.72

1.1

1.0

1.81

2.43

u/ml

—

Disorders of muscles

482

1.37

1.72

1.1

1.40

3.68

u/ml

1.97

181

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

312

2467

1.16

1.72

1.1

6.07

5.51

u/ml

0.13

130

1151

Benign neoplasm of other and ill-defined parts of digestive system

585

1.34

1.71

1.1

4.05

3.50

u/ml

0.12

216

Other nutritional deficiencies

553

4866

1.11

1.70

1.1

5.49

4.67

u/ml

0.27

232

1872

Concussion

464

3578

1.12

1.70

1.1

6.36

4.40

u/ml

0.73

207

1484

Dissection of aorta

0.00

1.70

0.0

1.0

—

2.80

—

Seropositive rheumatoid arthritis

1049

0.76

1.70

1.0

2.56

3.29

u/ml

0.15

372

Post-traumatic stress disorder

107

841

1.28

1.69

1.1

8.78

5.15

u/ml

0.39

348

Localized swelling, mass and lump of skin and subcutaneous tissue

198

1660

1.20

1.69

1.1

4.15

3.91

u/ml

0.07

665

Disorders of refraction and accommodation

260

2223

1.17

1.69

1.1

8.00

5.03

u/ml

0.39

105

948

Other congenital malformations

103

806

1.28

1.68

1.1

12.68

5.30

u/ml

0.61

356

Benign neoplasm of colon, rectum, anus and anal canal

201

1708

0.84

1.68

1.1

2.59

3.10

u/ml

0.20

633

Heart failure and coronary heart disease

314

0.62

1.68

1.2

1.1

7.20

2.39

u/ml

0.51

127

Benign intracranial hypertension

1.97

1.67

1.1

1.0

8.53

6.06

u/ml

—

Habitual aborter

205

1.58

1.64

1.1

2.30

3.18

u/ml

0.23

Injury of muscle and tendon at lower leg level

703

1.30

1.64

1.1

2.36

3.21

u/ml

0.41

276

Other/unspecified seropositive rheumatoid arthritis

1023

0.76

1.64

1.1

2.63

3.42

u/ml

0.16

370

False labour

421

2345

1.13

1.64

1.1

3.78

5.78

u/ml

1.24

166

865

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

114

985

0.80

1.64

1.1

1.0

0.81

2.94

u/ml

4.34

380

Fracture of lumbar spine and pelvis

654

0.70

1.63

1.1

1.61

3.08

u/ml

0.65

245

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

608

0.69

1.62

1.0

1.1

10.04

3.22

u/ml

0.53

220

Other diseases of lip and oral mucosa

669

1.30

1.62

1.1

4.46

4.71

u/ml

0.04

230

Acute alcohol intoxication, ICD10

1212

0.78

1.62

1.1

10.46

4.07

u/ml

1.39

486

Disturbance of activity and attention

164

1342

1.21

1.62

1.1

7.95

5.65

u/ml

0.33

636

Haemangioma and lymphangioma, any site

462

1.37

1.62

1.1

17.63

4.98

u/ml

0.43

180

Alcoholic liver disease

264

0.53

1.62

1.1

1.0

10.20

2.34

u/ml

—

105

Guttate psoriasis

2.09

1.61

1.1

1.0

1.78

1.40

u/ml

—

Hernia of abdominal wall

244

2093

1.17

1.61

1.0

1.1

4.79

3.55

u/ml

0.42

110

800

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

229

2674

0.85

1.60

1.1

4.75

4.80

u/ml

0.01

1051

Complications associated with artificial fertilization

167

1.64

1.60

1.1

10.50

3.64

u/ml

0.49

Diseases of arteries, arterioles and capillaries (FINNGEN)

770

0.77

1.60

1.0

1.99

3.07

u/ml

0.66

286

Hydronephrosis

425

0.63

1.59

1.1

7.11

3.84

u/ml

—

162

Other nonscarring hair loss

2.24

1.58

1.1

1.0

3.60

4.48

u/ml

—

Convergence insufficiency and excess

1.88

1.57

1.3

1.0

0.92

4.74

u/ml

1.17

Monosomies and deletions from the autosomes, not elsewhere classified

0.00

1.57

0.0

1.1

—

9.39

—

Polyuria

770

1.28

1.56

1.1

1.27

3.29

u/ml

2.02

291

Diagnoses used for exclusion with ILD

118

948

1.25

1.56

1.1

3.98

3.16

u/ml

0.21

360

Supervision of normal pregnancy

255

1690

0.86

1.56

1.1

4.05

5.86

u/ml

0.90

631

Endometriosis of ovary

137

1117

1.23

1.55

1.1

2.52

4.58

u/ml

1.41

410

Autoimmune diseases

968

5337

0.93

1.55

1.1

3.97

4.90

u/ml

0.83

386

2213

Mixed disorders of conduct and emotions

309

0.58

1.55

1.1

5.81

6.11

u/ml

—

136

Focal epilepsy, mode (most common among epilepsy diagnosis)

1024

0.77

1.55

1.1

2.10

4.24

u/ml

1.65

441

Contraceptive management

432

2710

1.12

1.55

1.1

3.32

4.85

u/ml

1.08

154

1036

Other and unspecified follicular disorders

200

1.56

1.54

1.1

1.0

3.32

3.86

u/ml

0.09

Trigger finger

631

1.30

1.54

1.1

1.0

2.52

3.37

u/ml

0.26

220

Thyroiditis

390

1.39

1.54

1.1

5.10

4.20

u/ml

0.10

142

Seropositive rheumatoid arthritis, wide

1035

0.77

1.54

1.1

2.56

3.52

u/ml

0.20

373

Vascular disorders of the intestines

1.93

1.54

1.1

0.14

2.08

u/ml

—

LeFortI or BSSRO operation

315

1.44

1.53

1.2

1.1

5.00

4.21

u/ml

0.09

116

Infectious mononucleosis

120

970

1.24

1.53

1.1

3.84

4.72

u/ml

0.27

399

Sequelae of injuries, of poisoning and of other consequences of external causes

164

1367

1.20

1.53

1.1

5.36

3.81

u/ml

0.42

541

Impacted maxillary canine

1.90

1.53

1.1

6.10

7.70

u/ml

—

Other complications of labour and delivery, not elsewhere classified

117

1391

0.81

1.53

1.1

6.96

5.08

u/ml

0.24

523

Noninfectious colitis NAS

773

1.27

1.53

1.1

2.97

4.22

u/ml

0.50

313

Streptococcal septicaemia

284

0.56

1.53

1.1

7.87

4.08

u/ml

—

126

Mycoses

162

1349

1.20

1.53

1.1

5.21

3.73

u/ml

0.40

542

Melanocytic naevi

224

1919

1.17

1.52

1.1

2.73

4.62

u/ml

1.44

762

Outcome of delivery

190

1392

0.84

1.52

1.0

1.1

2.72

6.12

u/ml

2.18

523

Acute alcohol intoxication

112

1389

0.80

1.51

1.1

9.73

4.19

u/ml

1.33

544

Disorders of vestibular function (Vertigo)

219

1860

1.17

1.51

1.1

5.34

3.40

u/ml

0.56

683

Acute nasopharyngitis (common cold)

734

1.28

1.51

1.1

3.56

3.52

u/ml

0.01

296

CR(E)ST syndrome

2.18

1.51

1.1

1.0

0.27

2.21

u/ml

—

Delivery, wide proxy

249

1536

0.86

1.51

1.1

5.95

5.26

u/ml

0.19

110

616

Other specified disorders of external ear

1.87

1.50

1.0

2.84

2.35

u/ml

—

Congenital malformations of cardiac septa

621

0.71

1.50

1.1

7.17

6.13

u/ml

0.16

313

Symptoms and signs involving cognition, perception, emotional state and behaviour

634

4866

0.91

1.50

1.1

3.29

4.59

u/ml

0.69

271

1899

Hypothyroidism (congenital or acquired)

389

1983

1.13

1.50

1.1

3.59

5.46

u/ml

1.28

152

814

Varicose veins of other sites

283

1.46

1.50

1.0

1.1

2.21

2.54

u/ml

0.12

122

Infections of the skin and subcutaneous tissue

478

4289

1.11

1.50

1.1

5.45

4.59

u/ml

0.43

218

1772

Haemangioma and lymphangioma, any site

469

1.35

1.50

1.1

17.63

4.84

u/ml

0.44

190

Other viral diseases, not elsewhere classified

184

1550

1.19

1.50

1.1

7.18

5.08

u/ml

0.52

666

Other symptoms and signs involving the digestive system and abdomen

784

1.27

1.50

1.1

1.0

2.38

4.07

u/ml

0.73

301

Other maternal disorders predominantly related to pregnancy

596

3406

1.10

1.49

1.1

4.41

5.19

u/ml

0.36

217

1287

Covid-19 confirmed case

202

1719

1.18

1.49

1.1

4.23

4.79

u/ml

0.15

700

Infections with a predominantly sexual mode of transmission

341

3013

1.13

1.49

1.1

4.42

4.79

u/ml

0.12

128

1209

Benign neoplasm of middle ear and respiratory system

242

1.49

1.1

4.25

3.95

u/ml

0.04

Tic and related disorders

124

1.72

1.49

1.0

1.1

3.01

8.97

u/ml

1.66

Unspecified fall

332

2907

1.13

1.49

1.1

4.89

4.97

u/ml

0.03

155

1230

Other specified/unspecified bacterial intestinal infections

218

1.52

1.49

1.1

1.0

21.00

3.44

u/ml

0.57

Immunodeficiencies

259

1.48

1.1

6.86

5.44

u/ml

0.11

101

Benign neoplasm: Transverse colon

210

1.53

1.48

1.1

0.46

2.32

u/ml

—

Other heart diseases

432

3183

0.89

1.48

1.1

4.22

4.81

u/ml

0.28

178

1258

Other complications of surgical and medical care, not elsewhere classified

479

1.34

1.47

1.2

1.1

2.66

3.92

u/ml

0.55

174

Medicines for HER+ breast cancer

124

1477

0.82

1.47

1.0

1.1

2.52

3.75

u/ml

0.78

506

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

339

2997

1.13

1.47

1.1

7.60

4.36

u/ml

0.58

142

1139

Focal epilepsy

1205

0.79

1.47

1.1

3.86

3.99

u/ml

0.02

520

Skin changes due to chronic exposure to nonionizing radiation

510

1.32

1.46

1.0

2.60

2.37

u/ml

0.04

207

Injuries to the knee and lower leg

1065

5680

1.07

1.45

1.1

4.85

4.63

u/ml

0.11

433

2274

Polyarthrosis

476

1.33

1.45

1.1

1.0

0.63

2.97

u/ml

3.72

152

Retinal detachments and breaks

125

1020

1.23

1.45

1.1

1.0

3.38

3.09

u/ml

0.09

367

Gonarthrosis,primary

356

2524

0.89

1.45

1.1

2.67

3.38

u/ml

0.62

147

873

Explicit bacterial Sepsis

414

0.65

1.44

1.0

1.1

14.03

4.33

u/ml

—

173

Pain in limb

654

4329

1.09

1.44

1.1

4.31

5.03

u/ml

0.40

264

1754

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

125

1.69

1.44

1.0

6.52

3.18

u/ml

—

Testicular dysfunction

172

1.58

1.43

1.0

1.1

0.65

3.03

u/ml

2.21

Fracture of shoulder and upper arm

160

1902

0.84

1.43

1.1

3.85

4.66

u/ml

0.25

790

L04AA Selective immunosuppressants

104

1290

0.80

1.43

1.1

3.77

4.63

u/ml

0.22

509

Other arthrosis

301

1889

1.14

1.43

1.1

2.99

3.23

u/ml

0.10

129

659

Budesonide

745

1.27

1.43

1.1

1.0

2.11

2.62

u/ml

0.29

264

Benign neoplasm of eye and adnexa

328

1.41

1.42

1.0

1.1

0.92

3.34

u/ml

1.77

120

Benign neoplasm: Ascending colon

253

1.47

1.42

1.1

1.58

1.99

u/ml

0.16

102

Scar conditions and fibrosis of skin

226

0.53

1.42

1.0

11.78

3.21

u/ml

—

Malignant neoplasm of breast, HER-negative

693

0.73

1.42

1.0

5.87

3.12

u/ml

0.50

243

Angina pectoris

142

1156

0.83

1.42

1.1

1.0

2.19

2.87

u/ml

0.29

421

Sacrococcygeal disorders, not elsewhere classified

157

1.60

1.41

1.0

1.38

2.65

u/ml

—

Haemangioma, any site

414

1.36

1.41

1.1

4.36

5.33

u/ml

0.15

166

Malignant neoplasm of skin

132

1204

0.82

1.41

1.1

1.0

1.87

2.93

u/ml

0.61

444

Congenital malformations, deformations and chromosomal abnormalities

609

5340

1.09

1.40

1.1

6.64

4.73

u/ml

0.70

271

2175

Dental pulpitis 4

910

5089

0.93

1.40

1.1

3.99

4.46

u/ml

0.33

380

2041

Dental pulpitis 1

910

5090

0.93

1.40

1.1

3.99

4.46

u/ml

0.33

380

2041

Myocardial infarction

111

982

0.81

1.40

1.1

1.0

5.43

3.05

u/ml

0.67

368

Supervision of high-risk pregnancy

225

1575

0.86

1.39

1.1

2.31

6.09

u/ml

3.88

579

Benign neoplasm: Skin of eyelid, including canthus

510

1.32

1.39

1.1

5.11

3.46

u/ml

0.27

194

Generalized skin eruption due to drugs and medicaments

190

1.54

1.38

1.1

5.94

4.06

u/ml

0.42

Care involving dialysis

287

0.59

1.37

1.0

1.1

1.34

4.34

u/ml

—

123

Hyperkinetic disorders

173

1449

1.18

1.37

1.1

7.73

5.54

u/ml

0.34

689

Mixed disorders of conduct and emotions, excluding more controls

298

0.60

1.37

1.1

5.81

5.87

u/ml

—

134

Sarcoidosis

581

1.29

1.37

1.1

5.27

2.74

u/ml

0.48

209

Other reaction to severe stress, and adjustment disorders

373

3337

1.12

1.37

1.1

4.81

4.86

u/ml

0.02

161

1321

Diseases of pulp and periapical tissues, including avohilmo

910

5084

0.93

1.37

1.1

3.97

4.47

u/ml

0.36

382

2038

Other disorders of breast

750

1.26

1.37

1.1

1.73

3.69

u/ml

1.53

273

Cervicobrachial syndrome

142

1183

1.20

1.36

1.1

1.34

3.51

u/ml

3.51

418

Benign neoplasm of eye and adnexa

331

1.39

1.36

1.0

1.1

0.92

3.27

u/ml

1.73

122

Congenital malformations of the urinary system

407

0.66

1.36

1.0

1.1

17.23

5.89

u/ml

0.82

192

Viral infections characterized by skin and mucous membrane lesions

310

2743

1.13

1.35

1.1

9.06

4.55

u/ml

1.99

126

1149

Congenital malformations of the respiratory system

120

1.69

1.35

1.2

1.1

5.36

8.98

u/ml

0.38

Other predominantly sexually transmitted diseases, not elsewhere classified

193

1654

1.17

1.35

1.1

5.34

4.77

u/ml

0.12

666

Systemic connective tissue disorders

192

1644

1.17

1.35

1.1

2.30

3.93

u/ml

0.85

620

Panniculitis affecting regions of neck and back

167

1.57

1.35

1.1

1.0

10.64

2.31

u/ml

—

Coxarthrosis [arthrosis of hip](FG)

172

1465

0.85

1.34

1.1

1.20

3.26

u/ml

4.29

517

Crowding of teeth, including avohilmo

150

1038

1.20

1.34

1.1

6.23

5.94

u/ml

0.07

488

Antenatal screening

272

1745

0.88

1.34

1.1

5.54

5.74

u/ml

0.05

107

655

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

128

1.65

1.33

1.0

1.1

6.52

3.26

u/ml

—

Other disorders of fluid, electrolyte and acid-base balance

901

0.78

1.33

1.1

1.93

4.02

u/ml

1.35

343

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

335

2953

1.12

1.33

1.1

5.48

5.14

u/ml

0.08

155

1232

Foreign body entering into or through eye or natural orifice

471

1.32

1.0

5.02

4.49

u/ml

0.08

198

Pregnancy, childbirth and the puerperium

220

1331

0.86

1.32

1.0

1.1

6.00

5.45

u/ml

0.14

535

Suppurative otitis media, unspecified

168

1.56

1.32

1.0

1.1

8.60

6.56

u/ml

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

197

1694

1.17

1.32

1.1

3.42

4.01

u/ml

0.33

668

Problems related to lifestyle

752

0.76

1.32

1.1

13.62

3.89

u/ml

0.54

291

Myocardial infarction, strict

886

0.81

1.32

1.1

1.0

4.46

3.21

u/ml

0.29

333

Hypertensive Heart Disease

332

0.66

1.31

1.0

0.35

3.30

u/ml

2.49

125

Hypertensive heart and/or renal disease

388

0.70

1.31

1.1

1.0

0.59

3.03

u/ml

2.12

144

Helminthiases

1.86

1.30

1.1

1.0

4.83

4.06

u/ml

—

Benign lipomatous neoplasm

150

1263

1.19

1.30

1.0

1.1

7.60

3.61

u/ml

0.32

476

929

0.78

1.29

1.2

1.1

8.69

3.68

u/ml

0.73

350

Other diseases of jaws

335

1.38

1.29

1.0

1.1

2.34

3.99

u/ml

0.68

112

Benign neoplasm: Choroid

145

1.59

1.29

1.0

0.23

2.30

u/ml

2.43

Nontraumatic intracranial haemmorrhage

450

0.69

1.29

1.1

4.59

2.44

u/ml

0.30

179

Parkinson's disease

206

0.53

1.29

1.0

1.21

1.89

u/ml

—

Xanthelasma of eyelid

2.81

1.29

1.0

1.1

—

0.50

—

Tic and related disorders

130

1.64

1.28

1.0

1.1

3.01

6.35

u/ml

0.97

Used for control exclusion in common control thyroid runs

947

5142

0.93

1.28

1.1

3.59

5.02

u/ml

1.69

374

2153

Biological medication for rheuma

101

1238

0.81

1.28

1.0

1.1

3.73

4.32

u/ml

0.13

492

Disorders of vitreous body

185

1553

1.17

1.28

1.1

1.0

2.09

3.34

u/ml

0.66

562

Actinic keratosis

465

1.31

1.28

1.0

2.92

2.34

u/ml

0.10

186

Invasive ventilation

293

0.61

1.28

1.1

1.47

5.18

u/ml

—

135

Crossbite

727

1.24

1.28

1.1

4.75

5.99

u/ml

0.35

357

Generalized epilepsy, strict definition

186

1.52

1.27

1.0

1.1

1.45

8.51

u/ml

3.25

Ulcer of lower limb, not elsewhere classified

293

0.61

1.27

1.2

1.0

11.12

2.50

u/ml

—

121

Benzodiazepine use

699

5376

0.92

1.27

1.1

3.63

4.62

u/ml

0.75

270

2100

Acne

146

1230

1.19

1.27

1.1

10.69

4.74

u/ml

0.53

548

Nonorganic sleeping disorders, excluding more controls

167

1423

1.18

1.27

1.1

2.72

4.07

u/ml

0.52

572

Cardiac arrhythmias

542

3914

0.91

1.27

1.1

3.87

4.44

u/ml

0.34

224

1500

Focal epilepsy, strict definition

1060

0.80

1.27

1.1

2.12

4.21

u/ml

1.69

461

Alopecia areata

154

1.57

1.26

1.0

17.51

6.23

u/ml

—

Chronic suppurative otitis media, including avohilmo

466

1.31

1.26

1.1

6.36

4.09

u/ml

0.27

202

Hydatidiform mole

1.76

1.26

1.0

11.29

3.59

u/ml

—

Other diseases of peritoneum

154

1.57

1.26

1.0

5.27

2.47

u/ml

—

Convulsions, not elsewhere classified

152

1768

0.85

1.26

1.1

5.63

4.98

u/ml

0.12

791

Acute pancreatitis

746

0.76

1.25

1.1

4.47

3.35

u/ml

0.21

282

Other/unspecified enthesopathies, not elsewhere classified

320

1.38

1.25

1.2

1.1

4.63

3.21

u/ml

0.23

115

Coxarthrosis

167

1327

0.85

1.24

1.1

1.24

3.19

u/ml

4.01

455

Oral lichen ruber planus, including avohilmo

195

1.49

1.24

1.1

1.12

2.41

u/ml

1.02

All dysplastic lesions of the vagina

131

1.62

1.24

1.0

0.85

2.19

u/ml

—

Parkinson's disease, including avohilmo

216

0.55

1.24

1.0

1.02

2.04

u/ml

—

Gout, FINNGEN

551

0.73

1.24

1.1

1.0

6.32

2.51

u/ml

0.58

218

Other disorders of male genital organs

179

1.52

1.24

1.0

1.1

0.30

3.51

u/ml

3.19

Other postsurgical states

290

0.62

1.24

1.0

1.1

1.47

5.79

u/ml

—

127

L04AC Interleukin inhibitors

302

0.63

1.24

1.0

1.1

9.25

3.05

u/ml

—

113

Testicular hypofunction

155

1.56

1.23

1.0

1.1

0.38

2.83

u/ml

—

Contact with machinery

407

1.33

1.23

1.1

2.05

2.96

u/ml

0.40

164

Other specified/unspecified soft tissue disorders

147

1.57

1.23

1.0

5.58

3.05

u/ml

—

Cellulitis

144

1216

1.19

1.23

1.1

5.29

3.71

u/ml

0.39

499

Disorders of iron metabolism

2.06

1.22

1.1

1.0

2.81

3.27

u/ml

—

Digestive system disorders of fetus and newborn

0.00

1.22

0.0

1.2

—

10.23

—

Insomnia

139

1171

1.19

1.22

1.1

2.98

4.06

u/ml

0.33

449

Unknown and unspecified causes of morbidity

356

1.35

1.22

1.0

11.15

2.88

u/ml

0.53

134

Nausea and vomiting

176

1487

1.17

1.21

1.1

2.52

5.70

u/ml

2.71

639

Acute pancreatitis (for exclusion)

742

0.77

1.21

1.1

4.47

3.48

u/ml

0.19

281

Open wound of wrist and hand

353

3144

1.11

1.21

1.1

6.63

4.18

u/ml

0.96

144

1280

Other and unspecified injuries of ankle and foot

314

1.38

1.21

1.1

1.0

14.70

3.88

u/ml

0.39

131

Obsessive-compulsive disorder

674

1.25

1.21

1.0

1.1

5.23

4.60

u/ml

0.10

280

Benign paroxysmal vertigo

127

1062

1.20

1.21

1.0

1.1

4.75

3.70

u/ml

0.18

387

148

1.57

1.21

1.1

1.0

20.24

3.30

u/ml

0.56

Unspecified privation

540

1.28

1.20

1.1

4.99

3.75

u/ml

0.25

205

Haemangioma, any site

426

1.32

1.20

1.1

4.36

5.05

u/ml

0.10

178

Heart failure and bmi 25plus

552

0.77

1.20

1.1

1.0

2.54

3.07

u/ml

0.11

220

Fracture at wrist and hand level

266

2354

1.13

1.20

1.1

7.53

4.17

u/ml

1.12

131

976

Secondary uncertain malignant neoplasm

312

0.64

1.20

1.1

0.37

3.39

u/ml

—

118

Uterine polyps

418

1.32

1.19

1.1

3.72

4.86

u/ml

0.16

145

Viral conjunctivitis

125

1.62

1.18

1.1

1.0

7.97

4.38

u/ml

—

Other shoulder lesions

524

1.28

1.18

1.1

4.92

2.99

u/ml

0.31

191

Long labour

282

2190

1.13

1.18

1.1

6.45

4.93

u/ml

0.21

116

791

Glomerular diseases

817

0.78

1.18

1.1

8.29

4.37

u/ml

0.48

331

Acute generalized exanthematous pustulosis

206

1.46

1.18

1.1

1.0

5.94

5.27

u/ml

0.11

Septal defects

588

0.74

1.17

1.1

7.17

6.30

u/ml

0.13

295

Other, unspecified and serous retinal detachments

1.78

1.17

1.0

11.11

2.65

u/ml

—

severe traumatic brain injury, does not include concussion

636

0.75

1.17

1.1

6.44

2.91

u/ml

0.83

254

Certain conditions originating in the perinatal period

146

1100

1.18

1.17

1.1

8.84

6.20

u/ml

0.66

563

Injury of muscle and tendon at hip and thigh level

437

1.31

1.17

1.1

3.20

3.30

u/ml

0.02

161

Perineal laceration during delivery

172

1775

0.86

1.17

1.1

2.81

5.52

u/ml

1.66

674

Fever of other and unknown origin

409

3444

1.10

1.16

1.1

7.48

4.41

u/ml

1.07

176

1420

Alcoholic gastritis

0.00

1.16

0.0

1.0

—

0.92

—

Non-ischemic cardiomyopathy

569

0.76

1.16

1.1

0.62

2.92

u/ml

3.72

224

Benign neoplasm: Ascending colon

265

1.40

1.16

1.1

1.58

2.08

u/ml

0.20

110

Gout

496

0.73

1.15

1.1

1.0

6.32

2.44

u/ml

0.60

188

Gout, unspecified

357

0.67

1.15

1.0

1.1

4.70

1.73

u/ml

0.36

144

Volume depletion

248

0.60

1.15

1.1

15.41

4.86

u/ml

—

Juvenile osteochondrosis

266

1.40

1.15

1.1

1.0

3.98

5.65

u/ml

0.33

102

Effects of foreign body entering through natural orifice

183

1586

1.16

1.15

1.1

3.92

4.74

u/ml

0.34

678

malignant neoplasm of female genital organs

392

0.69

1.15

1.0

13.01

3.45

u/ml

—

141

Coeliac disease

750

1.23

1.15

1.0

1.1

7.74

4.31

u/ml

0.60

302

Single delivery by caesarean section

207

1370

0.87

1.14

1.1

4.36

5.64

u/ml

0.38

537

Disorders of vitreous body and globe

190

1610

1.15

1.14

1.1

2.16

3.34

u/ml

0.63

583

Impingement syndrome of shoulder

120

1005

1.20

1.14

1.1

1.0

2.34

3.28

u/ml

0.52

355

Dental caries

145

1681

0.85

1.14

1.2

1.1

1.69

5.74

u/ml

7.58

691

Postmenopausal bleeding

112

508

1.21

1.13

1.0

2.34

4.56

u/ml

1.00

166

Other heart diseases, wide

759

5048

0.93

1.13

1.1

3.90

4.54

u/ml

0.47

322

1987

Melanocytic naevi

224

1972

1.14

1.13

1.1

2.73

4.82

u/ml

1.67

781

Infections of genitourinary tract in pregnancy

732

0.78

1.12

1.1

6.85

5.20

u/ml

0.17

288

Chronic suppurative otitis media

379

1.32

1.12

1.1

7.23

5.80

u/ml

0.13

154

Polyp of the female genital tract

227

1159

1.14

1.12

1.1

2.64

4.70

u/ml

1.28

416

Immunodeficiency with predominantly antibody defects

143

1.55

1.12

1.1

1.0

10.30

4.83

u/ml

0.33

Recurring oral aphthae

242

1.41

1.12

1.1

5.30

4.44

u/ml

0.09

103

Feeding problems of newborn

1.75

1.12

1.1

5.43

6.50

u/ml

—

Sacroiliitis, not elsewhere classified

362

1.33

1.12

1.0

1.52

4.07

u/ml

1.56

135

Disorders of eyelid in diseases classified elsewhere

135

1.57

1.11

1.2

1.0

9.10

2.76

u/ml

0.78

Persistent delusional disorders

318

0.66

1.11

1.0

1.1

5.51

2.59

u/ml

0.50

126

Viral hepatitis, IBD co-morbidity

400

0.70

1.11

1.1

1.0

4.10

3.34

u/ml

0.11

170

Behavioural syndromes associated with physiological disturbances and physical factors

327

2947

1.11

1.10

1.1

3.41

5.40

u/ml

1.12

137

1231

Meniscus derangement

362

2240

1.11

1.10

1.1

2.98

3.40

u/ml

0.22

147

801

Other epidermal thickening

168

1.50

1.10

1.1

1.0

6.37

3.57

u/ml

0.37

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

391

3554

1.10

1.09

1.1

7.93

4.62

u/ml

0.81

159

1463

Other appendicitis

442

1.29

1.09

1.1

5.30

2.59

u/ml

0.69

156

Syncope and collapse

249

1958

1.13

1.09

1.1

6.01

4.05

u/ml

0.70

102

798

Impetigo

390

1.32

1.09

1.2

1.1

5.82

5.12

u/ml

0.11

171

Chronic iridocyclitis

231

0.60

1.08

1.0

1.1

2.57

3.08

u/ml

—

Bilateral sagittal split ramus osteotomy operation

261

1.39

1.08

1.2

1.1

6.16

4.05

u/ml

0.22

Autonomic disorders

1.70

1.08

1.0

0.46

5.00

u/ml

—

Shoulder lesions

509

2865

1.09

1.08

1.1

2.48

4.08

u/ml

1.50

193

1055

Sequelae of other external causes

202

1.44

1.07

1.2

1.0

6.42

3.75

u/ml

0.32

Superficial injury of hip and thigh

567

1.25

1.07

1.1

14.02

3.61

u/ml

0.77

225

Medical abortion

593

2981

1.08

1.07

1.1

5.47

5.07

u/ml

0.15

231

1120

Other symptoms and signs involving the circulatory and respiratory systems

244

1.40

1.07

1.1

1.0

1.54

3.16

u/ml

—

Diseases of inner ear

261

2279

1.12

1.07

1.1

4.55

3.40

u/ml

0.36

100

853

Use of hypnotics and sedatives

746

4617

0.93

1.07

1.1

3.44

4.37

u/ml

0.74

285

1782

Parkinson's disease, excluding more controls

188

0.57

1.06

1.0

1.21

1.90

u/ml

—

453

0.73

1.06

1.1

9.05

6.43

u/ml

0.18

253

Complications of medical and surgical care

469

4092

1.09

1.06

1.1

7.52

4.15

u/ml

0.90

197

1553

Other diseases of intestines

1009

5529

1.06

1.1

3.78

4.86

u/ml

1.01

396

2261

Valvular operations

373

0.70

1.06

1.0

1.1

3.04

4.04

u/ml

—

164

Other disorders of binocular vision

1.69

1.05

1.1

1.0

3.37

4.82

u/ml

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

362

1.29

1.05

1.1

1.0

5.81

2.32

u/ml

0.58

143

Urethritis and urethral syndrome

1.68

1.04

1.3

1.0

2.02

4.18

u/ml

—

Tic disorders

130

1.56

1.04

1.1

2.49

9.12

u/ml

1.89

Alcohol abuse, main dg, excluding more controls

945

0.81

1.04

1.1

10.78

3.94

u/ml

1.36

378

Care involving use of rehabilitation procedures

435

3788

1.09

1.04

1.1

4.51

4.27

u/ml

0.08

202

1477

Colonic or urogenital fistula

157

1358

1.16

1.04

1.1

5.12

3.57

u/ml

0.40

528

Aplastic and other anaemias

126

1402

0.85

1.04

1.1

2.95

3.98

u/ml

0.44

565

Abscess of external ear

1.85

1.03

1.0

1.1

0.83

1.34

u/ml

—

Alcohol abuse, main dg

944

0.81

1.03

1.1

10.78

4.22

u/ml

1.27

376

Systemic sclerosis (FG)

1.74

1.03

1.1

1.0

0.27

3.94

u/ml

—

Chronic periodontitis, complicated

288

0.66

1.03

1.1

0.87

2.20

u/ml

—

107

Other/unspecified rheumatoid arthritis

347

0.69

1.02

1.2

1.1

1.05

2.22

u/ml

0.84

128

Fall involving playground equipment

1.66

1.02

1.3

1.1

7.79

5.52

u/ml

0.12

Other factor of the environment

1.91

1.02

1.2

1.0

2.03

3.62

u/ml

—

Benign neoplasm: Colon

169

1442

1.15

1.01

1.1

1.0

2.27

3.02

u/ml

0.33

533

Antihypertensive medication - note that there are other indications

842

4328

1.07

1.00

1.1

5.19

4.85

u/ml

0.15

348

1780

Disorders of ocular muscles, binocular movement, accommodation and refraction

427

3890

1.09

1.00

1.1

5.78

4.96

u/ml

0.16

184

1615

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

600

1.24

1.00

1.0

1.1

1.98

2.82

u/ml

0.57

224

Disorders of orbit

197

1.43

1.00

1.1

1.0

3.19

2.27

u/ml

0.18

Wide developmental disorders

413

0.72

1.00

1.1

0.63

7.09

u/ml

7.59

211

Glomerular disorders in diseases classified elsewhere

449

0.73

1.00

1.1

10.66

3.60

u/ml

0.50

183

5-aminosalicylic acid

162

1410

1.15

1.00

1.1

2.41

3.84

u/ml

1.02

531

Other erythematous conditions

123

1.55

1.00

1.1

1.0

1.30

4.22

u/ml

—

Severe mental retardation

0.00

0.99

0.0

1.1

—

6.07

—

Poor fetal growth

117

1373

0.85

0.99

1.0

1.1

5.06

4.85

u/ml

0.04

528

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

380

2638

0.91

0.99

1.1

2.28

4.32

u/ml

2.33

143

961

Use of pramipexole

691

1.22

0.99

1.1

2.62

2.84

u/ml

0.07

256

Viral pneumonia (unknown virus, not influenza)

352

1.31

0.99

1.1

9.72

3.80

u/ml

0.91

141

Other abnormal uterine and vaginal bleeding

141

864

1.17

0.99

1.1

4.57

5.42

u/ml

0.16

313

Myopia

129

1105

1.17

0.99

1.1

7.37

4.75

u/ml

0.18

457

Status post-ami

0.00

0.98

0.0

1.0

—

0.20

—

Other puerperal infections

100

839

1.20

0.98

1.1

7.49

4.50

u/ml

0.46

324

Benign neoplasm: Choroid

156

1.48

0.98

1.0

0.23

2.33

u/ml

2.41

Lung transplant status

0.00

0.98

0.0

1.1

—

3.24

—

Lung transplantation

0.00

0.98

0.0

1.1

—

3.24

—

Other noninflammatory disorders of vulva and perineum

557

1.24

0.98

1.1

5.06

4.82

u/ml

0.03

206

Drug-induced cataract

1.68

0.98

1.1

1.0

8.36

2.82

u/ml

—

Mixed conductive and sensorineural hearing loss

335

1.32

0.98

1.0

1.1

7.16

2.48

u/ml

0.72

134

Ulcerative colitis (strict definition, all Crohn cases excluded)

1025

0.83

0.98

1.1

2.37

3.78

u/ml

0.85

408

Disorders of thyroid, IBD co-morbidities

166

1054

1.15

0.98

1.0

1.1

2.69

3.65

u/ml

0.41

421

Intentional self-harm by jumping from a high place

0.00

0.98

0.0

1.0

—

1.35

—

Leukaemia of unspecified cell type

0.00

0.98

0.0

1.0

—

1.28

—

Leukaemia of unspecified cell type

0.00

0.98

0.0

1.0

—

1.37

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

229

2563

0.89

0.98

1.1

4.75

4.56

u/ml

0.06

1001

Abnormal findings on diagnostic imaging of central nervous system

232

1.39

0.98

1.0

1.1

4.36

4.92

u/ml

0.08

Foreign body in ear

1.64

0.97

1.1

1.0

13.39

10.12

u/ml

—

Benign neoplasm of bone and articular cartilage

486

1.26

0.97

1.0

3.86

4.24

u/ml

0.05

176

Dentinal caries

124

1439

0.86

0.97

1.2

1.1

1.66

5.82

u/ml

7.25

598

Tuberculosis

1.63

0.97

1.1

1.0

2.20

2.22

u/ml

—

Malignant neoplasm of small intestine

0.00

0.96

0.0

1.0

—

1.20

—

Spontaneous abortion

433

2709

1.09

0.96

1.1

3.33

5.01

u/ml

1.14

161

1005

Colorectal cancer, excluding all cancers (controls excluding all cancers)

606

0.78

0.96

1.0

5.37

2.94

u/ml

0.38

231

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

577

4035

0.93

0.96

1.1

3.64

3.88

u/ml

0.11

216

1513

Other and unspecified disorders of skin and subcutaneous tissue

233

1.38

0.95

1.1

1.0

0.79

2.33

u/ml

1.45

Puerperal sepsis

686

1.21

0.95

1.1

1.0

4.16

3.10

u/ml

0.25

236

Other inflammation of vagina/vulva

294

1.34

0.95

1.0

2.60

4.54

u/ml

0.55

102

Stomatitis and related lesions

488

1.25

0.95

1.1

8.42

4.75

u/ml

0.49

182

406

0.73

0.94

1.1

9.57

6.78

u/ml

0.18

227

Other skin changes

605

1.23

0.94

1.0

1.1

10.82

3.83

u/ml

0.88

234

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

1.78

0.94

1.1

1.09

0.68

u/ml

—

Traumatic subdural haemorrhage

230

0.64

0.94

1.1

1.0

10.25

1.47

u/ml

—

Postpartum haemorrhage due to anatomy

124

1065

1.17

0.94

1.1

4.83

4.90

u/ml

0.01

412

Disorders of lens

251

1763

0.90

0.94

1.0

1.1

4.73

3.40

u/ml

0.59

106

640

Enlarged lymph nodes

105

889

1.18

0.93

1.1

12.49

3.78

u/ml

0.79

359

Left ventricular outflow tract obstruction (LVOTO), broad definition

556

0.77

0.93

1.0

1.1

1.98

4.83

u/ml

1.43

248

Peripheral artery operations in Hilmo

209

0.62

0.93

1.2

1.1

0.20

2.10

u/ml

—

Exposure to other and unspecified animate mechanical forces

226

1.38

0.93

1.1

0.99

5.72

u/ml

2.48

Complications of procedures, not elsewhere classified

569

4583

1.07

0.93

1.1

5.71

4.27

u/ml

0.37

229

1743

Toxic effect of contact with venomous animals

209

1.40

0.92

1.0

8.62

3.88

u/ml

—

Other infective otitis externa

269

1.34

0.92

1.1

10.43

3.91

u/ml

0.96

100

Hyperplasia of prostate

113

546

1.18

0.92

1.0

0.99

3.25

u/ml

3.09

215

Other disorders starting during childhood or adolescence

766

1.20

0.92

1.1

3.63

6.43

u/ml

1.16

386

Cardiomyopathy (excluding other)

362

0.72

0.92

1.2

1.0

4.35

2.87

u/ml

—

145

Tumor necrosis factor alpha inhibitors

1136

0.84

0.92

1.0

1.1

3.50

4.20

u/ml

0.16

454

Cardiovascular diseases

869

4469

1.06

0.91

1.1

3.64

5.11

u/ml

1.51

359

1858

Scleritis and episcleritis

322

1.31

0.91

1.0

1.1

2.33

2.25

u/ml

0.02

113

Unstable angina pectoris

608

0.80

0.91

1.0

1.63

2.87

u/ml

0.57

227

Campylobacter enteritis

110

1.55

0.91

1.0

3.55

3.13

u/ml

—

Non-selective monoamine reuptake inhibitors

191

1643

1.13

0.91

1.1

1.0

2.63

3.06

u/ml

0.18

582

Other gastritis (incl. Duodenitis)

763

1.19

0.91

1.1

1.0

4.41

3.70

u/ml

0.17

283

Respiratory tuberculosis, confirmed and not-confirmed

1.63

0.91

1.0

2.20

2.26

u/ml

—

Respiratory tuberculosis

1.63

0.91

1.0

2.20

2.26

u/ml

—

Pedal cyclist injured in noncollision transport accidents

709

0.80

0.91

1.1

2.60

4.09

u/ml

0.92

281

Other/unspecified disorders of vestibular function

102

1.58

0.90

1.1

1.0

1.10

4.60

u/ml

—

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

207

0.63

0.90

1.1

1.0

3.32

3.21

u/ml

—

Dental pulpitis 4, only avohilmo

932

5138

0.95

0.90

1.1

4.69

4.43

u/ml

0.12

394

2057

Other benign neoplasms of connective and other soft tissue

462

0.76

0.89

1.1

4.15

3.48

u/ml

0.07

176

Other congenital malformations of the digestive system

383

1.28

0.89

1.1

6.88

6.90

u/ml

0.00

194

Subarachnoid haemorrhage

278

0.68

0.89

1.2

1.1

7.89

2.37

u/ml

—

103

Other congenital malformations, not elsewhere classified

1.64

0.89

1.1

1.0

5.74

6.04

u/ml

—

Decubitus ulcer and pressure area

103

0.48

0.89

1.0

12.22

3.02

u/ml

—

Maternal care for other conditions predominantly related to pregnancy

246

2189

1.11

0.89

1.1

2.13

5.37

u/ml

3.09

819

Divergent concomitant strabismus

495

0.76

0.88

1.1

3.53

4.93

u/ml

0.40

178

Speech and linguistic disorders, excluding more controls

112

904

1.17

0.88

1.1

5.25

5.63

u/ml

0.08

441

Other mental disorders due to brain damage and dysfunction and to physical disease

230

0.65

0.88

1.1

1.0

1.16

2.75

u/ml

—

Hypopituitarism

483

0.76

0.88

1.1

4.56

5.90

u/ml

0.20

219

Special screening examination for other diseases and disorders

502

1.24

0.88

1.2

1.0

4.18

3.43

u/ml

0.15

204

Mixed and other personality disorders

606

0.79

0.88

1.1

2.57

3.47

u/ml

0.43

231

Polyneuropathies and other disorders of the peripheral nervous system

629

1.21

0.87

1.1

4.39

2.39

u/ml

0.39

239

Oral leukoplakia

2.01

0.87

1.2

1.0

—

0.95

—

Ulcer of vagina/vulva

136

1.48

0.87

1.2

1.0

3.89

6.70

u/ml

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

356

3259

1.09

0.87

1.1

7.50

4.23

u/ml

0.61

145

1227

Cardiomyopathies, Primary/intrinsic

346

0.72

0.87

1.2

1.0

4.35

2.57

u/ml

—

141

Monoamine oxidase A inhibitors

485

1.24

0.87

1.1

1.0

2.30

2.45

u/ml

0.03

178

Trigeminal neuralgia

229

1.36

0.86

1.1

1.20

3.06

u/ml

—

Postpartum hemorraghe, parous women as controls

280

2229

1.10

0.86

1.1

4.20

4.97

u/ml

0.23

825

Synovial cyst of popliteal space [Baker]

195

1.39

0.86

1.2

1.1

2.37

3.11

u/ml

0.19

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

116

1299

0.86

1.1

9.26

5.48

u/ml

0.83

608

Dental caries 1 and operation codes

693

3340

1.07

0.86

1.1

3.07

4.59

u/ml

1.89

293

1297

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

1.68

0.86

1.1

6.87

4.12

u/ml

—

Pedal cyclist injured in collision with motor vehicle

187

1.40

0.85

1.1

1.0

4.38

5.32

u/ml

0.13

Unspecified event, undetermined intent

145

1.46

0.85

1.0

1.1

1.88

3.90

u/ml

0.78

Other perinatal digestive system disorders

0.00

0.85

0.0

1.2

—

11.92

—

Pericarditis

112

1.52

0.85

1.2

1.0

9.01

3.13

u/ml

—

Other female pelvic inflammatory diseases

105

899

1.17

0.84

1.1

1.0

3.87

3.89

u/ml

0.00

330

Other bursopathies

451

1.24

0.84

1.1

2.78

4.00

u/ml

0.45

162

Symptoms and signs involving the urinary system

384

3214

0.92

0.84

1.1

3.24

4.45

u/ml

0.78

153

1293

Open wound of ankle and foot

587

1.21

0.84

1.1

3.49

4.21

u/ml

0.17

236

Hydrocephalus

191

0.63

0.84

1.0

3.78

2.53

u/ml

—

Unspecified/other endometriosis

826

1.18

0.84

1.1

2.77

5.03

u/ml

0.82

321

Femoral hernia, unilateral

1.76

0.84

1.0

1.56

2.03

u/ml

—

Inguinal of femoral hernia, unilateral

1.76

0.84

1.0

1.56

2.03

u/ml

—

Inguinal hernia, unilateral

1.76

0.84

1.0

1.56

2.03

u/ml

—

Spinal stenosis

172

1195

1.13

0.82

1.0

1.90

2.81

u/ml

0.72

430

Other and unspecified erythematous conditions

113

1.51

0.82

1.1

1.0

1.21

4.54

u/ml

—

Superficial injury of lower leg

189

1690

1.12

0.82

1.1

6.81

4.87

u/ml

0.36

694

Congenital absence, atresia and stenosis of large intestine

0.00

0.81

0.0

1.1

—

7.79

—

Osteomyelitis

206

1.36

0.81

1.1

1.0

1.44

3.12

u/ml

0.80

Femoral hernia

1.58

0.81

1.0

1.76

2.81

u/ml

—

Fracture of skull and facial bones

114

1314

0.87

0.81

1.1

6.29

3.79

u/ml

0.51

533

Thoracic aortic aneurysm

302

1.29

0.81

1.1

1.0

3.12

2.09

u/ml

0.36

118

DVT of lower extremities

610

0.80

1.1

3.60

3.01

u/ml

0.08

221

Primary_lymphoid and hematopoietic malignant neoplasms

763

0.82

0.80

1.1

5.20

4.04

u/ml

0.14

319

Mumps

122

1.48

0.80

1.1

1.0

4.72

3.44

u/ml

—

Use of peginterferon beta-1a

0.00

0.80

0.0

1.0

—

1.28

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

783

1.18

0.80

1.1

3.63

5.82

u/ml

0.88

390

Amblyopia ex anopsia

312

1.29

0.80

1.1

19.89

7.31

u/ml

0.38

146

Disorders of other endocrine glands

326

2951

1.09

0.79

1.1

2.76

5.28

u/ml

3.13

144

1260

Intentional self-harm by hanging, strangulation and suffocation

0.00

0.79

0.0

1.1

—

1.90

—

Amiodarone users

176

0.62

0.79

1.0

1.1

1.08

2.67

u/ml

—

Malignant neoplasm of bone and articular cartilage

0.00

0.79

0.0

1.0

—

1.36

—

Chronic periodontitis

531

0.79

1.1

0.97

4.34

u/ml

3.86

191

Pulmonary embolism

101

867

1.17

0.79

1.1

2.88

3.02

u/ml

0.04

320

Brain glioblastoma

0.00

0.79

0.0

1.1

—

5.70

—

Anoxic brain damage

0.00

0.79

0.0

1.0

—

1.47

—

Injuries to the head

872

5974

0.95

0.79

1.1

6.13

4.42

u/ml

1.09

371

2414

Brain glioblastoma, excluding all cancers (controls excluding all cancers)

0.00

0.78

0.0

1.1

—

5.00

—

Other disorders of Eustachian tube

131

1.46

0.78

1.1

1.0

7.82

5.13

u/ml

—

Pulmonary heart disease

101

868

1.16

0.78

1.1

2.88

3.01

u/ml

0.04

321

Disorders of mineral metabolism

286

1.30

0.78

1.1

1.65

3.21

u/ml

0.96

114

Systemic sclerosis

1.59

0.78

1.1

1.0

0.27

3.48

u/ml

—

Intestinal malabsorption

225

1.34

0.78

1.0

1.1

2.60

3.74

u/ml

—

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

258

0.70

0.78

1.1

4.86

2.50

u/ml

—

107

Cutaneous abscess, furuncle and carbuncle

152

1713

0.89

0.78

1.1

4.29

4.48

u/ml

0.04

704

Carcinoma in situ of breast, intraductal

281

0.71

0.78

1.0

8.22

3.32

u/ml

—

Diabetes insipidus

0.00

0.78

0.0

1.0

—

1.08

—

Neoplasms

858

4840

0.95

0.77

1.1

4.71

4.98

u/ml

0.09

338

2032

Other diseases of liver

851

1.17

0.77

1.1

1.58

3.68

u/ml

2.41

322

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

395

0.76

0.77

1.1

4.06

2.40

u/ml

0.22

160

Benign neoplasm of bone and articular cartilage

502

1.22

0.77

1.0

1.1

3.86

3.97

u/ml

0.01

191

Azathioprine

986

0.85

0.77

1.0

1.1

2.87

3.68

u/ml

0.27

394

Gout, strict definition

280

0.71

0.76

1.1

5.16

1.93

u/ml

—

111

Presbycusis

1.58

0.76

1.0

0.19

0.73

u/ml

—

Other congenital malformations of tongue, mouth and pharynx

191

1.37

0.76

1.2

1.1

4.81

6.36

u/ml

0.30

110

Right bundle-branch block

1.70

0.76

1.0

8.38

0.83

u/ml

—

Ménière disease

270

1.30

0.76

1.1

7.27

2.51

u/ml

0.35

104

Personal history of malignant neoplasm

161

0.62

0.75

1.0

4.48

3.10

u/ml

—

Benign lipomatous neoplasm

150

1331

1.13

0.75

1.0

1.1

7.60

3.42

u/ml

0.34

512

Bursitis of shoulder

1.55

0.75

1.0

0.43

3.39

u/ml

—

Other misadventures during surgical and medical care

1.65

0.75

1.2

1.1

0.57

2.02

u/ml

—

Dental pulpitis 1, only avohilmo

939

5144

0.95

0.75

1.1

4.69

4.41

u/ml

0.13

394

2061

Falls/tendency to fall

1104

5285

1.05

0.75

1.1

5.43

4.50

u/ml

0.47

482

2091

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

726

5381

0.95

0.75

1.1

5.12

4.51

u/ml

0.28

343

2135

Persons with potential health hazards related to communicable diseases

439

4066

1.07

0.75

1.1

5.25

5.20

u/ml

0.01

198

1720

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

423

1.24

0.75

1.1

8.52

4.70

u/ml

0.41

196

Parapsoriasis

1.61

0.75

1.0

1.1

5.50

3.49

u/ml

—

Other specific arthropathies, wide

1.58

0.75

1.1

1.0

17.48

3.90

u/ml

—

Obesity

504

4683

1.07

0.75

1.1

5.58

4.57

u/ml

0.32

211

1795

Other benign neoplasms of skin

175

1568

1.12

0.75

1.1

1.0

4.21

3.51

u/ml

0.22

588

Papilloedema, unspecified

116

1.48

0.74

1.0

1.1

14.32

5.96

u/ml

—

Retinal detachment with retinal break

324

1.27

0.74

1.0

1.1

5.39

2.12

u/ml

0.47

125

Pyogenic arthritis

227

1.32

0.74

1.2

1.1

1.32

2.77

u/ml

0.97

Agranulocytosis

459

0.78

0.74

1.2

1.1

9.96

3.91

u/ml

0.38

175

Anogenital herpesviral [herpes simplex] infection

560

1.20

0.74

1.1

1.0

2.12

3.91

u/ml

0.98

213

Pilonidal cyst

755

0.83

0.74

1.1

4.20

4.26

u/ml

0.02

299

Other disorders of the musculoskeletal system and connective tissue

523

1.21

0.74

1.1

5.16

2.31

u/ml

0.54

190

Burn and corrosion confined to eye and adnexa

133

1.44

0.74

1.1

1.0

2.88

3.14

u/ml

—

Speech therapy

130

1145

1.14

0.74

1.1

1.77

3.71

u/ml

2.38

441

Congenital malformations of heart and great arteries

1023

0.86

0.74

1.1

7.80

5.53

u/ml

0.40

482

Gastroduodenal ulcer

590

0.81

0.74

1.1

1.0

3.20

4.17

u/ml

0.22

227

Adhesive capsulitis of shoulder

624

1.19

0.73

1.1

1.0

2.00

3.13

u/ml

0.36

218

Later onset COPD

164

1.34

0.73

1.0

8.67

1.29

u/ml

—

Wide developmental disorders, excluding more controls

386

0.76

0.73

1.1

0.63

6.71

u/ml

6.66

206

Other diseases of anus and rectum

132

1163

1.14

0.73

1.1

4.51

4.06

u/ml

0.10

446

Radiculopathy

551

1.20

0.73

1.1

1.0

1.89

2.30

u/ml

0.17

192

Disorders of adult personality and behaviour

238

2606

0.91

0.73

1.1

3.10

4.62

u/ml

1.25

107

1039

Sleep disorders

184

1657

1.11

0.73

1.1

2.61

5.16

u/ml

1.26

678

Heterophoria

607

1.19

0.73

1.1

3.66

5.12

u/ml

0.41

255

Foreign body in respiratory tract

281

1.29

0.72

1.1

1.0

3.22

5.43

u/ml

0.49

120

Placental disorders

1.60

0.72

1.0

5.47

3.52

u/ml

—

Cardiac murmurs and other cardiac sounds

682

1.18

0.72

1.1

4.91

5.23

u/ml

0.04

302

Adhesive middle ear disease

1.56

0.72

1.0

1.42

12.81

u/ml

—

Melanocytic naevi of other and unspecified parts of face

317

1.27

0.72

1.1

0.72

4.77

u/ml

3.28

118

Glucosamine medication

122

854

1.14

0.72

1.0

2.49

2.60

u/ml

0.04

313

Other and unspecified epidermal thickening

117

1.46

0.72

1.1

1.0

8.19

4.25

u/ml

—

Benign neoplasm: Conjunctiva

117

1.46

0.72

1.0

2.15

3.49

u/ml

—

Paralytic ileus

1.55

0.72

1.1

1.0

2.65

2.41

u/ml

—

Varicose veins

256

2112

0.92

0.72

1.0

1.1

1.92

3.16

u/ml

1.13

750

Other or ill-defined heart diseases

211

1.33

0.72

1.1

1.0

4.04

4.71

u/ml

0.08

Abnormal involuntary movements

617

1.19

0.71

1.1

5.82

3.72

u/ml

0.43

240

Other and unspecified injuries of lower leg

489

1.21

0.71

1.1

4.01

3.85

u/ml

0.03

183

Collagenous colitis

380

1.24

0.71

1.1

1.94

4.63

u/ml

1.18

141

Other benign neoplasms of connective and other soft tissue

445

0.78

0.71

1.1

4.15

3.32

u/ml

0.09

165

Benign neoplasm: Peripheral nerves and autonomic nervous system

1.76

0.71

1.0

—

1.00

—

Car occupant injured in other and unspecified transport accidents

164

1470

1.12

0.71

1.1

8.78

4.63

u/ml

0.51

596

Pleural effusion

287

0.73

0.71

1.0

1.1

10.77

2.13

u/ml

—

111

Cirrhosis of liver, NAS

109

1.47

0.71

1.1

0.20

1.62

u/ml

—

Ankyloglossia

238

1.31

0.70

1.1

3.78

6.79

u/ml

0.89

130

Achilles tendinitis

444

1.22

0.70

1.1

1.0

3.58

2.16

u/ml

0.25

160

Sequelae of infectious and parasitic diseases

345

1.25

0.70

1.2

1.0

2.28

2.86

u/ml

0.21

126

Other local infections of skin and subcutaneous tissue

481

1.21

0.70

1.0

1.1

8.33

4.20

u/ml

0.78

181

Tuberculosis, IBD comorbidity

126

1.43

0.70

1.0

3.73

2.32

u/ml

—

Benign neoplasm: Peripheral nerves and autonomic nervous system

1.72

0.70

1.0

—

1.07

—

Muscle strain

169

1.37

0.69

1.1

1.0

1.27

4.07

u/ml

—

Ovarian hyperstimulation (induction)

178

1.36

0.69

1.1

12.23

3.19

u/ml

0.57

Sciatica+with lumbago

329

2896

1.08

0.69

1.1

6.60

3.76

u/ml

1.31

128

1086

Contact with other sharp object(s)

498

0.80

0.69

1.0

1.69

4.78

u/ml

1.78

192

Burns and corrosions confined to eye and internal organs

152

1.39

0.69

1.1

2.26

3.22

u/ml

—

Other disorders originating in the perinatal period

170

1.38

0.69

1.0

1.1

9.44

7.31

u/ml

0.19

106

Other and unspecified nerve root and plexus disorders, also in other diseases

111

973

1.14

0.69

1.0

1.1

3.78

3.59

u/ml

0.05

369

Systemic sclerosis, icd10

1.54

0.69

1.1

1.0

0.27

3.33

u/ml

—

Neuromuscular dysfunction of bladder

301

1.27

0.69

1.1

5.54

2.58

u/ml

0.41

108

Any mental disorder

994

4760

1.05

0.69

1.1

5.55

4.46

u/ml

0.53

421

1879

Other conjunctival vascular disorders and cysts

1.65

0.68

1.2

1.0

3.98

1.02

u/ml

—

Spondylosis

247

1941

1.09

0.68

1.1

1.0

5.04

3.16

u/ml

0.64

693

Ulcerative colitis (strict definition, require KELA)

106

1209

0.88

0.68

1.1

2.56

3.85

u/ml

0.77

485

Other and unspecified local infections of skin and subcutaneous tissue

455

1.21

0.68

1.0

1.1

8.64

4.33

u/ml

0.79

171

Obesity and other hyperalimentation

504

4698

1.06

0.68

1.1

5.58

4.57

u/ml

0.32

211

1795

Intestinal adhesions without obstruction

213

1.32

0.68

1.0

6.49

3.25

u/ml

—

Tubulo-interstitial nephritis, not specified as acute or chronic

296

0.74

0.68

1.0

1.1

6.46

3.99

u/ml

—

109

Other disorders of gingiva or/and edentulous alveolar ridge

273

0.73

0.68

1.1

3.61

6.61

u/ml

0.52

122

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

630

1.18

0.68

1.0

1.1

1.98

2.70

u/ml

0.48

238

Etanercept

419

0.78

0.68

1.0

1.1

4.74

4.01

u/ml

0.08

157

Deposits [accretions] on teeth

490

0.81

0.68

1.1

3.42

6.79

u/ml

1.04

238

Coagulation defects, purpura and other haemorrhagic conditions

1080

0.87

0.67

1.1

0.77

4.01

u/ml

7.95

445

Dental caries 1, only avohilmo

617

2985

1.06

0.67

1.0

1.1

3.48

4.37

u/ml

0.70

264

1155

Presbyopia

276

1.27

0.66

1.1

11.44

2.94

u/ml

—

Other peripheral vertigo

276

1.27

0.66

1.1

4.98

2.56

u/ml

0.26

103

Pervasive developmental disorders excl. Autism + Asperger

189

0.68

0.66

1.0

1.1

0.52

7.05

u/ml

—

114

Nontoxic goitre/thyroid nodule

126

1118

1.13

0.66

1.0

1.1

1.26

3.47

u/ml

3.63

404

Injury of other and unspecified intrathoracic organs

237

0.72

0.66

1.0

1.1

3.07

2.78

u/ml

—

Other keratitis

660

1.17

0.66

1.1

10.10

3.67

u/ml

1.24

254

Fracture of lower leg, including ankle

313

3355

0.93

0.66

1.1

4.77

4.40

u/ml

0.12

136

1316

Other acquired deformities of musculoskeletal system and connective tissue

197

1.32

0.66

1.1

1.0

9.95

2.30

u/ml

—

Medial epicondylitis

171

1.35

0.65

1.1

1.0

1.17

2.88

u/ml

0.89

Postprocedural disorders of nervous system

614

0.83

0.65

1.1

7.69

3.75

u/ml

0.54

238

Nonorganic sleeping disorders

167

1508

1.11

0.65

1.1

2.72

5.05

u/ml

0.99

613

Chalazion

596

1.18

0.65

1.1

1.55

3.39

u/ml

1.41

227

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

1.49

0.65

1.0

1.1

2.39

4.01

u/ml

—

Malignant melanoma of skin

282

0.74

0.65

1.0

1.1

0.70

2.11

u/ml

—

109

Cramp and spasm

224

1.30

0.65

1.1

1.0

7.73

5.25

u/ml

0.30

Other disorders of binocular movement

163

1.36

0.64

1.2

1.1

1.91

5.08

u/ml

1.11

Benign neoplasm: Conjunctiva

120

1.42

0.64

1.0

2.15

3.41

u/ml

—

Fall on same level involving ice and snow

373

3489

1.07

0.64

1.1

4.77

4.22

u/ml

0.16

171

1376

Other and unspecified mononeuropathies, also in other diseases

1.48

0.64

1.1

1.0

1.83

3.23

u/ml

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

103

1170

0.88

0.64

1.1

2.56

3.90

u/ml

0.80

469

Contusion of toe(s) without damage to nail

172

1.35

0.64

1.1

4.22

5.26

u/ml

—

Other disorders of skin and subcutaneous tissue

333

3272

0.93

0.64

1.1

3.18

4.37

u/ml

0.79

139

1276

Lesion of plantar nerve

198

1.32

0.64

1.1

1.0

3.37

2.72

u/ml

0.09

Nail disorders

450

1.20

0.64

1.1

1.0

2.23

3.88

u/ml

0.86

179

Multiple delivery

612

0.83

0.63

1.1

1.0

0.33

2.81

u/ml

5.54

222

Other congenital malformations of circulatory system

112

1.44

0.63

1.1

1.0

6.85

5.00

u/ml

—

Delayed milestone in childhood

314

0.77

0.63

1.1

10.29

8.19

u/ml

0.15

191

Other and/or unspecified nontoxic goitre

278

1.26

0.63

1.0

1.47

2.52

u/ml

—

Symptoms and signs concerning food and fluid intake

505

1.19

0.63

1.1

3.32

4.86

u/ml

0.38

221

Sexual dysfunction

1.53

0.63

1.0

1.95

2.44

u/ml

—

Viral meningitis

243

1.28

0.63

1.0

7.52

3.83

u/ml

0.41

Maternal care for known or suspected abnormality of pelvic organs

299

1914

1.08

0.63

1.1

2.97

5.71

u/ml

1.49

117

696

Other coagulation defects

436

0.80

0.62

1.1

0.54

4.54

u/ml

3.90

162

Viral Sepsis

794

1.15

0.62

1.1

8.90

4.27

u/ml

0.86

328

KRA_PSY_EATING, excluding more controls

110

970

1.13

0.62

1.1

3.91

4.90

u/ml

0.17

406

Caught, crushed, jammed or pinched in or between objects

306

1.25

0.62

1.1

6.36

4.94

u/ml

0.15

122

Pedestrian injured in transport accident

342

1.23

0.62

1.1

1.0

4.29

3.90

u/ml

0.04

137

Diabetic retinopathy, strict definition

420

1.19

0.62

1.1

5.41

4.01

u/ml

0.24

175

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

235

1.28

0.61

1.1

1.0

8.73

5.65

u/ml

0.20

Fall on and from stairs and steps

143

1286

1.11

0.61

1.1

2.79

3.81

u/ml

0.65

514

Dental caries 3 and operation codes

742

3630

1.05

0.61

1.1

2.47

4.58

u/ml

4.18

312

1423

Complications of anaesthesia during pregnancy

0.00

0.61

0.0

1.1

—

3.50

—

Oesophageal obstruction

1.60

0.61

1.3

1.0

10.04

0.97

u/ml

—

Vertical strabismus

156

1.35

0.61

1.0

1.1

2.43

4.14

u/ml

—

Tuberculosis, wide

130

1.39

0.61

1.0

3.73

2.27

u/ml

—

Sicca syndrome [Sjögren]

343

1.23

0.61

1.0

5.17

2.99

u/ml

0.20

120

Viral pneumonia (known virus, not influenza)

1.48

0.61

1.2

1.1

3.32

7.03

u/ml

—

Vestibular neuronitis

307

1.24

0.61

1.0

1.1

4.67

2.94

u/ml

0.28

111

Presence of other functional implants

151

1185

0.90

0.60

1.1

1.0

3.31

3.42

u/ml

0.03

447

Wilms' tumor

0.00

0.60

0.0

1.3

—

3.94

—

Carcinoma in situ of breast, intraductal

267

0.75

0.60

1.0

8.22

2.82

u/ml

—

Other disorders of veins

214

1964

1.09

0.60

1.1

4.47

3.47

u/ml

0.29

706

Pregnancy with abortive outcome

618

3070

1.05

0.60

1.1

5.07

4.99

u/ml

0.03

232

1163

Malignant neoplasm of eye and adnexa

0.00

0.60

0.0

1.0

—

1.42

—

Personality disorders

222

2410

0.92

0.60

1.1

2.79

4.80

u/ml

2.01

102

947

Convergent concomitant strabismus

488

0.82

0.60

1.1

2.27

5.47

u/ml

1.87

199

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

244

0.74

0.60

1.1

3.06

2.26

u/ml

—

101

Female infertility, tubal origin

353

1.22

0.60

1.1

4.07

3.30

u/ml

0.13

123

Other disorders of conjunctiva

380

1.21

0.60

1.0

1.1

3.75

2.22

u/ml

0.36

140

Delayed puberty

1.46

0.60

1.1

9.40

7.31

u/ml

—

Otitis externa, unspecified

676

1.16

0.60

1.1

1.58

3.86

u/ml

2.36

269

Osteosarcoma, excluding all cancers (controls excluding all cancers)

0.00

0.60

0.0

1.0

—

1.89

—

Traumatic subarachnoid haemorrhage

1.50

0.60

1.0

8.92

2.22

u/ml

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

199

2155

0.92

0.59

1.1

3.85

4.60

u/ml

0.27

881

Spirochaetal infections, other/unspecified

317

1.23

0.59

1.1

6.69

3.57

u/ml

0.26

118

Alcohol induced polyneuropathy

0.00

0.59

0.0

1.0

—

0.35

—

Papulosquamous disorders

213

1958

1.09

0.59

1.1

3.80

3.73

u/ml

0.02

743

Heart failure and hypertrophic cardiomyopathy

0.00

0.59

0.0

1.0

—

5.92

—

Inguinal hernia

331

2388

0.93

0.59

1.0

1.1

2.58

4.05

u/ml

1.14

135

984

Bullous disorders

157

1.34

0.59

1.0

14.37

2.34

u/ml

—

Pulmonary heart disease, diseases of pulmonary circulation

108

958

1.13

0.59

1.1

2.76

3.35

u/ml

0.20

363

Contact with nonpowered hand tool

210

1.29

0.59

1.2

1.0

1.04

3.45

u/ml

1.81

Calculus of kidney and ureter

128

1148

1.12

0.58

1.1

3.83

3.51

u/ml

0.10

443

Spermatocele

166

1.33

0.58

1.0

4.12

2.93

u/ml

—

Dental pulpitis 3

205

1606

0.92

0.58

1.1

10.17

5.80

u/ml

0.92

104

761

Noise effects on inner ear

140

1.36

0.58

1.1

0.25

2.97

u/ml

—

Reactive arthropathies, FINNGEN

400

1.20

0.58

1.0

2.18

2.90

u/ml

0.26

141

ILD medications: azathioprine

959

0.87

0.58

1.0

1.1

2.87

3.96

u/ml

0.39

387

Melanocytic naevi, other sites/unspecified

437

1.19

0.58

1.0

1.1

3.46

3.65

u/ml

0.03

155

Endometriosis diagnosis and infertility diagnosis occurring together

947

0.87

0.57

1.1

1.85

3.68

u/ml

1.00

348

Intracerebral haemorrhage

219

0.73

0.57

1.1

5.29

1.56

u/ml

—

Deep endometriosis

595

1.16

0.57

1.1

1.47

3.11

u/ml

1.07

221

Complications of the puerperium, not elsewhere classified

386

0.80

0.57

1.1

1.0

2.58

3.16

u/ml

—

137

Pneumonia due to Streptococcus pneumoniae

158

1.33

0.57

1.0

30.94

2.61

u/ml

—

Abrasion of teeth

197

1328

1.09

0.57

1.1

1.0

3.09

4.42

u/ml

0.75

477

Gonarthrosis

337

2065

0.94

0.57

1.1

3.32

3.24

u/ml

0.03

140

701

Pain associated with micturition

549

1.17

0.57

1.0

1.1

7.42

4.67

u/ml

0.57

219

Hernia of abdominal wall, postoperative

745

1.14

0.56

1.0

1.1

5.73

3.64

u/ml

0.29

276

Implicit viral Sepsis

792

1.14

0.56

1.1

7.88

4.28

u/ml

0.64

327

Pneumonia due to other infectious organisms, not elsewhere classified

1.43

0.56

1.1

1.0

1.14

2.94

u/ml

—

Procreative management

336

2657

1.07

0.56

1.1

6.38

5.27

u/ml

0.23

173

1119

Premature rupture of membranes

273

1867

1.08

0.56

1.1

5.96

5.82

u/ml

0.02

105

707

Mandibular retrognathia AND surgery (BSSRO)

194

1.30

0.56

1.2

1.1

7.58

3.65

u/ml

0.34

Embedded teeth, including avohilmo

112

1001

1.12

0.56

1.1

8.54

4.45

u/ml

0.32

426

Other maltreatment syndromes

229

0.74

0.56

1.0

1.1

2.71

2.72

u/ml

—

Labour and delivery complicated by umbilical cord complications

385

0.80

0.56

1.0

4.04

3.01

u/ml

—

125

Melanocytic naevi of other and unspecified parts of face

329

1.22

0.56

1.1

0.72

4.76

u/ml

3.60

128

Intracranial injury

409

3730

1.06

0.56

1.1

6.75

4.56

u/ml

0.73

179

1564

Direct fill therapy

891

0.87

0.55

1.2

1.1

3.02

4.75

u/ml

0.60

377

Corneal ulcer

123

1106

1.11

0.55

1.0

1.1

6.73

3.65

u/ml

0.81

435

Primary_lymphoid and hematopoietic malignant neoplasms

731

0.86

0.55

1.1

5.20

4.05

u/ml

0.13

303

Certolizumab pegol

124

0.64

0.55

1.0

1.1

1.49

5.29

u/ml

—

Failed induction of labour

644

0.85

0.55

1.1

4.38

3.40

u/ml

0.12

234

Prepatellar bursitis

168

1.31

0.55

1.0

3.39

3.06

u/ml

—

Cholangitis (primary sclerosing, PSC)

228

0.74

0.54

1.1

1.97

4.60

u/ml

—

Reactive arthropathies

468

1.18

0.54

1.0

4.63

2.95

u/ml

0.35

161

Tooth agenesis EXCLUDE clefts and syndromes

450

1.18

0.54

1.1

5.67

5.84

u/ml

0.02

195

Emotionally unstable personality disorder

112

1248

0.90

0.54

1.1

3.41

4.52

u/ml

0.49

496

Aneurysms, operations, SAH

536

0.84

0.54

1.1

6.86

2.41

u/ml

0.74

202

Episcleritis

285

1.23

0.54

1.1

2.56

2.36

u/ml

0.05

Cerebral cysts

358

1.21

0.54

1.2

1.1

5.36

4.21

u/ml

0.15

136

Carcinoma in situ of skin

1.42

0.54

1.0

0.66

1.36

u/ml

—

Anisometropia and aniseikonia

160

1.32

0.53

1.0

3.50

7.19

u/ml

—

Benign neoplasm of other and unspecified female genital organs

160

1.32

0.53

1.1

1.0

6.12

3.05

u/ml

—

Eustachian salpingitis and obstruction

722

1.14

0.53

1.1

4.11

4.44

u/ml

0.07

293

Unspecified jaundice

134

1.35

0.53

1.1

1.0

0.25

3.25

u/ml

—

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

349

0.80

0.52

1.0

1.1

4.11

3.00

u/ml

—

143

Osteonecrosis

181

0.72

0.52

1.0

1.19

2.69

u/ml

—

Other and unspecified injuries of wrist and hand

250

1.25

0.52

1.1

2.53

4.50

u/ml

0.72

Neonatal jaundice from other and unspecified causes

272

0.77

0.52

1.2

1.1

11.26

7.81

u/ml

0.22

157

Specific personality disorders

195

2111

0.92

0.52

1.1

2.92

4.94

u/ml

1.72

838

Examination and encounter for administrative purposes

117

1.37

0.52

1.2

1.0

1.10

3.50

u/ml

—

Ventral hernia

864

1.12

0.52

1.0

1.1

3.41

3.56

u/ml

0.04

328

Missing teeth due to accident, extraction or parodontitis

414

0.82

0.52

1.1

1.50

3.88

u/ml

1.58

133

Vitreous haemorrhage

304

0.79

0.52

1.0

1.1

0.22

2.57

u/ml

—

120

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

326

0.80

0.51

1.0

1.1

11.13

2.89

u/ml

—

138

Constipation

505

3798

0.95

0.51

1.1

2.78

4.76

u/ml

2.56

199

1527

Retention of urine

776

0.88

0.51

1.1

2.76

3.43

u/ml

0.19

309

Arthropathic psoriasis

554

0.85

0.51

1.0

1.1

4.00

3.09

u/ml

0.15

204

Open bite that required surgery (Lefort1 or BSSRO)

1.48

0.51

1.0

1.1

4.39

9.25

u/ml

—

Anorexia (incl.atypical)

596

0.85

0.51

1.1

7.72

5.29

u/ml

0.23

240

Barrett oesophagus

109

1.38

0.51

1.1

1.0

0.87

2.98

u/ml

—

!Aliquae complicationes praecoces traumatis

191

0.73

0.51

1.1

1.0

7.89

3.23

u/ml

—

Early complications of trauma

191

0.73

0.51

1.1

1.0

7.89

3.23

u/ml

—

Arthropathy in ulcerative colitis

1.39

0.51

1.1

1.0

—

3.32

u/ml

—

Congenital malformations of breast

153

1.32

0.51

1.2

1.1

0.38

4.31

u/ml

—

Inguinal hernia, bilateral

242

1.24

0.50

1.0

1.1

1.72

2.43

u/ml

0.39

Other abnormal immunological findings in serum

118

1.36

0.50

1.0

1.1

3.82

5.49

u/ml

—

Seborrhoeic keratosis

565

1.15

0.50

1.0

0.85

2.92

u/ml

3.03

211

Psoriasis

134

1472

0.91

0.50

1.1

4.67

3.77

u/ml

0.25

552

Other diseases of arteries and capillaries

297

1.21

0.50

1.0

1.1

6.40

3.02

u/ml

0.27

109

Injuries to unspecified part of trunk, limb or body region

509

0.84

0.50

1.0

10.22

3.91

u/ml

0.70

196

Open wound of abdomen, lower back and pelvis

180

1.28

0.50

1.1

1.0

2.67

4.60

u/ml

0.35

Mandibular prognathia AND surgery (LeFortI or BSSO or LeFortI AND BSSO), including avohilmo

1.44

0.50

1.2

1.1

2.38

6.63

u/ml

—

Glomerulonephritis

455

0.83

0.50

1.1

5.70

4.31

u/ml

0.13

195

Benign neoplasm: Long bones of lower limb

189

1.28

0.49

1.0

1.1

1.44

3.30

u/ml

—

Other and unspecified disease of Bartholin gland

101

1.39

0.49

1.3

1.0

8.93

2.44

u/ml

—

Family history of malignant neoplasm

712

0.87

0.49

1.1

1.16

3.78

u/ml

2.50

256

Conduction disorders

106

791

1.11

0.49

1.1

2.55

3.76

u/ml

0.55

302

Acute peritonitis

190

0.74

0.49

1.0

0.28

4.19

u/ml

—

Other/unspecified enthesopathies of lower limb, excluding foot

399

1.18

0.49

1.0

1.1

3.29

2.42

u/ml

0.24

146

Haemorrhoids and perianal venous thrombosis

109

981

1.11

0.49

1.0

1.1

3.75

2.97

u/ml

0.11

383

Corns and callosities

246

0.77

0.49

1.1

1.0

2.31

2.84

u/ml

0.22

Contact with and exposure to communicable diseases

385

3634

1.06

0.49

1.1

5.46

5.28

u/ml

0.06

168

1546

Peripheral arterial reconstruction

201

0.75

0.49

1.1

5.98

1.88

u/ml

—

Hyperlipidaemia, other/unspecified

944

0.89

0.49

1.1

1.0

2.10

3.21

u/ml

0.40

356

Other sleep disorders

539

1.15

0.49

1.1

1.58

3.81

u/ml

2.03

205

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

367

0.82

0.48

1.0

1.1

0.47

2.41

u/ml

—

140

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

118

1301

0.91

0.48

1.1

2.45

3.76

u/ml

0.89

531

Tramadol

557

3421

1.05

0.48

1.1

2.46

4.21

u/ml

2.58

244

1284

Nonischemic cardiomyopathy

178

0.73

0.48

1.4

1.1

7.62

2.78

u/ml

—

Other arthritis (FG)

175

1895

0.92

0.48

1.1

5.15

4.51

u/ml

0.16

728

Dizziness and giddiness

463

3577

1.05

0.48

1.1

3.45

4.63

u/ml

0.42

198

1368

Oral leukoplakia and related diseases, including avohilmo

271

1.22

0.48

1.1

4.92

2.72

u/ml

0.24

104

Disorders of synovium and tendon in diseases classified elsewhere

1.45

0.48

1.0

5.61

2.48

u/ml

—

Superficial injury of wrist and hand

177

1635

1.08

0.48

1.1

2.73

4.70

u/ml

1.69

682

Inflammatory disease of cervix uteri

244

1.23

0.48

1.2

1.0

0.82

2.06

u/ml

1.11

Benign neoplasm of mouth and pharynx

400

1.18

0.48

1.1

5.73

2.49

u/ml

0.36

147

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

343

0.81

0.48

1.1

2.92

7.26

u/ml

1.38

170

Osteopathies and chondropathies

315

2816

1.06

0.48

1.1

4.24

4.70

u/ml

0.15

134

1116

Other specified/unspecified hearing loss

226

1.24

0.48

1.1

1.0

1.65

4.32

u/ml

0.82

Rash and other nonspecific skin eruption

475

1.16

0.47

1.1

5.50

4.02

u/ml

0.24

192

Artificial joint re-operation

102

1.37

0.47

1.1

1.0

3.21

1.11

u/ml

—

Astigmatism

466

1.16

0.47

1.0

1.1

17.14

6.32

u/ml

0.40

218

Parodontitis, under 40 years, or operation codes

107

1182

0.90

0.47

1.1

4.44

5.07

u/ml

0.13

509

Other disorders of optic [2nd] nerve and visual pathways

309

1.20

0.47

1.1

8.40

5.08

u/ml

0.35

132

Family history of other conditions

1.39

0.46

1.2

1.1

1.13

8.75

u/ml

—

Macular pucker

200

1.25

0.46

1.0

1.1

1.60

1.43

u/ml

0.07

Injuries to the hip and thigh

217

1852

1.07

0.46

1.1

7.56

4.03

u/ml

0.71

731

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

221

0.77

0.46

1.1

3.06

2.36

u/ml

—

Cholecystectomy

400

3361

1.05

0.46

1.1

4.50

3.86

u/ml

0.25

144

1226

Other and unspecified myopathies

232

0.77

0.46

1.0

0.94

3.02

u/ml

—

Bitten or struck by other mammals

826

1.12

0.45

1.1

10.30

3.99

u/ml

0.72

321

Injuries to the elbow and forearm

495

4677

0.96

0.45

1.1

5.39

4.89

u/ml

0.22

214

1915

Torticollis

103

1.37

0.45

1.1

1.69

6.52

u/ml

—

Aortic valve malfunction, age under 60 years

439

0.84

0.45

1.0

1.1

2.25

2.93

u/ml

0.22

180

Other facial nerve disorders

103

1.36

0.45

1.1

1.0

2.20

2.49

u/ml

—

Parodontitis, under 40 years

107

1179

0.91

0.45

1.1

4.44

5.07

u/ml

0.13

507

Acute appendicitis, with complications

970

0.90

0.45

1.1

5.89

3.40

u/ml

0.53

362

Elevated blood glucose level

363

0.82

0.45

1.1

1.50

4.53

u/ml

2.02

147

Psychiatric diseases

981

4754

1.03

0.45

1.1

5.41

4.44

u/ml

0.46

413

1879

Sleep disorders, other/unspecified

242

0.78

0.45

1.1

1.0

0.16

5.38

u/ml

—

Injury of eye and orbit

107

970

1.10

0.45

1.0

1.1

6.72

4.33

u/ml

0.37

398

Melanocytic naevi, other sites/unspecified

450

1.16

0.44

1.0

1.1

3.46

3.45

u/ml

0.00

169

Pustular psoriasis

175

0.74

0.44

1.0

3.36

3.35

u/ml

—

Autoimmune hyperthyroidism

384

0.83

0.44

1.0

1.1

0.66

3.58

u/ml

—

137

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

384

0.83

0.44

1.0

1.1

5.69

2.81

u/ml

—

157

Conductive and sensorineural hearing loss

355

2591

0.95

0.44

1.1

3.50

3.85

u/ml

0.15

141

987

Epilepsy

170

1828

0.93

0.44

1.1

4.34

4.69

u/ml

0.07

774

Familial hypercholesterolemia, with ischemic heart disease

121

1.32

0.44

1.0

6.15

1.86

u/ml

—

Myocardial infarction, without ST-elevation

632

1.12

0.44

1.1

1.0

4.64

2.94

u/ml

0.41

239

Benign neoplasm: Colon

169

1398

0.93

0.44

1.1

2.27

3.15

u/ml

0.40

537

Erythema nodosum

130

1.31

0.44

1.1

1.0

0.66

4.40

u/ml

—

Psoriatic and enteropathic arthropathies

672

0.88

0.43

1.1

4.00

3.27

u/ml

0.12

244

Abnormal serum enzyme levels

820

0.89

0.43

1.1

1.52

3.26

u/ml

1.91

327

Pedal cyclist injured in transport accident

141

1531

0.92

0.43

1.1

3.72

4.74

u/ml

0.48

623

Benign neoplasm: Skin of trunk

184

1.25

0.43

1.1

1.0

2.26

3.22

u/ml

0.38

Diffuse brain injury

174

0.75

0.43

1.1

1.0

2.89

3.17

u/ml

—

Cardiovascular diseases (excluding rheumatic etc)

771

4611

0.96

0.43

1.1

4.29

4.75

u/ml

0.28

319

1869

Bacterial intestinal infections, IBD co-morbidities

706

1.12

0.43

1.1

11.74

3.86

u/ml

0.48

271

Hypotension

266

1.20

0.43

1.0

1.1

3.69

2.62

u/ml

0.18

103

Twin gestation

829

0.89

0.43

1.1

0.70

4.21

u/ml

2.36

295

Emotional disorders starting during childhood or adolecense, excluding more controls

618

1.13

0.42

1.2

1.1

5.34

6.24

u/ml

0.21

299

Nontoxic multinodular goitre

659

1.12

0.42

1.1

1.0

0.89

3.05

u/ml

2.83

233

Inguinal or femoral hernia, bilateral

248

1.21

0.42

1.0

1.1

1.72

2.38

u/ml

0.36

Hordeolum and other deep inflammation of eyelid

322

1.18

0.42

1.1

5.86

4.38

u/ml

0.12

131

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

258

0.80

0.42

1.0

1.1

11.59

8.17

u/ml

0.22

150

Maternal care for known or suspected fetal abnormality and damage

170

1627

0.93

0.42

1.1

4.35

5.58

u/ml

0.29

606

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

660

1.12

0.42

1.1

1.40

5.21

u/ml

1.84

249

Drug-induced neutropenia

229

0.78

0.42

1.1

1.0

4.32

2.92

u/ml

—

Speech disturbances, not elsewhere classified

251

0.80

0.42

1.1

7.72

2.76

u/ml

—

Symptoms and signs involving emotional state

194

1.24

0.42

1.1

3.00

5.48

u/ml

0.63

Other sexually transmitted chlamydial diseases

784

1.11

0.42

1.1

3.87

4.78

u/ml

0.20

328

Left ventricular outflow tract obstruction, narrow definition

316

0.82

0.42

1.0

1.1

1.87

6.38

u/ml

—

144

Disorders of endocrine glands in diseases classified elsewhere

0.00

0.42

0.0

1.1

—

3.76

—

Other disorders of kidney and ureter

392

0.84

0.42

1.2

1.1

6.35

2.61

u/ml

0.43

155

Congenital malformations of great arteries

267

0.80

0.42

1.1

13.37

9.04

u/ml

0.28

153

Crohn's disease (strict) with PSC

0.00

0.41

0.0

1.1

—

3.98

—

Marasmic kwashiorkor

0.00

0.41

0.0

1.0

—

0.47

—

Polyglandular dysfunction

0.00

0.41

0.0

1.0

—

1.98

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

190

2034

0.93

0.41

1.1

1.60

4.61

u/ml

5.17

815

Other specified and unspecified personality disorders

690

0.88

0.41

1.1

3.44

3.35

u/ml

0.02

267

Other (seronegative) rheumatoid arthritis, wide

722

0.89

0.41

1.1

3.15

3.62

u/ml

0.09

262

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

295

1.19

0.41

1.1

1.09

2.18

u/ml

0.68

115

Hidradenitis suppurativa

272

0.81

0.41

1.2

1.0

25.48

5.00

u/ml

—

102

Qualitative platelet defects

0.00

0.41

0.0

1.0

—

3.78

—

Epileptic seizures related to drugs

0.00

0.41

0.0

1.0

—

2.20

—

Disseminated intravascular coagulation [defibrination syndrome]

0.00

0.41

0.0

1.1

—

4.81

—

Adrenogenital disorders

0.00

0.41

0.0

1.0

—

1.62

—

Benign neoplasm: Tonsil

1.52

0.41

1.0

1.1

—

1.27

—

Dermatopolymyositis, unspecified

0.00

0.41

0.0

1.1

—

0.96

—

Epileptic seizures related to alcohol

0.00

0.41

0.0

1.1

—

4.11

—

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

0.00

0.41

0.0

1.0

—

1.68

—

Conotruncal defects

172

0.75

0.41

1.1

12.29

7.38

u/ml

—

Benign neoplasm: Endocrine pancreas

0.00

0.41

0.0

1.1

—

0.88

—

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

0.00

0.41

0.0

1.1

—

1.69

—

Small cell lung cancer, excluding all cancers (controls excluding all cancers)

0.00

0.41

0.0

1.1

—

0.11

—

Family history of mental and behavioural disorders

0.00

0.41

0.0

1.0

—

2.67

—

Small cell lung cancer, helper endpoint

0.00

0.41

0.0

1.1

—

0.09

—

Small cell lung cancer

0.00

0.41

0.0

1.1

—

0.09

—

Psoriatic arthropathies, ICD10

509

0.86

0.41

1.0

1.1

4.38

2.85

u/ml

—

191

Haemolytic-uraemic syndrome

0.00

0.41

0.0

1.1

—

8.39

—

Fall on and from ladder

231

1.21

0.41

1.1

1.01

3.44

u/ml

1.26

Reduction defects of lower limb

0.00

0.41

0.0

1.0

—

1.51

—

Speech and linguistic disorders

119

1047

1.09

0.41

1.1

5.61

5.71

u/ml

0.02

521

Other disorders of bladder

314

1.18

0.41

1.2

1.1

4.54

2.40

u/ml

0.31

129

Follicular adenocarcinoma of thyroid gland

0.00

0.41

0.0

1.0

—

1.92

—

Abnormal results of function studies

398

1.16

0.40

1.1

1.44

3.57

u/ml

1.57

152

Osteoporosis

546

0.87

0.40

1.0

1.1

5.43

3.07

u/ml

0.27

210

Benign neoplasm: Long bones of lower limb

195

1.24

0.40

1.0

1.1

1.44

3.57

u/ml

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

498

2810

1.04

0.40

1.1

5.22

5.36

u/ml

0.04

193

1032

Crohn's disease NAS

444

0.85

0.40

1.1

6.15

4.40

u/ml

0.29

171

Benign neoplasm: Tonsil

1.48

0.40

1.0

1.1

—

1.39

—

Other and unspecified visual disturbances

417

1.15

0.40

1.1

1.0

1.07

4.03

u/ml

2.40

152

Weight loss

389

1.16

0.40

1.1

3.55

5.84

u/ml

0.50

168

Exposure to other and unspecified inanimate mechanical forces

436

1.15

0.40

1.1

3.64

3.95

u/ml

0.06

174

Benign neoplasm: Endocrine pancreas

0.00

0.40

0.0

1.1

—

1.01

—

Retained placenta and membranes, without haemorrhage

777

1.11

0.40

1.1

5.31

3.70

u/ml

0.24

259

Strabismus

188

2005

0.93

0.40

1.1

4.93

5.12

u/ml

0.03

864

Agoraphobia

292

0.82

0.39

1.1

1.0

1.36

5.10

u/ml

—

120

Neuralgia and neuritis, unspecified

223

1.21

0.39

1.0

1.1

1.05

3.06

u/ml

1.09

Secondary hypertension

375

0.84

0.39

1.0

1.1

5.59

4.67

u/ml

—

156

Primary open-angle glaucoma

471

1.14

0.39

1.0

1.32

2.66

u/ml

1.18

188

Other aneurysm

1.34

0.39

1.0

3.69

1.08

u/ml

—

Residual foreign body in soft tissue

260

1.20

0.39

1.0

1.1

6.09

5.08

u/ml

0.06

103

Crushed, pushed or stepped on by crowd or human stampede

645

1.12

0.39

1.1

2.47

5.19

u/ml

1.43

274

Wilms' tumor, excluding all cancers (controls excluding all cancers)

0.00

0.39

0.0

1.3

—

3.94

—

Renal tubulo-interstitial disorders in diseases classified elsewhere

0.00

0.39

0.0

1.1

—

2.26

—

Chronic myeloproliferative disease

0.00

0.39

0.0

1.1

—

1.34

—

Endometriosis ASRM stages 3,4

167

1557

1.07

0.39

1.1

2.09

4.44

u/ml

1.92

575

Colorectal adenocarcinoma

335

0.84

0.39

1.0

1.1

4.11

2.35

u/ml

—

131

Multiple gestation

864

0.90

0.38

1.1

0.76

4.24

u/ml

2.50

312

Undescended testicle

147

0.74

0.38

1.0

1.1

4.10

4.06

u/ml

—

Abnormal findings on diagnostic imaging of other body structures

466

1.14

0.38

1.1

6.27

2.60

u/ml

0.47

169

Radial styloid tenosynovitis [de Quervain]

335

1.17

0.38

1.1

1.0

2.46

3.89

u/ml

0.39

120

Spontaneous rupture of synovium and tendon

233

1.20

0.38

1.0

1.1

2.90

3.04

u/ml

—

Sudden idiopathic hearing loss

307

1.17

0.38

1.0

8.78

2.58

u/ml

0.84

123

Generalized epilepsy, mode (most common among epilepsy diagnosis)

252

1.20

0.38

1.0

1.1

7.18

6.25

u/ml

0.05

113

Bacterial pneumonia (organism specified)

213

1825

1.06

0.38

1.1

6.13

4.32

u/ml

0.37

114

706

Algoneurodystrophy

197

1.22

0.38

1.1

3.51

4.85

u/ml

—

Impacted cerumen

317

1.17

0.37

1.1

2.73

5.23

u/ml

0.81

136

Other hearing loss

645

1.11

0.37

1.0

4.94

3.56

u/ml

0.27

250

Anankastic personality disorder

271

1.18

0.37

1.1

1.0

1.26

3.55

u/ml

1.29

100

Hypothyroidism, drug reimbursement

129

997

0.92

0.37

1.1

3.08

4.20

u/ml

0.43

383

Hernia

627

4402

0.97

0.37

1.0

1.1

3.51

4.46

u/ml

0.67

274

1714

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

472

0.87

0.37

1.1

1.77

4.54

u/ml

1.93

192

Infections of breast associated with childbirth

327

1.17

0.37

1.1

1.0

2.09

4.11

u/ml

0.69

117

Abscess of anal and rectal regions

472

0.87

0.37

1.0

1.1

1.74

3.90

u/ml

1.56

193

Maltreatment syndromes

461

0.87

0.37

1.1

1.0

7.25

3.90

u/ml

0.38

178

Benign neoplasm of thyroid gland

116

1.30

0.37

1.2

1.0

1.36

3.15

u/ml

—

Use of interferon beta-1a

180

0.77

0.37

1.0

2.16

3.77

u/ml

—

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

397

0.85

0.37

1.0

1.1

1.88

3.01

u/ml

0.58

153

Lesion of radial nerve

134

1.27

0.37

1.1

1.0

4.63

3.00

u/ml

—

Myeloproliferative diseases

213

0.80

0.36

1.1

1.0

1.91

2.16

u/ml

—

Haemorrhagic and haematological disorders of fetus and newborn

347

0.85

0.36

1.2

1.1

9.41

7.24

u/ml

0.16

197

Fracture of rib(s), sternum and thoracic spine

1080

0.92

0.36

1.1

4.96

3.19

u/ml

0.47

410

Other and unspecified iron deficiency

163

1523

1.07

0.36

1.1

4.34

4.75

u/ml

0.09

601

Hypertrichosis

189

1.22

0.36

1.0

2.13

5.49

u/ml

—

Urolithiasis

130

1205

1.08

0.36

1.1

3.83

3.41

u/ml

0.13

464

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

716

1.11

0.36

1.1

1.0

1.41

3.51

u/ml

1.75

249

Other pulmonary heart/vessel disease

1.36

0.36

1.2

1.0

1.22

2.50

u/ml

—

Glaucoma

177

1456

1.07

0.36

1.0

1.1

2.78

3.36

u/ml

0.20

557

Benign neoplasm: Skin of trunk

189

1.22

0.36

1.1

1.0

2.26

3.28

u/ml

0.41

Premenstrual syndrome

1.34

0.36

1.0

1.1

1.13

6.12

u/ml

—

Disorders in reading

162

1.24

0.36

1.2

1.0

4.93

5.51

u/ml

—

Other arrhythmias

442

3250

1.04

0.36

1.1

3.16

4.52

u/ml

1.09

185

1218

Methotrexate

629

0.89

0.36

1.0

3.59

2.84

u/ml

0.09

208

Personal history of other diseases and conditions

128

1182

1.08

0.35

1.1

4.97

4.88

u/ml

0.01

517

Injuries involving multiple body regions

212

0.80

0.35

1.1

1.82

3.85

u/ml

—

Dental caries, including avohilmo

598

2951

1.04

0.35

1.1

3.57

4.49

u/ml

0.69

253

1140

Other and unspecified acne

108

1.30

0.35

1.0

0.34

5.41

u/ml

—

Abnormal weight loss

319

1.16

0.35

1.2

1.1

3.85

5.91

u/ml

0.38

133

Basal cell carcinoma

110

951

0.92

0.35

1.1

1.0

0.83

2.75

u/ml

3.48

352

Other diseases of pancreas

201

0.79

0.35

1.0

1.49

2.39

u/ml

—

Oligomenorrhoea

282

1.17

0.35

1.0

1.1

3.47

4.58

u/ml

—

114

Carcinoma in situ of skin

108

1.30

0.35

1.0

1.1

0.66

1.39

u/ml

—

Intestinal stricture

994

0.91

0.35

1.0

1.1

3.10

3.83

u/ml

0.24

382

Dental caries 1

598

2952

1.04

0.35

1.1

3.57

4.49

u/ml

0.69

253

1140

Diabetic nephropathy, excluding more controls

312

0.85

0.35

1.1

9.07

3.28

u/ml

0.57

123

Contact with other hot metals

1.38

0.34

1.0

8.01

5.04

u/ml

—

Hyperparathyroidism

418

1.14

0.34

1.1

1.0

3.51

2.83

u/ml

0.11

154

Secondary and unspecified malignant neoplasm of lymph nodes

233

0.81

0.34

1.1

0.37

4.02

u/ml

—

Other disorders of breast and lactation associated with childbirth

172

1.23

0.34

1.1

0.48

4.65

u/ml

—

Alcohol-induced chronic pancreatitis

222

0.81

0.34

1.0

1.1

2.89

1.94

u/ml

—

Other symptoms and signs involving general sensations and perceptions

156

0.77

0.34

1.2

1.1

1.01

5.12

u/ml

—

In situ neoplasms

149

1520

0.93

0.34

1.0

1.1

4.63

3.91

u/ml

0.13

582

Unspecified misadventure during surgical and medical care

181

1.22

0.34

1.1

1.0

3.71

3.15

u/ml

0.10

Cholesteatoma of middle ear

156

0.77

0.34

1.0

1.1

19.73

3.55

u/ml

—

Superficial injury of ankle and foot

113

1045

1.08

0.34

1.1

9.37

4.56

u/ml

0.51

447

Benign neoplasm of brain and other parts of central nervous system

276

0.83

0.34

1.1

1.19

2.85

u/ml

0.98

114

Dystonia

255

1.18

0.34

1.1

4.14

3.17

u/ml

—

Myositis

1.35

0.34

1.0

1.10

3.53

u/ml

—

Other and unspecified injuries of head

308

0.84

0.34

1.1

1.0

3.01

4.24

u/ml

0.39

122

Acute alcohol intoxication ICD-9

1.32

0.33

1.0

1.1

7.12

2.06

u/ml

—

Benign neoplasm: Skin of other and unspecified parts of face

372

0.86

0.33

1.1

1.73

3.10

u/ml

0.54

147

Polyarthritis, unspecified

145

1.24

0.33

1.1

2.05

3.54

u/ml

—

Disturbances of smell and taste

145

1.24

0.33

1.1

1.0

2.19

3.19

u/ml

—

Disorders of parathyroid gland

531

1.12

0.33

1.1

1.0

3.49

3.36

u/ml

0.03

189

Contact with sharp object, undetermined intent

133

0.75

0.33

1.0

3.98

2.80

u/ml

—

Intrahepatic Cholestasis of Pregnancy (ICP)

672

1.10

0.33

1.1

1.40

3.64

u/ml

1.81

235

Ulcer of oesophagus

136

1.25

0.33

1.1

1.35

2.27

u/ml

—

Other noninflammatory disorders of uterus, except cervix

542

1.10

0.33

1.1

2.18

4.00

u/ml

0.79

176

Other diseases of the digestive system

1043

0.92

0.33

1.1

3.70

4.42

u/ml

0.26

419

Juvenile arthritis (FINNGEN)

488

0.88

0.33

1.0

1.1

1.95

5.49

u/ml

1.98

206

Benign neoplasm of colon, rectum, anus and anal canal

206

1757

1.06

0.33

1.1

2.52

3.13

u/ml

0.25

659

Familial hypercholesterolemia

321

1.15

0.33

1.0

1.1

2.98

2.47

u/ml

0.13

120

Arthropod-borne viral fevers and viral haemorrhagic fevers

414

0.87

0.33

1.1

3.50

2.82

u/ml

0.15

156

Other infectious diseases

275

0.84

0.33

1.1

2.60

3.51

u/ml

0.31

106

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

520

1.12

0.33

1.1

3.76

4.02

u/ml

0.05

204

Disorders of speech understanding and production

416

0.87

0.33

1.2

1.1

10.44

6.95

u/ml

0.29

219

Basal cell carcinoma, including avohilmo

118

1001

0.93

0.33

1.1

1.0

0.81

2.71

u/ml

3.71

371

Obstructed labour due to maternal pelvic abnormality

826

1.09

0.33

1.0

1.29

3.16

u/ml

2.04

263

Benign neoplasm of other and unspecified female genital organs

173

1.22

0.33

1.1

6.12

2.64

u/ml

—

Primary coxarthrosis, bilateral

539

1.11

0.33

1.1

1.0

0.84

2.52

u/ml

2.26

201

Other anaemias

122

1265

0.93

0.33

1.1

2.88

3.73

u/ml

0.34

504

Other/unspecified reactive arthropathies

350

1.15

0.33

1.0

1.1

1.86

3.50

u/ml

0.61

129

GI-bleeding

1041

0.92

0.32

1.1

4.57

4.21

u/ml

0.09

424

229

1.19

0.32

1.1

0.94

6.62

u/ml

3.36

Dislocation, sprain and strain of joints and ligaments of thorax

155

1.23

0.32

1.1

1.0

1.54

4.80

u/ml

—

Pain, not elsewhere classified

187

1766

1.06

0.32

1.1

4.74

4.25

u/ml

0.12

710

Covid-19 suspected case

194

1835

1.06

0.32

1.0

1.1

2.97

5.19

u/ml

1.47

743

Sequelae of other and unspecified infectious and parasitic diseases

332

1.15

0.32

1.2

1.0

2.35

2.92

u/ml

0.19

120

Haemorrhage, not elsewhere classified

1.33

0.32

1.2

1.0

3.51

6.09

u/ml

—

Need for immunization against other single viral diseases

1.31

0.32

1.1

1.0

6.47

6.11

u/ml

—

Malignant melanoma, excluding all cancers (controls excluding all cancers)

444

0.88

0.32

1.0

1.1

0.45

2.41

u/ml

4.21

168

Other and unspecified anaemias

121

1256

0.93

0.31

1.1

2.88

3.73

u/ml

0.34

504

Postpartum haemorrhage due to retained placenta

122

1137

1.07

0.31

1.0

1.1

6.03

5.08

u/ml

0.13

425

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

348

0.86

0.31

1.0

1.1

1.90

2.56

u/ml

—

131

Ectopic pregnancy

129

1205

1.07

0.31

1.1

3.28

4.17

u/ml

0.34

438

Adalimumab

664

0.90

0.31

1.0

1.1

0.81

4.52

u/ml

5.68

255

Pneumonias (Asthma/COPD co-morbidities)

779

5543

0.97

0.31

1.1

5.35

4.51

u/ml

0.45

372

2196

Fracture of forearm

342

3335

0.96

0.31

1.1

5.97

4.78

u/ml

0.45

146

1338

Medical treatment for female infertility

241

2290

1.05

0.31

1.1

4.55

4.44

u/ml

0.03

846

Mucosal proctocolitis

914

0.92

0.31

1.1

3.11

3.93

u/ml

0.26

368

Contact with other hot fluids

202

1.19

0.31

1.0

1.1

13.38

5.32

u/ml

0.44

Hypo-osmolality and hyponatraemia

389

0.87

0.31

1.1

1.55

3.62

u/ml

1.12

153

Other congenital malformations of ear

147

1.23

0.31

1.1

10.70

6.19

u/ml

—

Myocardial infarction, unclassifiable

253

0.85

0.31

1.2

1.1

6.78

3.10

u/ml

0.40

108

Unspecified urinary incontinence

286

1.16

0.31

1.1

1.26

4.02

u/ml

1.74

114

Other noninflammatory disorders of cervix uteri

156

1.22

0.31

1.0

1.1

2.95

3.85

u/ml

—

Other bacterial intestinal infections

714

1.09

0.31

1.1

11.63

3.04

u/ml

0.51

284

LSIL lesion of the cervix uteri, vagina or vulva

112

1203

0.93

0.31

1.0

1.1

0.85

4.71

u/ml

4.54

442

Ingrowing nail

305

1.15

0.31

1.1

1.0

2.66

4.49

u/ml

0.71

120

Benign mammary dysplasia

561

1.11

0.30

1.1

2.13

3.68

u/ml

0.61

196

Postpartum haemorrhage

280

2331

1.05

0.30

1.1

4.20

5.07

u/ml

0.27

847

Dental pulpitis 3, only avohilmo

195

1502

0.95

0.30

1.1

10.53

5.72

u/ml

0.97

719

Aortic aneurysm

402

1.12

0.30

1.0

2.42

2.24

u/ml

0.06

163

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

696

1.09

0.30

1.1

1.35

5.18

u/ml

2.02

267

Foreign body on external eye

869

1.08

0.30

1.0

1.1

2.64

4.30

u/ml

1.06

364

Mandibular retrognathia

608

1.10

0.30

1.1

15.32

4.87

u/ml

0.71

258

Pyogenic granuloma

1.31

0.30

1.0

11.10

5.28

u/ml

—

Contact with heat and hot substances

334

1.14

0.30

1.0

1.1

14.75

5.32

u/ml

0.74

139

Primary gonarthrosis, bilateral

150

1234

1.06

0.30

1.0

2.33

3.05

u/ml

0.49

420

Obesity, other/unspecified

254

2426

1.05

0.30

1.1

6.87

4.57

u/ml

0.41

100

932

Hemiplegia

196

0.81

0.30

1.1

1.0

4.68

2.63

u/ml

—

Crohn disease (strict definition, require KELA)

486

1.11

0.30

1.0

1.1

4.03

4.10

u/ml

0.01

187

All pneumoniae

788

5579

0.97

0.30

1.1

5.36

4.48

u/ml

0.48

376

2212

Psoriatic arthropathies

515

0.89

0.30

1.0

1.1

4.00

2.71

u/ml

0.23

185

Malignant neoplasm of thyroid gland

282

0.85

0.29

1.0

1.1

1.90

2.65

u/ml

—

103

Pregnancy hypertension

367

3434

0.96

0.29

1.1

2.28

4.76

u/ml

3.78

127

1258

Injury of muscle and tendon at wrist and hand level

724

0.91

0.29

1.1

3.86

3.38

u/ml

0.10

280

Cerebral palsy

152

0.79

0.29

1.0

1.1

1.72

5.93

u/ml

—

Hyperfunction of pituitary gland

388

0.87

0.29

1.1

0.78

4.75

u/ml

4.12

150

Pustulosis palmaris et plantaris

163

0.80

0.29

1.0

3.36

3.40

u/ml

—

Benign neoplasm: Rectum, anus and anal canal

477

1.11

0.29

1.0

1.1

3.44

2.70

u/ml

0.11

187

Follow-up care involving plastic surgery

148

1.22

0.29

1.1

1.0

0.64

2.61

u/ml

—

Follicular cysts of skin and subcutaneous tissue

919

1.08

0.29

1.1

1.0

3.39

3.54

u/ml

0.02

359

Other psoriatic arthropathies

493

0.89

0.29

1.0

1.1

4.37

2.70

u/ml

—

182

Convalescence

241

1.16

0.29

1.1

1.0

6.17

3.10

u/ml

0.40

Injury of unspecified body region

366

0.87

0.29

1.1

11.51

4.38

u/ml

0.64

148

Other cataract

129

1065

0.94

0.29

1.0

1.1

5.84

3.22

u/ml

0.83

409

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

307

1.14

0.28

1.1

1.09

2.35

u/ml

0.82

122

Chronic pancreatitis

387

0.88

0.28

1.0

1.1

5.55

2.05

u/ml

0.54

150

Spondylopathies

445

2795

0.97

0.28

1.1

4.34

3.69

u/ml

0.29

167

1046

Chronic periapical parodontitis

971

0.93

0.28

1.1

2.52

5.15

u/ml

1.58

339

Abnormalities of forces of labour

882

1.08

0.28

1.1

6.28

4.00

u/ml

0.34

292

Transient global amnesia

167

1.20

0.28

1.1

1.0

1.69

1.89

u/ml

—

Maxillary retrognathism

158

1.21

0.28

1.2

1.1

0.21

5.91

u/ml

—

Congenital malformations of aortic and mitral valves

248

0.84

0.28

1.0

1.1

2.16

6.42

u/ml

—

114

Hypoplasia of dental enamel , including avohilmo

412

0.88

0.28

1.1

2.06

7.11

u/ml

3.39

216

Maternal care for known or suspected malpresentation of fetus

237

1688

1.05

0.28

1.1

4.84

5.28

u/ml

0.10

619

Abnormal findings on antenatal screening of mother

108

1009

1.07

0.28

1.1

7.47

5.50

u/ml

0.32

391

Open bite

556

1.10

0.27

1.1

4.58

5.28

u/ml

0.13

243

Mixed specific developmental disorders

329

0.87

0.27

1.1

13.22

8.47

u/ml

0.46

182

Other abnormal findings of blood chemistry

177

1.19

0.27

1.0

8.36

3.12

u/ml

—

Other follicular disorders

470

1.11

0.27

1.1

10.71

3.77

u/ml

0.65

172

Oral leukoplakia and related diseases

140

1.22

0.27

1.1

1.0

1.18

3.18

u/ml

—

Conductive hearing loss, unspecified

396

0.88

0.27

1.1

3.97

4.05

u/ml

0.01

153

Cyst of kidney

140

1.22

0.27

1.2

1.0

0.07

1.96

u/ml

—

Parodontitis, under 40 years and operation codes

104

1113

0.93

0.27

1.1

4.61

5.06

u/ml

0.09

481

Parodontitis, operation under 40 years and operation codes

104

1113

0.93

0.27

1.1

4.61

5.06

u/ml

0.09

481

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

140

1.22

0.27

1.1

0.94

1.53

u/ml

—

Hirsutism in women

168

1.20

0.27

1.1

1.0

2.41

5.96

u/ml

—

Contusion of other and unspecified parts of foot

404

1.12

0.27

1.1

12.88

4.63

u/ml

0.42

170

Rubella [German measles]

139

0.79

0.27

1.1

1.0

0.41

3.25

u/ml

—

Juvenile rheumatoid arthirtis

187

1.18

0.26

1.0

1.1

1.15

3.70

u/ml

—

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

193

0.83

0.26

1.0

8.36

2.69

u/ml

—

Tongue abnormality

187

1.18

0.26

1.0

0.69

3.43

u/ml

—

Ulcerative colitis

161

1697

0.95

0.26

1.1

2.94

4.15

u/ml

0.65

692

Dissociative [conversion] disorders

310

0.87

0.26

1.1

1.0

8.10

5.75

u/ml

—

120

Cerebral palsy and other paralytic syndromes

583

0.91

0.26

1.0

1.1

2.39

4.24

u/ml

0.81

236

Primary open-angle glaucoma, strict

394

1.11

0.26

1.0

1.54

2.74

u/ml

0.82

163

Myocardial infarction, with ST-elevation

289

0.86

0.26

1.0

1.1

0.19

2.13

u/ml

—

115

Malignant neoplasm of endocrine gland

310

0.87

0.26

1.0

1.1

1.88

2.71

u/ml

0.39

119

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

206

1.17

0.26

1.1

1.0

2.70

2.10

u/ml

—

Other strabismus

174

1824

0.95

0.26

1.1

5.36

4.98

u/ml

0.06

785

Malignant neoplasm of kidney, except renal pelvis

171

0.82

0.26

1.1

3.52

2.14

u/ml

—

Autism spe, excluding more controls

267

0.86

0.26

1.1

0.76

6.74

u/ml

4.19

130

Crohn disease (strict definition, all UC cases excluded)

367

1.12

0.26

1.0

1.1

3.94

4.33

u/ml

0.06

143

Assault by bodily force

655

0.91

0.26

1.1

7.24

3.76

u/ml

0.54

260

Hydrocele

329

1.13

0.25

1.1

0.50

2.85

u/ml

4.57

151

Dental caries 3, only avohilmo

665

3314

1.03

0.25

1.1

2.76

4.53

u/ml

2.76

287

1299

Acne vulgaris

105

984

1.07

0.25

1.2

1.1

12.81

4.46

u/ml

0.64

426

Molar incisor enamel hypoplasia

447

0.90

0.25

1.0

1.1

2.40

7.29

u/ml

3.13

235

Other ulcerative colitis

377

1.12

0.25

1.1

1.16

3.63

u/ml

2.18

151

Scoliosis

623

0.91

0.25

1.0

1.1

5.59

4.94

u/ml

0.09

257

Benign lipomatous neoplasm of other sites/unspecified

235

1.15

0.25

1.0

34.72

2.95

u/ml

—

Malignant neoplasm of urinary organs

181

0.83

0.25

1.1

3.52

2.31

u/ml

—

Papillary adenocarcinoma of thyroid gland

213

0.84

0.25

1.1

1.0

2.14

2.83

u/ml

—

Other symptoms and signs involving cognitive functions and awareness

149

1473

0.95

0.25

1.1

2.48

3.56

u/ml

0.39

563

Pneumonitis due to solids and liquids

170

0.82

0.25

1.1

1.22

2.42

u/ml

—

Artrosis, including avohilmo

619

3309

1.03

0.25

1.1

4.54

3.84

u/ml

0.38

245

1221

Supplementary factors related to causes of morbidity and mortality classified elsewhere

210

2010

1.05

0.25

1.1

5.50

4.60

u/ml

0.29

118

822

Benign neoplasm of brain and other parts of central nervous system

266

0.86

0.25

1.1

1.19

3.03

u/ml

1.10

106

Thrombocytopenia, unspecified

266

0.86

0.25

1.0

0.94

3.26

u/ml

—

118

Benign neoplasm: Rectum

397

1.11

0.24

1.0

1.1

3.93

2.77

u/ml

0.15

156

Autism

276

0.87

0.24

1.1

0.76

7.67

u/ml

4.69

126

Ulcerative rectosigmoiditis

507

0.91

0.24

1.0

1.1

1.31

3.82

u/ml

2.05

187

Congenital malformations and deformations of the musculoskeletal system

947

0.93

0.24

1.1

13.04

5.93

u/ml

0.53

439

Viral warts

657

1.08

0.24

1.1

6.49

3.72

u/ml

0.31

262

Gonarthrosis, primary, with knee surgery

136

1173

0.95

0.24

1.0

2.84

3.07

u/ml

0.08

393

Bacterial pneumonia, not elsewhere classified

187

1580

1.05

0.24

1.1

4.50

4.20

u/ml

0.09

102

612

Pneumonia, organism unspecified

649

4807

0.98

0.24

1.1

5.31

4.52

u/ml

0.35

305

1910

Generalized epilepsy

350

1.12

0.24

1.0

1.1

5.88

6.89

u/ml

0.08

148

Car occupant injured in noncollision transport accident

244

0.86

0.24

1.2

1.0

9.46

4.28

u/ml

0.31

Complications of surgical and medical care, not elsewhere classified

674

4947

0.98

0.24

1.1

5.35

4.42

u/ml

0.26

275

1914

Nephrotic syndrome

169

0.83

0.24

1.0

1.1

0.11

6.18

u/ml

—

Labour and delivery complicated by fetal stress [distress]

304

2101

0.96

0.24

1.1

6.67

5.28

u/ml

0.20

121

779

Benign neoplasm of thyroid gland

124

1.21

0.24

1.2

1.0

1.36

3.32

u/ml

—

Melanocytic naevi of lower limb, including hip

246

1.14

0.23

1.0

4.09

3.83

u/ml

0.04

Disorders of puberty, all

222

0.85

0.23

1.1

7.73

5.70

u/ml

0.22

108

Benign neoplasm of mouth and pharynx

427

1.10

0.23

1.1

5.73

2.55

u/ml

0.35

164

Excessive vomiting in pregnancy

726

1.08

0.23

1.1

1.43

4.74

u/ml

1.80

268

Chromosomal abnormalities, not elsewhere classified

253

0.86

0.23

1.3

1.1

4.90

7.11

u/ml

0.22

138

Hyperhidrosis

199

1.16

0.23

1.1

1.0

2.17

5.25

u/ml

—

Zoster [herpes zoster]

568

0.91

0.23

1.1

4.55

2.76

u/ml

0.51

210

Other specified/unspecified inflammatory spondylopathies

313

1.12

0.23

1.1

1.43

3.23

u/ml

0.99

113

Overjet

294

0.88

0.23

1.1

12.11

5.50

u/ml

0.60

140

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

708

1.08

0.22

1.1

1.35

3.67

u/ml

2.00

250

Pacemaker

528

1.09

0.22

1.1

5.02

2.15

u/ml

0.49

214

Iron deficiency anaemia

200

1899

1.04

0.22

1.1

3.84

4.68

u/ml

0.25

752

Injuries to the thorax

204

2125

0.96

0.22

1.1

4.70

4.25

u/ml

0.14

830

Assault by unspecified means

153

1.18

0.22

1.1

12.04

3.89

u/ml

—

Iron deficiency anaemia secondary to blood loss (chronic)

525

0.91

0.22

1.1

1.75

3.10

u/ml

0.92

195

Fentanyl

189

0.85

0.22

1.1

1.0

2.08

3.52

u/ml

—

Chronic tubulo-interstitial nephritis

125

1.20

0.22

1.2

1.0

12.19

3.63

u/ml

—

Intentional self-harm by sharp object

219

1.15

0.22

1.1

1.0

6.29

5.49

u/ml

0.10

Social phobias

876

0.93

0.22

1.0

1.1

7.68

4.02

u/ml

0.50

362

Specific development disorders of speech and language

617

1.08

0.22

1.1

5.31

6.36

u/ml

0.18

318

Crohn disease (strict definition, require KELA, min 2 HDR)

477

1.09

0.22

1.0

1.1

4.29

3.92

u/ml

0.06

183

Other disorders of teeth and supporting structures

104

981

1.06

0.22

1.2

1.1

3.00

5.39

u/ml

0.97

350

Colectomy operation

462

0.91

0.22

1.0

1.1

0.70

2.61

u/ml

—

182

Complications of internal orthopaedic prosthetic devices, implants and grafts

506

1.09

0.22

1.1

1.0

4.69

2.88

u/ml

0.30

194

Mental disorders, not otherwise specified

669

0.93

0.22

1.1

1.83

3.67

u/ml

1.44

264

Noonan syndrome

0.00

0.21

0.0

1.0

—

1.29

—

Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism

0.00

0.21

0.0

1.1

—

7.81

—

Osteosarcoma

0.00

0.21

0.0

1.0

—

2.69

—

Other leukaemias of specified cell type

0.00

0.21

0.0

1.0

—

0.57

—

Other leukaemias of specified cell type

0.00

0.21

0.0

1.0

—

0.57

—

Obesity due to excess calories

351

3407

1.03

0.21

1.1

6.47

4.79

u/ml

0.42

148

1320

Hypertrophy of bone

0.00

0.21

0.0

1.0

—

2.04

—

Systemic disorders of connective tissue in diseases classified elsewhere

0.00

0.21

0.0

1.0

—

2.41

—

Viral infections of the central nervous system

401

1.10

0.21

1.0

6.33

4.01

u/ml

0.34

152

Chondrosarcoma, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.0

—

2.62

—

Other embolism and thrombosis

449

1.09

0.21

1.0

1.1

5.58

3.83

u/ml

0.18

166

Other benign neoplasms of skin

175

1644

1.04

0.21

1.1

4.21

3.36

u/ml

0.28

634

Other surgical follow-up care

182

1.16

0.21

1.1

20.81

5.20

u/ml

—

Labyrinthitis

0.00

0.21

0.0

1.0

—

0.95

—

Other and unspecified disorders of psychological development

174

0.84

0.21

1.2

1.1

0.80

7.36

u/ml

—

Blindness or visual impairment, binocular

0.00

0.21

0.0

1.0

—

0.96

—

Congenital malformations of the circulatory system

109

1115

0.95

0.21

1.1

7.14

5.25

u/ml

0.40

523

117

1110

1.06

0.21

1.1

4.05

4.79

u/ml

0.16

411

Viral and other specified intestinal infections

243

2290

1.04

0.21

1.1

8.27

5.40

u/ml

0.63

117

1052

Leisure time condition

112

1061

1.06

0.21

1.1

2.90

4.35

u/ml

0.64

436

Hirsprung

0.00

0.21

0.0

1.1

—

1.42

—

Purpura and other haemorrhagic conditions

647

0.93

0.21

1.1

0.88

4.40

u/ml

5.46

269

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

173

1.16

0.21

1.1

1.0

10.70

3.73

u/ml

—

Disorders of puberty

198

0.85

0.21

1.1

7.73

6.79

u/ml

0.09

Other primary thrombocytopenia

0.00

0.21

0.0

1.1

—

1.13

—

Malignant neoplasm of other endocrine glands and related structures, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.2

—

3.66

—

Early lumbar disc prolapse, operated

896

1.06

0.21

1.0

1.1

5.33

3.38

u/ml

0.45

346

Persons encountering health services for specific procedures, not carried out

450

1.09

0.21

1.1

3.89

4.39

u/ml

0.08

174

Malignant neoplasm of floor of mouth, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.1

—

1.71

—

Other drug-induced secondary parkinsonism

0.00

0.21

0.0

1.1

—

3.23

—

Acquired absence of limb

0.00

0.21

0.0

1.1

—

1.03

—

Benign neoplasms

925

5071

1.02

0.20

1.1

4.22

4.85

u/ml

0.25

352

2067

Nonspecific lymphadenitis

354

1.10

0.20

1.1

1.0

2.64

2.99

u/ml

0.08

127

Benign neoplasm of major salivary glands

287

1.12

0.20

1.0

1.1

3.83

2.97

u/ml

0.15

110

Other problems related to primary support group, including family circumstances

122

1250

0.95

0.20

1.1

5.92

4.83

u/ml

0.22

564

Crohn's disease of small intestine

489

1.09

0.20

1.0

1.1

3.68

4.52

u/ml

0.18

181

Other blood glucose lowering drugs, excl. Insulins

387

0.90

0.20

1.1

3.36

2.09

u/ml

0.18

146

Varicella [chickenpox]

316

1.11

0.20

1.1

11.13

3.87

u/ml

0.58

129

Diabetic retinopathy, excluding more controls

452

0.93

0.20

1.1

5.30

3.91

u/ml

0.28

183

Ankylosing spondylitis, strict definition

303

0.89

0.20

1.0

2.55

3.43

u/ml

0.30

114

Pediculosis and phthiriasis

0.00

0.20

0.0

1.1

—

5.70

—

Dislocation of lens

0.00

0.20

0.0

1.1

—

0.89

—

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

187

0.85

0.20

1.0

8.36

2.78

u/ml

—

Smoking dependency

376

0.90

0.20

1.1

17.26

3.58

u/ml

0.84

139

Mental and behavioural disorders due to tobacco

376

0.90

0.20

1.1

17.26

3.60

u/ml

0.84

138

Superficial injury of thorax

722

1.07

0.20

1.2

1.1

4.78

3.45

u/ml

0.31

275

Benign neoplasm of breast

596

1.07

0.20

1.1

2.36

3.57

u/ml

0.42

216

Type of accident

192

1847

1.04

0.20

1.1

4.77

4.79

u/ml

0.00

107

749

Use of antiglaucoma preparations and miotics

108

1.20

0.20

1.0

1.95

1.94

u/ml

—

Assault

108

1138

0.95

0.20

1.1

8.99

3.82

u/ml

1.12

465

Fibroblastic disorders

752

1.06

0.19

1.0

0.88

3.32

u/ml

3.95

266

Tooth eruption problems

185

1762

1.04

0.19

1.1

6.26

5.07

u/ml

0.13

801

Diseases of tongue

231

1.13

0.19

1.0

1.1

18.62

5.05

u/ml

—

Benign neoplasm: Caecum

193

1.14

0.19

1.0

6.47

1.99

u/ml

—

Nontoxic single thyroid nodule

302

0.89

0.19

1.0

1.73

2.86

u/ml

—

105

Male infertility

346

1.10

0.19

1.1

0.96

4.86

u/ml

3.60

164

Other functional intestinal disorders

263

2425

1.03

0.19

1.1

3.43

4.95

u/ml

0.96

118

1025

Carbimazole or st.post thyroidectomy, condition for graves disease

113

1188

0.95

0.19

1.1

3.02

3.44

u/ml

0.10

435

LSIL lesion of the cervix uteri

1024

0.95

0.19

1.0

1.1

0.80

4.93

u/ml

3.99

378

Pediculosis, acariasis and other infestations

354

0.90

0.19

1.1

3.55

4.28

u/ml

0.10

137

Other secondary gonarthrosis

146

1.17

0.19

1.0

1.12

2.54

u/ml

—

Allergic purpura

184

1.14

0.19

1.1

1.0

1.02

4.35

u/ml

—

Glaucoma, exfoliation

1.22

0.19

1.0

0.25

1.15

u/ml

—

Abnormal findings on examination of urine, without diagnosis

184

1.14

0.19

1.0

0.34

3.91

u/ml

—

Postprocedural musculoskeletal disorders, not elsewhere classified

184

1.14

0.19

1.0

3.15

2.95

u/ml

0.03

HSIL lesion of the cervix uteri, vagina or vulva

189

1821

1.04

0.19

1.1

3.60

4.35

u/ml

0.19

684

Foreign body or object entering through skin

366

1.09

0.19

1.1

1.42

4.53

u/ml

2.35

147

Diseases of the digestive system

219

2111

1.04

0.18

1.1

4.77

4.36

u/ml

0.13

866

Polymyalgia rheumatica

175

0.86

0.18

1.0

1.1

1.05

1.59

u/ml

—

Benign neoplasm: Stomach

251

1.12

0.18

1.1

1.0

5.73

2.16

u/ml

0.44

Antepartum haemorrhage, not elsewhere classified

889

0.94

0.18

1.1

4.34

4.27

u/ml

0.01

320

Disorders of optic nerve and visual pathways

589

1.07

0.18

1.1

5.57

4.55

u/ml

0.16

240

Cholecystitis

376

1.09

0.18

1.1

4.78

2.36

u/ml

0.37

141

Prolonged pregnancy

176

1667

0.96

0.18

1.0

1.1

5.33

5.48

u/ml

0.03

639

Other endocrine disorders

539

1.07

0.18

1.1

3.16

7.63

u/ml

2.26

276

Phobic anxiety disorders

141

1351

1.04

0.18

1.1

5.33

4.80

u/ml

0.09

588

Artificial opening status

185

0.86

0.18

1.1

2.12

5.69

u/ml

—

Personality disorders, excluding more controls

222

2294

0.97

0.18

1.1

2.79

4.17

u/ml

1.36

102

891

Pneumothorax

206

0.87

0.18

1.2

1.0

6.04

1.55

u/ml

0.58

Sequelae of injuries of lower limb

512

1.08

0.18

1.1

3.96

3.73

u/ml

0.04

187

L02BA Anti-estrogens

703

0.94

0.18

1.0

1.1

2.59

2.97

u/ml

0.11

232

Bulimia nervosa (incl. atypical)

377

1.09

0.18

1.1

1.01

4.64

u/ml

2.70

135

Fourth [trochlear] nerve palsy

1.17

0.18

1.0

—

3.80

—

Viral agents as the cause of diseases classified to other chapters

119

1.18

0.17

1.1

1.0

6.01

7.53

u/ml

—

Calcific tendinitis of shoulder

252

1.11

0.17

1.0

1.1

6.12

2.29

u/ml

—

Benign neoplasm: Rectum, anus and anal canal

493

1.08

0.17

1.0

1.1

3.44

2.78

u/ml

0.09

200

Paroxysmal tachycardia

154

1251

1.04

0.17

1.1

3.67

4.19

u/ml

0.17

477

Other diseases of blood and blood-forming organs

233

1.12

0.17

1.0

2.61

2.77

u/ml

0.04

Benign neoplasm of other and unspecified endocrine glands

503

1.07

0.17

1.0

1.1

1.35

2.63

u/ml

0.99

186

Overexertion and strenuous or repetitive movements

579

0.93

0.17

1.1

5.98

3.68

u/ml

0.45

220

195

1.13

0.17

1.1

1.0

5.47

4.17

u/ml

—

Disorders of tooth development and eruption

556

1.07

0.17

1.1

0.72

7.05

u/ml

6.39

251

Torsion of testis

176

1.14

0.17

1.1

2.88

2.94

u/ml

—

Other necrotizing vasculopathies (FG)

142

0.84

0.17

1.0

0.84

2.59

u/ml

—

Infections, IBD-co-morbidities

105

728

1.05

0.17

1.1

9.46

3.87

u/ml

0.45

294

Polycystic ovarian syndrome, broad definition

134

1285

1.04

0.17

1.0

1.1

6.51

5.25

u/ml

0.15

509

Ptosis of eyelid

262

1.11

0.17

1.1

1.36

2.56

u/ml

0.87

104

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

109

1142

0.95

0.17

1.0

1.94

3.38

u/ml

0.75

414

Calcific aortic valvular stenosis, including rheumatic fever

384

0.92

0.17

1.1

3.45

1.97

u/ml

0.64

159

Disorder of lipoprotein metabolism, unspecified

291

1.10

0.17

1.0

4.62

2.08

u/ml

0.34

111

Coxarthrosis, primary

159

1328

1.04

0.17

1.1

1.0

1.29

3.12

u/ml

3.49

499

Abnormalities of gait and mobility

351

0.91

0.17

1.1

12.06

4.85

u/ml

0.43

148

Hyperprolactinaemia

272

1.11

0.17

1.1

0.78

4.95

u/ml

2.68

Injury of nerves at forearm level

0.74

0.17

1.0

—

1.71

—

Meningitis

257

0.89

0.17

1.0

5.74

2.98

u/ml

0.39

Cardiomyopathy

547

0.93

0.17

1.2

1.1

5.53

3.85

u/ml

0.27

222

Other disorders of pigmentation

167

1.14

0.17

1.1

1.0

1.45

3.56

u/ml

—

Hypertrophic scar

388

1.08

0.17

1.0

1.1

1.25

4.36

u/ml

2.80

149

Other peripheral vascular diseases

359

1.09

0.16

1.1

5.23

2.50

u/ml

0.37

129

Thyrotoxicosis

128

1334

0.96

0.16

1.1

3.25

4.14

u/ml

0.27

505

All dysplastic lesions of the cervix uteri, vagina or vulva

269

2747

0.97

0.16

1.1

2.91

4.67

u/ml

0.81

1008

Diseases of peritoneum

340

1.09

0.16

1.0

1.1

3.51

3.29

u/ml

0.03

124

Other specified/unspecified systemic involvement of connective tissue

263

1.10

0.16

1.1

6.79

2.95

u/ml

0.34

conjunctival haemorrhage

177

1.13

0.16

1.0

5.51

2.07

u/ml

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

111

916

0.96

0.16

1.1

1.0

2.03

2.79

u/ml

0.33

336

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

273

1.10

0.16

1.1

1.0

10.10

3.47

u/ml

0.67

104

Autism spe

256

0.90

0.16

1.1

0.76

6.34

u/ml

4.12

115

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

308

0.91

0.16

1.0

1.1

1.90

2.71

u/ml

—

116

HSIL lesion of the cervix uteri

180

1741

1.03

0.16

1.1

3.73

4.43

u/ml

0.17

658

Melanocytic naevi of lower limb, including hip

254

1.10

0.16

1.0

4.09

3.56

u/ml

0.09

103

Sequelae of external causes of morbidity and mortality

109

1043

1.05

0.16

1.2

1.0

3.88

3.67

u/ml

0.05

406

Phlebitis and thrombophlebitis (not including DVT)

945

1.05

0.16

1.1

4.77

3.18

u/ml

0.32

343

Pathological resorption of teeth

151

0.86

0.15

1.0

3.15

4.60

u/ml

—

Psoriasis (vulgaris), strict definition

151

0.86

0.15

1.1

1.0

11.00

2.51

u/ml

—

Benign neoplasm: Parotid gland

235

1.11

0.15

1.0

4.88

3.21

u/ml

—

Calcific aortic valvular stenosis, diagnosis (helper)

382

0.92

0.15

1.1

3.45

1.97

u/ml

0.64

159

Operations 2 for CAVS

382

0.92

0.15

1.1

3.45

1.97

u/ml

0.64

159

Polyhydramnios

448

1.07

0.15

1.0

1.1

1.87

4.33

u/ml

0.55

164

Infections specific to the perinatal period

197

1.12

0.15

1.2

1.1

12.43

6.62

u/ml

0.53

110

Dislocation, sprain and strain of joints and ligaments of head

328

0.91

0.15

1.1

1.0

9.52

5.38

u/ml

—

127

Other specified congenital malformation syndromes affecting multiple systems

182

0.88

0.15

1.1

5.18

5.82

u/ml

—

Protozoal diseases

1.21

0.15

1.0

1.02

3.13

u/ml

—

Colorectal cancer

452

0.93

0.15

1.0

5.74

2.37

u/ml

0.52

173

Benign neoplasm: Tongue

1.16

0.15

1.1

1.0

—

1.76

—

Motorcycle rider injured in other and unspecified transport accidents

458

1.07

0.15

1.1

1.05

4.38

u/ml

3.99

192

Dipeptidyl peptidase 4 (DPP-4) inhibitors

245

1.10

0.15

1.0

1.1

0.91

2.28

u/ml

1.27

101

Benign neoplasm: Tongue

1.14

0.15

1.1

1.0

—

1.78

—

Superficial injuries involving multiple body regions

140

0.86

0.15

1.1

2.47

4.54

u/ml

—

Misadventures to patients during surgical and medical care

614

1.06

0.15

1.1

1.94

3.01

u/ml

0.62

234

Hypoparathyroidism

102

1.18

0.15

1.2

1.0

3.43

2.80

u/ml

—

DVT of lower extremities and pulmonary embolism

144

1384

1.04

0.15

1.1

1.0

3.15

3.50

u/ml

0.10

522

Acute gastritis

226

1.11

0.15

1.0

2.42

3.26

u/ml

0.22

Transitory endocrine and metabolic disorders specific to fetus and newborn

259

0.90

0.15

1.1

3.68

7.62

u/ml

1.17

148

Preterm labour and delivery

196

1901

1.03

0.15

1.1

3.83

3.86

u/ml

0.01

662

Thyrotoxicosis, other and/or unspecified

107

1116

0.96

0.15

1.1

3.11

4.31

u/ml

0.32

425

Lesion of ulnar nerve

644

1.06

0.14

1.0

1.1

0.87

3.65

u/ml

3.63

237

Abnormal findings on examination of blood, without diagnosis

177

1709

0.97

0.14

1.1

4.29

3.93

u/ml

0.10

685

Pedal cyclist injured in other and unspecified transport accidents

656

0.94

0.14

1.0

1.1

4.95

4.11

u/ml

0.17

253

Lichen sclerosus et atrophicus

352

1.08

0.14

1.1

2.74

2.94

u/ml

0.05

129

Filling of root of tooth

150

0.87

0.14

1.2

1.0

1.19

3.34

u/ml

—

Inflammatory diseases of the central nervous system

430

0.93

0.14

1.1

7.05

3.88

u/ml

0.37

163

Behavioural disorders

223

0.89

0.14

1.2

1.0

8.89

5.43

u/ml

—

104

Distal bite

466

1.07

0.14

1.1

9.14

5.22

u/ml

0.58

226

Hypertrophic disorders of skin

411

1.07

0.14

1.0

1.1

1.24

4.32

u/ml

3.02

160

Motor disorders, excluding more controls

226

1.10

0.14

1.2

1.1

3.67

9.42

u/ml

1.46

136

Benign neoplasm: Sigmoid colon

411

1.07

0.14

1.0

1.1

1.90

2.45

u/ml

—

157

Ankylosing spondylitis

499

1.06

0.14

1.0

1.1

1.93

3.09

u/ml

0.70

190

Cerebral aneurysm, nonruptured

295

0.91

0.14

1.1

6.67

2.19

u/ml

—

103

Benign leiomyoma with endometriosis

634

0.95

0.14

1.1

4.41

2.92

u/ml

0.25

226

Other and unspecified psoriasis

237

1.10

0.14

1.2

1.1

2.10

2.93

u/ml

—

Lung diseases due to external agents

324

1.08

0.14

1.1

1.64

2.57

u/ml

0.44

129

Diseases of pulp and periapical tissues

214

2083

1.03

0.14

1.1

3.66

5.33

u/ml

0.72

758

Other vitreous opacities

103

1.17

0.13

1.2

1.0

1.35

1.22

u/ml

—

Conduct disorder

222

0.90

0.13

1.2

1.1

8.89

5.64

u/ml

—

105

Benign neoplasm: Skin of other and unspecified parts of face

346

0.92

0.13

1.1

1.0

1.73

3.26

u/ml

0.61

134

Other disorders of amniotic fluid and membranes

155

1488

1.03

0.13

1.1

7.41

5.16

u/ml

0.43

559

Benign neoplasm: Pituitary gland, craniopharyngeal duct

257

1.09

0.13

1.0

1.00

3.26

u/ml

—

Postpartum hemorraghe, all women as controls

280

2726

1.02

0.13

1.1

4.20

4.98

u/ml

0.24

1023

Paralytic ileus and intestinal obstruction

816

0.96

0.13

1.0

1.1

4.61

3.69

u/ml

0.17

314

Superficial injury of abdomen, lower back and pelvis

969

0.96

0.13

1.1

4.33

4.42

u/ml

0.02

392

Congenital malformations of the nervous system

211

0.90

0.13

1.0

1.1

8.01

9.71

u/ml

0.14

233

0.91

0.13

1.1

1.0

0.28

1.59

u/ml

—

Other diseases of pericardium

117

0.85

0.13

1.1

13.99

4.30

u/ml

—

Superficial injury of forearm

716

1.05

0.13

1.1

3.86

4.39

u/ml

0.12

298

Bicipital tendinitis

161

1.12

0.13

1.1

1.0

1.17

2.86

u/ml

—

Other osteochondropathies

413

1.07

0.13

1.0

1.1

0.91

4.16

u/ml

2.96

152

Complications of labour and delivery

559

3068

1.02

0.13

1.1

4.73

4.90

u/ml

0.04

218

1142

Calcific aortic valvular stenosis

388

0.93

0.13

1.1

3.28

2.49

u/ml

0.27

161

Calcific aortic valvular stenosis, operated

388

0.93

0.13

1.1

3.28

2.49

u/ml

0.27

161

Dental caries 3

652

3285

1.01

0.12

1.1

2.73

4.57

u/ml

2.91

282

1284

Respiratory and cardiovascular disorders specific to the perinatal period

395

1.06

0.12

1.1

13.23

6.56

u/ml

0.83

228

Psychotic depression

324

0.93

0.12

1.0

2.25

2.24

u/ml

0.00

131

Benign neoplasm of breast

609

1.05

0.12

1.1

2.36

4.08

u/ml

0.65

225

Palmar fascial fibromatosis [Dupuytren]

287

1.08

0.12

1.0

1.1

0.20

3.41

u/ml

—

112

Event of undetermined intent

404

1.07

0.12

1.0

3.63

3.97

u/ml

0.09

158

Senile cataract

194

1235

0.97

0.12

1.0

3.30

3.02

u/ml

0.10

436

Bell's palsy

559

0.95

0.12

1.0

1.1

7.07

3.50

u/ml

0.44

218

Open wound of head

297

2984

0.98

0.12

1.1

7.20

4.55

u/ml

1.14

131

1251

Hodgkin lymphoma

137

0.87

0.12

1.2

1.1

7.30

3.73

u/ml

—

Tobacco use

278

1.08

0.12

1.0

1.1

19.51

4.23

u/ml

0.39

Emotional disorders and disorders of social functioning with onset specific to childhood

738

1.04

0.11

1.1

5.17

5.73

u/ml

0.13

356

Bipolar affective disorders

155

1594

0.97

0.11

1.0

1.1

3.73

3.71

u/ml

0.00

626

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

384

0.94

0.11

1.1

2.11

2.94

u/ml

0.25

142

Benign neoplasm: Caecum

201

1.10

0.11

1.0

1.1

6.47

1.86

u/ml

—

Recurrent dislocation of patella

523

1.05

0.11

1.1

13.30

4.32

u/ml

0.67

194

Other necrotizing vasculopathies

178

0.90

0.11

1.0

1.40

3.16

u/ml

—

Myeloproliferative diseases (CML excluded)

178

0.90

0.11

1.1

1.0

1.91

2.30

u/ml

—

Graves disease, strict definition

659

0.96

0.11

1.0

1.1

4.31

3.38

u/ml

0.12

241

Normotensive glaucoma

105

1.14

0.11

1.0

1.53

0.70

u/ml

—

Benign neoplasm: Cerebral meninges

250

1.08

0.11

1.0

9.84

2.22

u/ml

—

Open wound of forearm

516

0.95

0.11

1.1

4.39

4.15

u/ml

0.04

199

Sequelae with surgical and medical care as external cause

730

1.04

0.11

1.2

1.0

3.06

3.59

u/ml

0.15

277

Other and unspecified injuries of shoulder and upper arm

134

1.12

0.11

1.3

1.0

1.81

4.74

u/ml

—

Benign neoplasm: Rectum

416

1.06

0.11

1.0

1.1

3.93

3.06

u/ml

0.11

167

Sulfasalazine

160

1559

1.03

0.10

1.1

3.16

3.20

u/ml

0.01

547

Other disorders of glucose regulation and pancreatic internal secretion

434

0.94

0.10

1.1

4.38

5.46

u/ml

0.16

185

Toxic effect of ethanol

270

0.92

0.10

1.0

8.26

4.83

u/ml

—

109

Placenta praevia

444

0.94

0.10

1.0

1.1

1.51

4.44

u/ml

0.69

155

Recurrent dislocation and subluxation of joint

556

0.95

0.10

1.1

3.08

3.77

u/ml

0.18

216

Thyrotoxicosis with diffuse goitre

851

0.96

0.10

1.0

3.80

3.71

u/ml

0.02

310

Arthrosis

476

2654

0.99

0.10

1.1

3.65

3.34

u/ml

0.16

193

949

Benign neoplasm of meninges

280

1.07

0.10

1.0

9.84

2.50

u/ml

—

102

Diabetic neuropathy

201

1.09

0.10

1.0

1.1

5.44

3.32

u/ml

0.21

Other symptoms and signs involving the urinary system

372

0.94

0.10

1.1

1.41

3.26

u/ml

1.53

147

Benign lipomatous neoplasm of other sites/unspecified

251

1.08

0.10

1.0

1.1

34.73

2.67

u/ml

—

103

Other and unspecified intracranial injuries

125

1.12

0.10

1.3

1.0

2.88

2.84

u/ml

—

Retinal vascular occlusion

183

1.09

0.10

1.1

6.09

1.28

u/ml

—

Other CVD

378

1.06

0.10

1.0

1.1

3.39

2.70

u/ml

0.12

153

Frostbite

1.14

0.10

1.4

1.0

0.14

1.60

u/ml

—

Nutritional anaemias

222

2116

1.02

0.10

1.1

3.55

4.68

u/ml

0.40

835

Gender identity disorders

135

0.89

0.10

1.2

1.1

0.55

5.88

u/ml

—

Effects of other external causes

197

0.91

0.10

1.0

0.47

3.04

u/ml

—

Disorder of thyroid, unspecified

1.11

0.10

1.0

—

0.98

—

Other juvenile arthritis

412

0.95

0.09

1.0

1.1

1.95

5.85

u/ml

2.08

174

Melanocytic naevi of trunk

697

0.96

0.09

1.1

2.01

3.30

u/ml

0.77

274

Arthropathy in Crohn disease

1.09

0.09

1.0

1.1

—

4.77

—

Benign neoplasm: Vagina

1.09

0.09

1.0

—

1.21

—

Benign neoplasm: Vagina

1.09

0.09

1.0

—

1.11

—

Gestational [pregnancy-induced] hypertension

243

2470

0.98

0.09

1.1

2.39

4.68

u/ml

2.30

923

Inflammatory bowel disease

224

2284

0.98

0.09

1.1

3.35

4.75

u/ml

0.81

924

Contusion of ankle

281

1.07

0.09

1.0

1.1

3.39

4.54

u/ml

0.21

114

Crohn disease

940

1.03

0.09

1.1

3.98

3.70

u/ml

0.07

377

Female genital prolapse

161

907

1.02

0.09

1.0

1.1

5.75

3.90

u/ml

0.38

316

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

400

3548

0.99

0.09

1.1

2.77

4.80

u/ml

1.78

137

1305

Superficial injury of head

141

1375

1.03

0.09

1.1

3.71

4.59

u/ml

0.37

574

Amenorrhoea

706

0.96

0.09

1.0

1.1

6.39

5.02

u/ml

0.10

287

Myocarditis

252

1.07

0.09

1.1

1.21

2.98

u/ml

1.26

Polycystic ovarian syndrome, consortium definition

642

3914

0.99

0.09

1.1

3.29

5.13

u/ml

1.79

235

1490

Disorder of external ear, unspecified

124

0.89

0.09

1.1

1.0

17.04

3.16

u/ml

—

Left bundle-branch block

155

0.90

0.09

1.1

1.0

3.31

2.49

u/ml

—

Crohn's disease of large intestine

360

1.06

0.09

1.0

1.1

1.13

4.39

u/ml

2.31

136

Intracranial trauma

495

3743

0.99

0.09

1.1

6.51

4.37

u/ml

0.87

218

1547

Cysts of oral region, not elsewhere classified

194

1.08

0.09

1.0

1.1

1.36

3.99

u/ml

—

Exclusion endpoint for clefts

206

0.92

0.09

1.1

4.61

6.65

u/ml

—

107

Carcinoma in situ of other and unspecified genital organs

1.09

0.09

1.2

1.0

—

2.66

—

Other neurotic disorders

165

0.91

0.09

1.4

1.1

0.51

2.77

u/ml

—

Burns and corrosions

932

1.03

0.08

1.1

8.52

4.87

u/ml

0.49

388

Animal-rider or occupant of animal-drawn vehicle injured in transport accident

107

1.12

0.08

1.1

1.0

51.48

8.11

u/ml

—

Carcinoma in situ of other and unspecified genital organs

1.05

0.08

1.2

1.0

—

2.51

—

Diabetes mellitus in pregnancy

412

2706

0.99

0.08

1.1

4.05

5.66

u/ml

0.82

155

1028

Hypermetropia

518

1.04

0.08

1.1

11.62

6.76

u/ml

0.32

244

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

113

0.88

0.08

1.0

10.05

1.55

u/ml

—

Spondylopathies (FG)

103

1002

1.03

0.08

1.1

1.59

4.18

u/ml

3.56

380

Congenital malformations of ovaries, fallopian tubes and broad ligaments

479

1.04

0.08

1.1

4.06

4.04

u/ml

0.00

178

Benign neoplasm: Pituitary gland, craniopharyngeal duct

263

1.07

0.08

1.0

1.1

1.00

3.42

u/ml

—

Psoriasis vulgaris

937

0.97

0.08

1.1

5.60

3.50

u/ml

0.48

354

Autoimmune diseases related-to ILD

631

5603

0.99

0.08

1.1

3.87

4.54

u/ml

0.46

231

2219

Fetus and newborn affected by maternal complications of pregnancy

123

0.89

0.08

1.0

1.1

14.12

8.98

u/ml

—

Inflammatory bowel disease, strict (require KELA)

176

1795

0.98

0.08

1.1

2.98

4.72

u/ml

1.12

733

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

224

1.07

0.08

1.1

2.70

1.90

u/ml

—

Other congenital malformations of limb(s)

1.14

0.08

1.1

0.17

6.60

u/ml

—

Other diseases of intestine

328

0.94

0.08

1.1

1.55

3.41

u/ml

1.11

137

Gonococcal infection

154

0.91

0.08

1.1

1.0

1.49

2.94

u/ml

—

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

251

0.93

0.08

1.1

3.68

7.54

u/ml

1.13

143

Other disorders of ear

567

3816

0.99

0.08

1.1

4.07

4.49

u/ml

0.22

233

1507

Benign neoplasm of ovary

734

0.97

0.08

1.1

2.71

3.86

u/ml

0.48

274

Other obstructed labour

519

1.04

0.08

1.1

1.21

3.58

u/ml

1.60

176

Burn and corrosion of ankle and foot

1.05

0.08

1.0

—

4.02

u/ml

—

Malignant melanoma

348

0.95

0.08

1.0

1.1

0.60

2.19

u/ml

—

131

Other assisted single delivery

166

1.09

0.08

1.0

0.79

3.01

u/ml

1.29

Pneumonia derived septicemia

127

1.10

0.08

1.0

10.97

3.93

u/ml

—

Benign neoplasm: Descending colon

127

1.10

0.08

1.1

1.0

0.41

2.75

u/ml

—

Other and unspecified coagulation defects

307

0.94

0.07

1.1

0.59

4.78

u/ml

2.78

112

Sequelae of injuries of head

254

1.06

0.07

1.1

8.43

2.81

u/ml

—

Degeneration of macula and posterior pole

638

0.97

0.07

1.0

1.03

2.30

u/ml

1.50

245

Meralgia paraesthetica

137

1.10

0.07

1.1

1.0

1.75

2.40

u/ml

—

All dysplastic lesions of the vulva

225

0.93

0.07

1.1

1.0

0.94

2.66

u/ml

—

Family history of certain disabilities and chronic diseases leading to disablement

398

0.95

0.07

1.1

9.13

4.52

u/ml

0.50

147

Persistent mood disorders

119

1163

1.02

0.07

1.1

8.30

3.04

u/ml

0.79

451

IBD patients in KELA-register

176

1792

0.98

0.07

1.1

2.98

4.79

u/ml

1.19

729

Dental caries 3 and operation codes, only avohilmo

315

1561

1.01

0.07

1.1

2.88

3.93

u/ml

0.76

118

647

Cluster headache, wide,, including avohilmo

343

1.05

0.07

1.1

5.34

3.47

u/ml

0.20

127

Other metabolic disorders

803

0.97

0.07

1.2

1.1

5.12

3.26

u/ml

0.41

301

Carcinoma in situ of cervix uteri

833

0.97

0.07

1.0

1.1

6.20

4.51

u/ml

0.18

320

Diverticular disease of intestine

302

2032

0.99

0.07

1.0

1.1

1.61

3.65

u/ml

3.21

107

730

Benign neoplasm: Adrenal gland

196

1.07

0.07

1.0

1.1

2.07

2.06

u/ml

—

Other diseases of pleura

128

1110

1.02

0.07

1.1

1.0

5.65

4.10

u/ml

0.41

433

Congenital deformities of hip

196

1.07

0.07

1.1

16.25

9.46

u/ml

0.41

Other congenital malformations of face and neck

204

0.93

0.07

1.1

1.0

1.11

5.07

u/ml

—

Disorders of psychological development

146

1379

0.98

0.07

1.1

5.56

5.70

u/ml

0.03

669

Other specified and unspecified disorders of eye and adnexa

157

1.08

0.07

1.0

11.92

3.82

u/ml

—

Obstructed labour due to malposition and malpresentation of fetus

239

2219

1.01

0.07

1.1

3.17

4.30

u/ml

0.59

781

Hallux valgus (acquired)

165

1216

0.98

0.07

1.1

3.74

3.39

u/ml

0.08

390

Orchitis and epididymitis

326

0.95

0.07

1.0

1.1

0.43

3.81

u/ml

5.29

159

Short stature, not elsewhere classified

368

1.05

0.07

1.1

3.22

8.47

u/ml

2.10

206

Additional codes for the location of defect, injury or illness

265

1.06

0.07

1.1

1.0

1.53

5.19

u/ml

—

102

Enteropathic arthropathies

128

1.10

0.06

1.1

1.0

—

3.64

u/ml

—

Enterocolitis due to Clostridium difficile

285

0.95

0.06

1.1

1.00

3.03

u/ml

—

107

Specific development disorders of scholastic skills

545

1.03

0.06

1.1

4.57

5.74

u/ml

0.25

260

Female infertility, associated with anovulation

878

1.03

0.06

1.0

1.1

9.13

4.95

u/ml

0.40

344

Nerve, nerve root and plexus disorders

751

4682

1.01

0.06

1.1

3.50

4.32

u/ml

0.66

286

1799

Injuries to the shoulder and upper arm

535

4523

0.99

0.06

1.1

3.39

4.54

u/ml

1.05

221

1819

Oral lichen ruber planus wide, hypothyreosis or thyroxin

138

1.09

0.06

1.1

1.0

2.97

2.78

u/ml

—

Retinal vascular disorders

187

1.07

0.06

1.1

6.09

1.29

u/ml

—

Congenital malformations of uterus and cervix

197

1.07

0.06

1.0

1.1

1.41

5.03

u/ml

—

Diplopia

542

1.03

0.06

1.1

3.88

3.54

u/ml

0.06

201

Burn and corrosion of trunk

148

1.08

0.06

1.0

1.1

16.33

5.58

u/ml

—

Vitamin deficiency

197

1.07

0.06

1.0

0.74

3.25

u/ml

—

Vitamin deficiency, wide

197

1.07

0.06

1.0

0.73

3.25

u/ml

—

Other CVD (FINNGEN)

240

1.05

0.06

1.0

3.69

2.92

u/ml

0.12

Burn and corrosion of shoulder and upper limb, except wrist and hand

109

1.10

0.06

1.0

25.97

4.53

u/ml

—

Atrophic disorders of skin

679

0.97

0.06

1.1

3.99

3.56

u/ml

0.08

256

Viral haemorrhagic fevers, not elsewhere classified/unspecified

345

0.96

0.06

1.1

1.0

3.76

2.62

u/ml

0.25

131

Motorcycle rider injured in noncollision transport accidents

223

0.94

0.06

1.0

1.1

3.69

5.29

u/ml

0.28

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

612

1.03

0.06

1.1

2.84

3.87

u/ml

0.33

233

Urethral stricture

119

1.09

0.06

1.1

1.65

2.31

u/ml

—

Plantar fascial fibromatosis

456

0.96

0.05

1.0

1.1

1.02

3.20

u/ml

2.40

154

Manic episode

182

0.93

0.05

1.0

11.44

3.72

u/ml

—

Degenerative macular diseases

178

1.07

0.05

1.0

1.22

1.99

u/ml

—

Endocrine, nutritional and metabolic diseases

917

4693

0.99

0.05

1.1

4.25

5.06

u/ml

0.65

373

1929

Isolated proteinuria

129

1.09

0.05

1.0

1.1

0.44

3.37

u/ml

—

Abnormal spermatozoa

188

1.06

0.05

1.1

4.01

1.91

u/ml

—

Other specified/unspecified dorsopathies

141

0.92

0.05

1.0

3.27

1.95

u/ml

—

Disorders of calcium metabolism

202

0.94

0.05

1.1

1.0

1.27

3.70

u/ml

—

Benign neoplasm: salivary glands, exclude unknown (D119)

267

1.05

0.05

1.0

1.1

4.41

3.17

u/ml

—

101

Visual field defects

277

1.05

0.05

1.0

12.86

2.44

u/ml

—

Systemic atrophies primarily affecting the central nervous system

100

1.10

0.05

1.1

1.0

3.97

6.13

u/ml

—

Single delivery by forceps and vacuum extractor

204

1226

1.01

0.05

1.1

6.04

5.53

u/ml

0.04

486

Bacterial, viral and other infectious agents

564

1.03

0.05

1.1

4.01

4.48

u/ml

0.11

223

Scabies

287

1.05

0.05

1.1

3.78

4.25

u/ml

0.06

114

Other specified/unspecified arthritis

156

1583

0.99

0.05

1.1

5.55

4.09

u/ml

0.39

590

AV-block

312

0.96

0.05

1.1

0.74

2.25

u/ml

2.12

122

Biomechanical lesions, not elsewhere classified

159

1.07

0.05

1.1

1.0

3.53

3.40

u/ml

—

Hypertrophic cardiomyopathy

110

0.91

0.05

1.0

1.1

4.31

4.33

u/ml

—

Other fall from one level to another

163

1652

0.99

0.05

1.1

3.08

4.82

u/ml

1.00

734

All dysplastic lesions of the cervix uteri

252

2541

0.99

0.05

1.1

3.04

4.81

u/ml

0.74

954

Bacterial pneumoniae

200

1749

1.01

0.05

1.1

6.46

4.52

u/ml

0.37

107

680

Influenza and pneumonia

891

5827

1.01

0.05

1.1

5.23

4.52

u/ml

0.41

422

2310

Dental caries 1 and operation codes, only avohilmo

254

1263

1.01

0.04

1.0

1.1

3.98

3.64

u/ml

0.12

514

Benign neoplasm: Cerebral meninges

258

1.05

0.04

1.0

1.1

9.84

2.52

u/ml

—

Premature separation of placenta [abruptio placentae]

189

1.06

0.04

1.0

1.1

2.20

2.65

u/ml

—

Lactose intolerance

189

1.06

0.04

1.1

1.13

5.00

u/ml

—

Gastric ulcer

357

1.04

0.04

1.1

3.73

3.45

u/ml

0.04

133

Adjustment and management of implanted device

367

1.04

0.04

1.1

3.67

2.99

u/ml

0.11

146

Fibrosis and cirrhosis of liver

199

1.06

0.04

1.0

1.62

2.63

u/ml

0.27

Anterior Iridocyclitis

105

1068

0.98

0.04

1.0

1.1

2.59

3.69

u/ml

0.71

406

Cluster headache, strict

211

0.95

0.04

1.1

6.85

3.55

u/ml

0.24

Ankylosing spondylitis, ICD10

516

1.03

0.04

1.0

1.1

1.93

2.90

u/ml

0.60

190

Spondyloarthritis

109

1072

1.02

0.04

1.1

3.39

3.83

u/ml

0.13

414

Opening and dilatation of root channel of tooth

413

0.97

0.04

1.2

1.1

2.01

3.78

u/ml

0.84

156

Exclusions for E4_PCOS_BROAD

122

1201

1.02

0.04

1.1

1.73

4.50

u/ml

4.07

512

Erosion and ectropion of cervix uteri

1.10

0.04

1.1

0.31

3.17

u/ml

—

Diabetic retinopathy

526

1.02

0.04

1.1

5.39

3.96

u/ml

0.32

213

Lactose intolerance, other/unspecified

160

0.94

0.04

1.0

1.17

2.97

u/ml

—

Early lumbar disc prolapse operation

996

0.98

0.04

1.0

1.1

5.08

3.45

u/ml

0.38

386

Abnormal blood-pressure reading, without diagnosis

180

1.06

0.04

1.0

1.12

3.72

u/ml

—

Other obstetric trauma

513

0.97

0.04

1.0

1.1

3.85

3.47

u/ml

0.06

177

Benign neoplasm of meninges

289

1.04

0.04

1.0

1.1

9.84

3.17

u/ml

—

110

Other disorders of skin and subcutaneous tissue, not elsewhere classified

537

1.02

0.04

1.1

2.88

3.42

u/ml

0.08

206

Liveborn infants according to place of birth

139

1.07

0.04

1.0

1.1

2.54

9.68

u/ml

—

Dental pulpitis 2

528

2688

1.01

0.03

1.0

1.1

3.51

4.41

u/ml

0.66

216

1034

Hodgkin lymphoma, hilmo

129

0.93

0.03

1.2

1.1

7.30

3.98

u/ml

—

Carrier of infectious disease

131

1.07

0.03

1.1

1.0

0.80

3.68

u/ml

—

Pregnancy examination and test

225

1417

0.99

0.03

1.1

5.07

5.97

u/ml

0.22

547

Dislocation, sprain and strain of joints and ligaments of elbow

482

0.97

0.03

1.1

4.02

5.77

u/ml

0.42

202

Other orthopaedic follow-up care

230

1.04

0.03

1.0

4.47

2.97

u/ml

0.18

Other condition

826

1.02

0.03

1.1

6.89

4.07

u/ml

0.70

320

Other and unspecified mood [affective] disorders

673

0.98

0.03

1.0

1.1

2.75

4.07

u/ml

0.71

268

Salpingitis and oophoritis

896

1.02

0.03

1.1

1.0

4.14

4.13

u/ml

0.00

309

Other or unspecified ileus, impaction or obstruction

488

1.02

0.03

1.0

1.1

2.85

3.52

u/ml

0.12

194

Anaemias

266

1782

0.99

0.03

1.1

3.08

5.73

u/ml

1.87

113

757

Benign neoplasm: Stomach

270

1.04

0.03

1.1

5.73

2.57

u/ml

0.37

108

Benign neoplasms

843

4752

1.00

0.03

1.1

4.49

4.91

u/ml

0.14

321

1960

ILD medications: immunosuppressive drugs

402

3875

0.99

0.03

1.0

1.1

5.54

3.85

u/ml

0.76

162

1438

Eating disorders

119

1175

1.01

0.03

1.1

5.01

5.31

u/ml

0.05

510

Benign neoplasm of other and unspecified endocrine glands

529

1.02

0.03

1.0

1.1

1.35

2.92

u/ml

1.29

206

Other diseases of biliary tract

219

0.96

0.03

1.0

1.1

2.66

3.25

u/ml

—

Gestational diabetes (for exclusion)

441

3135

1.00

0.02

1.1

2.82

5.34

u/ml

2.55

156

1186

Diseases of the myoneural junction and muscle

410

0.98

0.02

1.1

3.82

2.81

u/ml

0.15

167

In situ neoplasms

149

1476

1.01

0.02

1.0

1.1

4.63

4.19

u/ml

0.07

558

Superficial injury of neck

138

0.94

0.02

1.2

1.1

0.53

5.05

u/ml

—

Need for other prophylactic measures

269

0.97

0.02

1.1

0.92

4.28

u/ml

2.18

118

Unspecified abortion

279

0.97

0.02

1.0

1.1

1.43

4.08

u/ml

—

Traumatic amputation of wrist and hand

142

1.06

0.02

1.0

1.1

1.25

2.21

u/ml

—

Fracture of foot, except ankle

174

1754

0.99

0.02

1.1

4.08

4.24

u/ml

0.04

703

Unspecified lump in breast

759

1.01

0.02

1.1

1.0

3.52

4.10

u/ml

0.08

270

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

309

0.97

0.02

1.1

1.33

2.64

u/ml

0.91

116

Open wound of lower leg

771

0.99

0.02

1.1

4.41

3.82

u/ml

0.09

316

Disorders of continuity of bone

540

0.98

0.02

1.1

6.69

3.93

u/ml

0.34

197

Memory loss

178

0.95

0.02

1.0

1.16

2.05

u/ml

—

Bicuspidal aortic valve syndrome

182

1.04

0.02

1.0

1.1

1.14

4.82

u/ml

—

Brachial plexus disorders

650

1.02

0.02

1.0

1.1

4.48

3.46

u/ml

0.14

242

Other diseases of blood and blood-forming organs, wide

100

989

1.01

0.02

1.1

8.38

3.39

u/ml

0.78

395

Maternal care for known or suspected disproportion

419

0.98

0.02

1.0

1.1

9.86

2.68

u/ml

0.48

134

Benign neoplasm of ovary

700

1.01

0.02

1.1

2.71

4.24

u/ml

0.67

244

Paralytic strabismus

218

0.96

0.02

1.0

1.1

0.93

3.03

u/ml

—

Burn and corrosion of wrist and hand

262

1.03

0.02

1.1

3.87

4.42

u/ml

0.09

111

Malignant neoplasm of colon

262

1.03

0.02

1.0

5.69

1.65

u/ml

—

Fungal Sepsis

107

0.93

0.02

1.4

1.0

1.68

3.17

u/ml

—

Respiratory distress of newborn

276

0.97

0.01

1.1

13.15

7.26

u/ml

0.47

167

Injury of muscle and tendon at ankle and foot level

133

1.05

0.01

1.0

0.52

2.70

u/ml

—

Pneumococcal septicemia

137

0.95

0.01

1.0

10.97

4.78

u/ml

—

Eating disorder

110

1089

1.01

0.01

1.1

3.91

5.73

u/ml

0.34

464

Bacterial meningitis

153

1.05

0.01

1.1

1.0

5.89

2.48

u/ml

—

Herpesviral keratitis and keratoconjunctivitis

163

1.04

0.01

1.1

1.0

14.10

2.58

u/ml

—

Torsion of ovary, ovarian pedicle and fallopian tube

167

0.96

0.01

1.1

0.38

3.92

u/ml

—

Congenital deformities of feet

203

1.04

0.01

1.0

4.11

6.46

u/ml

0.56

Other eating disorders

622

1.01

0.01

1.1

2.24

5.99

u/ml

1.17

259

Maternal care for cervical incompetence

223

1.03

0.01

1.0

1.40

4.06

u/ml

—

Polycystic ovarian syndrome

632

1.01

0.01

1.0

1.1

1.51

6.03

u/ml

2.19

245

Impacted maxillary molar

668

0.99

0.01

1.1

2.08

5.02

u/ml

1.86

273

Diseases of liver

150

1509

0.99

0.01

1.1

2.37

3.83

u/ml

0.89

579

Optic neuritis

303

1.02

0.01

1.0

1.49

4.18

u/ml

1.30

111

Hypokalaemia

367

0.98

0.01

1.2

1.1

2.56

3.03

u/ml

0.10

142

Lack of expected normal physiological development

316

1.02

0.01

1.1

14.14

7.59

u/ml

0.54

183

Seronegative rheumatoid arthritis

453

1.02

0.01

1.1

1.12

2.76

u/ml

1.49

153

Dermatophytosis

473

1.01

0.01

1.0

1.1

3.10

2.86

u/ml

0.08

199

Other Crohn's disease

527

0.99

0.01

1.1

3.18

4.53

u/ml

0.32

201

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

537

0.99

0.01

1.1

1.0

5.67

3.61

u/ml

0.16

200

Dental pulpitis 2, only avohilmo

533

2722

1.00

0.01

1.0

1.1

3.39

4.48

u/ml

0.87

217

1046

Coxarthrosis, primary, with hip surgery

903

1.01

0.01

1.1

1.0

1.34

2.93

u/ml

1.91

327

Congenital malformations of genital organs

977

1.01

0.01

1.0

1.1

3.41

4.07

u/ml

0.20

427

Congenital malformations of the musculoskeletal system, not elsewhere classified

116

0.95

0.00

1.0

1.1

4.23

7.11

u/ml

—

Haemolytic anaemias

136

0.96

0.00

1.2

1.1

2.78

8.72

u/ml

—

Benign neoplasm: Descending colon

146

0.96

0.00

1.1

0.41

2.62

u/ml

—

Other disorders of nervous system

204

1.03

0.00

1.1

1.0

1.97

2.62

u/ml

—

Cluster headache, strict, including avohilmo

334

1.02

0.00

1.1

5.34

3.60

u/ml

0.19

122

Other disorders of the genitourinary system

344

1.02

0.00

1.1

1.0

3.68

2.66

u/ml

0.19

120

Motor disorders

265

0.98

0.00

1.2

1.1

3.67

8.92

u/ml

1.36

155

Venous thromboembolism

205

1996

1.00

0.00

1.1

3.91

3.42

u/ml

0.15

760

Superficial injury of shoulder and upper arm

624

1.01

0.00

1.1

6.20

3.87

u/ml

0.39

239

Burns and corrosions of external body surface, specified by site

714

1.01

0.00

1.0

1.1

11.29

4.92

u/ml

0.66

289

Postprocedural endocrine and metabolic disorders, not elsewhere classified

734

1.01

0.00

1.1

5.14

3.18

u/ml

0.39

268

Ovarian dysfunction

794

1.01

0.00

1.1

2.51

5.34

u/ml

0.92

309

Scissor bite

333

1.02

0.00

1.1

5.98

5.52

u/ml

0.05

170

Wet age-related macular degeneration

114

1.03

0.00

1.0

0.32

0.68

u/ml

—

Cardiodefibrillation

737

1.00

0.00

1.0

1.68

2.98

u/ml

0.92

290

Other and unspecified vascular occlusions

138

1.01

0.00

1.1

7.57

1.45

u/ml

—

Vitamin B12 deficiency anaemia

221

1.00

0.00

1.0

0.81

2.93

u/ml

—

Otosclerosis

245

1.02

0.00

1.1

0.58

2.36

u/ml

—

Other obstructive and reflux uropathy

265

0.98

0.00

1.1

1.0

17.81

4.73

u/ml

0.70

Benign leiomyoma with endometriosis

598

1.00

0.00

1.1

4.41

3.32

u/ml

0.17

204

Mixed connective tissue disease

295

0.98

0.00

1.1

5.99

3.12

u/ml

0.22

103

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

191

0.99

0.00

1.1

2.69

3.75

u/ml

—

Cardiomyopathy, other and unspecified

229

1.00

0.00

1.1

1.0

6.31

2.51

u/ml

—

Benign neoplasm: Parotid gland

261

1.00

0.00

1.0

1.1

4.88

3.21

u/ml

—

105

Diabetic nephropathy

321

1.01

0.00

1.1

9.07

2.49

u/ml

0.68

130

Melanocytic naevi of trunk

665

1.01

0.00

1.1

2.01

3.38

u/ml

0.81

253

Congenital malformations of eye, ear, face and neck

606

1.01

0.00

1.1

4.47

5.63

u/ml

0.22

264

Behavioural disorders, excluding more controls

202

0.99

0.00

1.2

1.0

8.89

5.41

u/ml

—

Iridocyclitis

118

1175

1.00

0.00

1.1

4.07

3.84

u/ml

0.05

444

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

156

1.02

0.00

1.0

1.1

0.49

1.98

u/ml

—

Implicit fungal Sepsis

1.04

0.00

1.4

1.0

1.68

3.49

u/ml

—

Cytomegaloviral disease

1.03

0.00

1.0

1.23

3.67

u/ml

—

Lesion of lateral popliteal nerve

174

0.98

0.00

1.1

1.0

10.45

2.69

u/ml

—

Hyperkinetic disorders (excl. ADHD)

227

1.00

0.00

1.1

4.14

6.97

u/ml

0.85

119

Benign neoplasm: Adrenal gland

214

0.98

0.00

1.0

1.1

2.07

2.27

u/ml

—

Palatinal maxillary operation

112

0.98

0.00

1.0

1.1

13.21

6.05

u/ml

—

Exclusion endpoint for supernumerary teeth

118

1.02

0.00

1.3

1.1

1.05

3.34

u/ml

—

Artificial joint operation, meniscal resection

476

3167

1.00

0.00

1.1

3.21

3.66

u/ml

0.25

195

1177

Abscess of Bartholin gland

188

1.01

0.00

1.1

1.0

1.87

2.94

u/ml

—

Ulcerative colitis, NAS

934

1.00

0.00

1.1

1.39

3.21

u/ml

2.62

373

Unspecified haematuria

140

1202

1.00

0.00

1.1

3.93

3.84

u/ml

0.01

484

Visual impairment including blindness (binocular or monocular)

233

0.99

0.00

1.0

7.40

5.24

u/ml

0.21

Ulcerative proctitis

402

0.99

0.00

1.1

3.02

4.00

u/ml

0.26

144

Toxic effects of substances chiefly nonmedicinal as to source

743

1.00

0.00

1.0

1.1

7.08

4.10

u/ml

0.62

303

Preparatory care for dialysis

119

1.01

0.00

1.0

1.1

1.71

2.30

u/ml

—

Mandibular prognathia

121

0.99

0.00

1.3

1.1

2.38

6.33

u/ml

—

Benign neoplasm: Sigmoid colon

435

1.01

0.00

1.0

1.1

1.90

2.86

u/ml

—

173

Perioral dermatitis

139

1.01

0.00

1.1

1.0

11.33

3.60

u/ml

—

Ulcerative enterocolitis

181

0.99

0.00

1.1

4.18

3.43

u/ml

—

Lung cancer and mesothelioma

159

1.02

0.00

1.1

1.0

12.57

1.15

u/ml

—

Cluster headache, wide

221

1.00

0.00

1.1

6.85

3.35

u/ml

0.26

Contact with sharp glass

279

1.00

0.00

1.0

1.40

4.37

u/ml

—

110

Benign neoplasm of major salivary glands

316

1.01

0.00

1.0

1.1

3.83

3.07

u/ml

0.13

124

Sensorineural hearing loss

318

2228

1.00

0.00

1.1

3.46

3.84

u/ml

0.15

126

846

Squamous cell neoplasms and carcinomas of the skin

101

0.99

0.00

1.0

10.05

1.54

u/ml

—

Acute and subacute iridocyclitis

102

1021

1.00

0.00

1.0

1.1

2.63

3.47

u/ml

0.48

376

Impotence

138

1.01

0.00

1.0

1.1

1.97

2.54

u/ml

—

Injury of nerves at wrist and hand level

197

1.02

0.00

1.0

1.1

1.01

2.62

u/ml

—

Emotional disorders starting during childhood or adolescence

713

1.00

0.00

1.2

1.1

5.25

5.87

u/ml

0.14

336

Problems related to social environment

132

0.98

0.00

1.1

1.57

4.71

u/ml

—

Ulcerative ileocolitis

257

1.01

0.00

1.1

2.30

3.07

u/ml

—

Carcinoma in situ of cervix uteri

807

1.00

0.00

1.0

1.1

6.20

4.57

u/ml

0.18

309

Hypoglycaemia, other or unspecified

355

0.99

0.00

1.2

1.1

5.15

4.61

u/ml

0.07

156

Golimumab

235

0.98

0.00

1.0

1.1

1.70

3.76

u/ml

0.94

Extreme obesity with alveolar hypoventilation

135

0.96

0.00

1.0

0.43

2.21

u/ml

—

Cyst of Bartholin Gland

245

0.98

0.00

1.2

1.0

2.60

2.95

u/ml

—

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

114

0.96

0.00

1.0

0.12

2.37

u/ml

—

Congenital malformations of pulmonary and tricuspid valves

106

1.04

0.00

1.0

1.1

8.76

9.00

u/ml

—

Other inflammatory liver diseases

272

0.99

0.00

1.0

1.1

2.03

2.94

u/ml

—

106

Specific developmental disorder of motor function

252

1.01

0.00

1.2

1.1

3.67

8.97

u/ml

1.34

145

Actinomycosis

0.00

0.0

1.0

—

Tympanosclerosis

0.00

0.0

1.0

—

Multiple superficial injuries of ankle and foot

0.00

0.0

1.0

—

Assault by sharp object

110

1.00

0.00

1.0

1.1

7.13

1.82

u/ml

—

Malignant neoplasm of other and unspecified major salivary glands

0.00

0.0

1.0

—

Vascular dementia (mixed)

0.00

0.0

1.0

—

Other salmonella infections

150

1.00

0.00

1.0

7.76

3.29

u/ml

—

Use of rivastigmine

0.94

0.00

1.2

1.0

—

0.57

—

Disorder of amino-acid metabolism, other/unspecified

0.00

0.0

1.0

—

2.34

—

Other disorders of thyroid

1.02

0.00

1.0

—

0.97

—

Nephropathy induced by other drugs, medicaments and biological substances

0.00

0.0

1.0

—

Other and unspecified iridocyclitis

200

1.00

0.00

1.1

1.0

12.03

2.43

u/ml

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Dog dander IgE Ab [Units/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS